SK11082000A3 - Substituované oxoazaheterocyklické inhibítory faktora xa, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents

Substituované oxoazaheterocyklické inhibítory faktora xa, farmaceutický prostriedok s ich obsahom a ich použitie Download PDF

Info

Publication number: SK11082000A3
Authority: SK; Slovakia
Prior art keywords: ylmethyl; piperazin; chloro; amino; aminoquinazolin
Prior art date: 1998-01-27

Application number

SK1108-2000A

Other languages

English (en)

Slovak (sk)

Inventor

William R. Ewing

Michael R. Becker

Yong Mi Choi-Sledeski

Heinz W. Pauls

Wei He

Stephen M. Condon

Roderick S. Davis

Barbara A. Hanney

Alfred P. Spada

Christopher J. Burns

John Z. Jiang

Aiwen Li

Michael R. Myers

Wan F. Lau

Gregory B. Poli

Original Assignee

Aventis Pharmaceuticals Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-27

Filing date

1999-01-27

Publication date

2001-01-18

1999-01-27 Application filed by Aventis Pharmaceuticals Products Inc. filed Critical Aventis Pharmaceuticals Products Inc.

2001-01-18 Publication of SK11082000A3 publication Critical patent/SK11082000A3/sk

Links

239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 6
229940123583 Factor Xa inhibitor Drugs 0.000 title description 5
150000001875 compounds Chemical class 0.000 claims abstract description 270
238000000034 method Methods 0.000 claims abstract description 43
108010074860 Factor Xa Proteins 0.000 claims abstract description 18
230000002401 inhibitory effect Effects 0.000 claims abstract description 6
-1 4-tert-butoxycarbonylaminopyridin-3-yl Chemical group 0.000 claims description 1173
239000000203 mixture Substances 0.000 claims description 87
IWELDVXSEVIIGI-UHFFFAOYSA-N piperazin-2-one Chemical compound O=C1CNCCN1 IWELDVXSEVIIGI-UHFFFAOYSA-N 0.000 claims description 73
125000001072 heteroaryl group Chemical group 0.000 claims description 70
229910052739 hydrogen Inorganic materials 0.000 claims description 60
239000001257 hydrogen Substances 0.000 claims description 58
229910052757 nitrogen Inorganic materials 0.000 claims description 56
229910052717 sulfur Inorganic materials 0.000 claims description 53
150000003839 salts Chemical class 0.000 claims description 51
125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 claims description 48
229910052760 oxygen Inorganic materials 0.000 claims description 48
125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 47
239000002253 acid Substances 0.000 claims description 43
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 41
125000000623 heterocyclic group Chemical group 0.000 claims description 37
125000000547 substituted alkyl group Chemical group 0.000 claims description 37
150000004702 methyl esters Chemical class 0.000 claims description 36
125000003710 aryl alkyl group Chemical group 0.000 claims description 35
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 35
125000004433 nitrogen atom Chemical group N* 0.000 claims description 31
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 29
125000004446 heteroarylalkyl group Chemical group 0.000 claims description 28
150000001204 N-oxides Chemical class 0.000 claims description 27
125000003545 alkoxy group Chemical group 0.000 claims description 27
125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 27
125000003107 substituted aryl group Chemical group 0.000 claims description 27
150000002431 hydrogen Chemical class 0.000 claims description 26
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 25
239000012453 solvate Substances 0.000 claims description 24
125000004450 alkenylene group Chemical group 0.000 claims description 20
229940002612 prodrug Drugs 0.000 claims description 20
239000000651 prodrug Substances 0.000 claims description 20
125000006514 pyridin-2-ylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 claims description 19
150000001408 amides Chemical class 0.000 claims description 18
125000000392 cycloalkenyl group Chemical group 0.000 claims description 18
230000015572 biosynthetic process Effects 0.000 claims description 17
PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical compound NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 claims description 15
125000004432 carbon atom Chemical group C* 0.000 claims description 15
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 14
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 14
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 13
125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 12
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 12
KJCIMSSFGUGTGA-UHFFFAOYSA-N 1-methylpiperazin-2-one Chemical compound CN1CCNCC1=O KJCIMSSFGUGTGA-UHFFFAOYSA-N 0.000 claims description 11
125000002947 alkylene group Chemical group 0.000 claims description 11
125000004350 aryl cycloalkyl group Chemical group 0.000 claims description 11
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 11
125000005349 heteroarylcycloalkyl group Chemical group 0.000 claims description 11
125000005156 substituted alkylene group Chemical group 0.000 claims description 11
QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 claims description 10
APAMKXUATGRDBB-UHFFFAOYSA-N 6-chloro-1-benzothiophene Chemical compound ClC1=CC=C2C=CSC2=C1 APAMKXUATGRDBB-UHFFFAOYSA-N 0.000 claims description 10
125000004419 alkynylene group Chemical group 0.000 claims description 10
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 9
108090000190 Thrombin Proteins 0.000 claims description 8
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
125000005346 substituted cycloalkyl group Chemical group 0.000 claims description 8
229960004072 thrombin Drugs 0.000 claims description 8
GSFNQBFZFXUTBN-UHFFFAOYSA-N 2-chlorothiophene Chemical compound ClC1=CC=CS1 GSFNQBFZFXUTBN-UHFFFAOYSA-N 0.000 claims description 7
230000000694 effects Effects 0.000 claims description 7
125000004494 ethyl ester group Chemical group 0.000 claims description 7
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 7
125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims description 7
125000004076 pyridyl group Chemical group 0.000 claims description 7
WDEJJPNCFNYSGS-RUINGEJQSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-6-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)C(C)C1)=O)COC)C(=O)COC1=CC=C(Cl)S1 WDEJJPNCFNYSGS-RUINGEJQSA-N 0.000 claims description 6
FSUYPAIFVPOMGN-HNNXBMFYSA-N (3s)-1-[(4-aminoquinolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]-3-methylpiperazin-2-one Chemical compound NC1=CC=NC2=CC(CN3CCN(CC=4NC5=CC=C(Cl)C=C5C=4)[C@H](C3=O)C)=CC=C21 FSUYPAIFVPOMGN-HNNXBMFYSA-N 0.000 claims description 6
RHESQXOYNCWQQP-FQEVSTJZSA-N (3s)-4-[3-(6-aminopyridin-3-yl)prop-2-enoyl]-1-[(4-aminoquinazolin-7-yl)methyl]-3-propylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCC)C(=O)C=CC1=CC=C(N)N=C1 RHESQXOYNCWQQP-FQEVSTJZSA-N 0.000 claims description 6
KRZJRNZICWNMOA-GXSJLCMTSA-N (3s,4r)-4,8-dihydroxy-3-methoxy-3,4-dihydro-2h-naphthalen-1-one Chemical compound C1=CC=C2[C@@H](O)[C@@H](OC)CC(=O)C2=C1O KRZJRNZICWNMOA-GXSJLCMTSA-N 0.000 claims description 6
YEIRMODVXOUDEP-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]-6-oxopiperazine-2-carboxylic acid Chemical compound ClC1=CC=C2NC(CN3CC(N(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)C(O)=O)=CC2=C1 YEIRMODVXOUDEP-UHFFFAOYSA-N 0.000 claims description 6
KTOJLHCKDVXMRK-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)Cl)=CC2=C1 KTOJLHCKDVXMRK-UHFFFAOYSA-N 0.000 claims description 6
JLLYLQLDYORLBB-UHFFFAOYSA-N 5-bromo-n-methylthiophene-2-sulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(Br)S1 JLLYLQLDYORLBB-UHFFFAOYSA-N 0.000 claims description 6
208000007536 Thrombosis Diseases 0.000 claims description 6
NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 6
239000003146 anticoagulant agent Substances 0.000 claims description 6
JSSXHAMIXJGYCS-UHFFFAOYSA-N piperazin-4-ium-2-carboxylate Chemical compound OC(=O)C1CNCCN1 JSSXHAMIXJGYCS-UHFFFAOYSA-N 0.000 claims description 6
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 6
125000004588 thienopyridyl group Chemical group S1C(=CC2=C1C=CC=N2)* 0.000 claims description 6
230000001052 transient effect Effects 0.000 claims description 6
XUKLJATTXIDZOK-FQEVSTJZSA-N (3s)-1-[(4-aminoquinolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-ethylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CC=C(N)C3=CC=2)CC1)=O)CC)C(=O)C=CC1=CC=C(Cl)S1 XUKLJATTXIDZOK-FQEVSTJZSA-N 0.000 claims description 5
IULVBFFYXSEISI-OAHLLOKOSA-N (6r)-4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]-6-(hydroxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C([C@@H](N(C(=O)C1)CC=2NC3=CC=NC=C3C=2)CO)N1S(=O)(=O)C=CC1=CC=C(Cl)S1 IULVBFFYXSEISI-OAHLLOKOSA-N 0.000 claims description 5
PLWVUIRWJVKSSD-UHFFFAOYSA-N 4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound S1C(Cl)=CC=C1C=CS(=O)(=O)N1CC(=O)N(CC=2NC3=CC=NC=C3C=2)CC1 PLWVUIRWJVKSSD-UHFFFAOYSA-N 0.000 claims description 5
210000004351 coronary vessel Anatomy 0.000 claims description 5
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
238000002560 therapeutic procedure Methods 0.000 claims description 5
XFIAZOWJEYRZFE-KRWDZBQOSA-N (3s)-1-[(1-aminoisoquinolin-6-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3C=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC1=CC=C(Cl)S1 XFIAZOWJEYRZFE-KRWDZBQOSA-N 0.000 claims description 4
YNNCDVMRFAUEHB-HNNXBMFYSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(7-chloroisoquinolin-3-yl)methyl]-3-methylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4N=CC5=CC(Cl)=CC=C5C=4)[C@H](C3=O)C)=CC=C21 YNNCDVMRFAUEHB-HNNXBMFYSA-N 0.000 claims description 4
ZFBLUIGZEYFDJI-KRWDZBQOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-(ethoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COCC)C(=O)COC1=CC=C(Cl)S1 ZFBLUIGZEYFDJI-KRWDZBQOSA-N 0.000 claims description 4
MXYZABNETCECPJ-INIZCTEOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC1=CC=C(Cl)S1 MXYZABNETCECPJ-INIZCTEOSA-N 0.000 claims description 4
GDOHFABQTHNBJK-RUINGEJQSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-ethyl-6-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)C(C)C1)=O)CC)C(=O)COC1=CC=C(Cl)S1 GDOHFABQTHNBJK-RUINGEJQSA-N 0.000 claims description 4
YQOUBCQHPDMPDJ-UWBLVGDVSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-3-yl)oxyacetyl]-3-(methoxymethyl)-6-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)C(C)C1)=O)COC)C(=O)COC1=CSC(Cl)=C1 YQOUBCQHPDMPDJ-UWBLVGDVSA-N 0.000 claims description 4
ULVVVFNFXFHWSH-KRWDZBQOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-3-yl)oxyacetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC1=CSC(Cl)=C1 ULVVVFNFXFHWSH-KRWDZBQOSA-N 0.000 claims description 4
BYRCHTQDKADKBB-ZDUSSCGKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-chlorothiophen-2-yl)prop-2-enoyl]-3-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)C)C(=O)C=CC1=CC(Cl)=CS1 BYRCHTQDKADKBB-ZDUSSCGKSA-N 0.000 claims description 4
YQEMHDLGQQZCKI-SFHVURJKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-bromothiophen-2-yl)prop-2-enoyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)C=CC1=CC=C(Br)S1 YQEMHDLGQQZCKI-SFHVURJKSA-N 0.000 claims description 4
DPVOUFWSGIVGEM-PKDNWHCCSA-N (3s)-1-[(4-aminoquinolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-6-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CC=C(N)C3=CC=2)C(C)C1)=O)COC)C(=O)COC1=CC=C(Cl)S1 DPVOUFWSGIVGEM-PKDNWHCCSA-N 0.000 claims description 4
PIRLGEDSPILCDG-FXMQYSIJSA-N (3s)-1-[(4-aminoquinolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-ethyl-6-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CC=C(N)C3=CC=2)C(C)C1)=O)CC)C(=O)C=CC1=CC=C(Cl)S1 PIRLGEDSPILCDG-FXMQYSIJSA-N 0.000 claims description 4
XWVIEMGPBIPVCN-NRFANRHFSA-N (3s)-4-[2-(5-chlorothiophen-3-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxypyridin-3-yl)phenyl]methyl]piperazin-2-one Chemical compound C=1SC(Cl)=CC=1OCC(=O)N([C@H](C1=O)COC)CCN1CC(C=C1)=CC=C1C1=CC=C(OC)N=C1 XWVIEMGPBIPVCN-NRFANRHFSA-N 0.000 claims description 4
MSFXBEBFVOAJEQ-UHFFFAOYSA-N 1,4-bis(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC=4NC5=CC=NC=C5C=4)CC3=O)=CC2=C1 MSFXBEBFVOAJEQ-UHFFFAOYSA-N 0.000 claims description 4
WJDHFTMQMRRPEF-UHFFFAOYSA-N 1-[(1-aminoisoquinolin-6-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC=3C=C4C=CN=C(C4=CC=3)N)=CC2=C1 WJDHFTMQMRRPEF-UHFFFAOYSA-N 0.000 claims description 4
SEKKRDRUSDOVRH-UHFFFAOYSA-N 1-[(1-aminoisoquinolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC3=CC=C4C=CN=C(C4=C3)N)=CC2=C1 SEKKRDRUSDOVRH-UHFFFAOYSA-N 0.000 claims description 4
XVVYXVUINZKQRF-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(3-chloro-1h-indol-6-yl)methyl]piperazin-2-one Chemical compound C1=C2C(Cl)=CNC2=CC(CN2CCN(C(C2)=O)CC=2C=C3N=CN=C(C3=CC=2)N)=C1 XVVYXVUINZKQRF-UHFFFAOYSA-N 0.000 claims description 4
FEAWZTFWPFWTDN-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 FEAWZTFWPFWTDN-UHFFFAOYSA-N 0.000 claims description 4
UBDHHNYVNUTFEY-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-benzimidazol-2-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2NC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=NC2=C1 UBDHHNYVNUTFEY-UHFFFAOYSA-N 0.000 claims description 4
HEVKGOPJZXFCLZ-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(7-chloroisoquinolin-3-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2C=NC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 HEVKGOPJZXFCLZ-UHFFFAOYSA-N 0.000 claims description 4
RTALUUJEFBQNKW-UHFFFAOYSA-N 1-[(4-aminoquinolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]piperazin-2-one Chemical compound ClC1=CC=C2NC(CN3CCN(C(C3)=O)CC=3C=C4N=CC=C(C4=CC=3)N)=CC2=C1 RTALUUJEFBQNKW-UHFFFAOYSA-N 0.000 claims description 4
VFTFIDJYZGHGCD-UHFFFAOYSA-N 1-[(4-aminoquinolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC=3C=C4N=CC=C(C4=CC=3)N)=CC2=C1 VFTFIDJYZGHGCD-UHFFFAOYSA-N 0.000 claims description 4
LITASNRODRZXHG-UHFFFAOYSA-N 1-[(4-aminoquinolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]piperazin-2-one Chemical compound C=1C=C2C(N)=CC=NC2=CC=1CN(C(C1)=O)CCN1S(=O)(=O)C=CC1=CC=C(Cl)S1 LITASNRODRZXHG-UHFFFAOYSA-N 0.000 claims description 4
WBHNYUXNVGXADU-KRWDZBQOSA-N 2-[2-[2-[(2s)-4-[(4-aminoquinazolin-7-yl)methyl]-2-ethyl-3-oxopiperazin-1-yl]-2-oxoethoxy]-5-chlorothiophen-3-yl]acetic acid Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CC)C(=O)COC=1SC(Cl)=CC=1CC(O)=O WBHNYUXNVGXADU-KRWDZBQOSA-N 0.000 claims description 4
TVPJSBRCNWTROP-UHFFFAOYSA-N 3-[[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazin-1-yl]methyl]-7-chloro-1h-quinolin-2-one Chemical compound C1=C(Cl)C=C2NC(=O)C(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 TVPJSBRCNWTROP-UHFFFAOYSA-N 0.000 claims description 4
BMWPEMIDDMRFQL-UHFFFAOYSA-N 4-(6-chlorothieno[2,3-b]pyridin-2-yl)sulfonyl-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(N=C4S3)Cl)=CC2=C1 BMWPEMIDDMRFQL-UHFFFAOYSA-N 0.000 claims description 4
IKMGUSTUEXADKO-UHFFFAOYSA-N 4-[(6-bromo-1-benzothiophen-2-yl)sulfonyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)Br)=CC2=C1 IKMGUSTUEXADKO-UHFFFAOYSA-N 0.000 claims description 4
TVKPIDAZMYJGTO-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[(1-methylpyrrolo[3,2-c]pyridin-2-yl)methyl]piperazin-2-one Chemical compound N1=CC=C2N(C)C(CN3C(CN(CC3)S(=O)(=O)C=3SC4=CC(Cl)=CC=C4C=3)=O)=CC2=C1 TVKPIDAZMYJGTO-UHFFFAOYSA-N 0.000 claims description 4
CVRCWWMSSGWOAD-UHFFFAOYSA-N 4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]-1-(2-pyrrolo[3,2-c]pyridin-1-ylethyl)piperazin-2-one Chemical compound S1C(Cl)=CC=C1C=CS(=O)(=O)N1CC(=O)N(CCN2C3=CC=NC=C3C=C2)CC1 CVRCWWMSSGWOAD-UHFFFAOYSA-N 0.000 claims description 4
NKUSSCLFEZURMH-UHFFFAOYSA-N 4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]-1-[2-(pyridin-4-ylamino)ethyl]piperazin-2-one Chemical compound S1C(Cl)=CC=C1C=CS(=O)(=O)N1CC(=O)N(CCNC=2C=CN=CC=2)CC1 NKUSSCLFEZURMH-UHFFFAOYSA-N 0.000 claims description 4
NGGKGNBCZPQUKE-UHFFFAOYSA-N 4-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]piperidine-1-carboximidamide Chemical compound C1CN(C(=N)N)CCC1CN1C(=O)CN(S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)CC1 NGGKGNBCZPQUKE-UHFFFAOYSA-N 0.000 claims description 4
VSVJJXWSXSFJKN-UHFFFAOYSA-N 4-prop-2-ynyl-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound O=C1CN(CC#C)CCN1CC1=CC2=CN=CC=C2N1 VSVJJXWSXSFJKN-UHFFFAOYSA-N 0.000 claims description 4
DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 4
XSMUTBRZFSOIJT-UHFFFAOYSA-N ClC=1C=CC2=C(SC(=C2)S(=O)(=O)N2CC(N(CC2)CC2=CC=3C(=CN=CC3)N2CC(=O)O)=O)C1 Chemical compound ClC=1C=CC2=C(SC(=C2)S(=O)(=O)N2CC(N(CC2)CC2=CC=3C(=CN=CC3)N2CC(=O)O)=O)C1 XSMUTBRZFSOIJT-UHFFFAOYSA-N 0.000 claims description 4
206010028980 Neoplasm Diseases 0.000 claims description 4
DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 claims description 4
230000002159 abnormal effect Effects 0.000 claims description 4
206010000891 acute myocardial infarction Diseases 0.000 claims description 4
125000005334 azaindolyl group Chemical group N1N=C(C2=CC=CC=C12)* 0.000 claims description 4
125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims description 4
125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims description 4
201000011510 cancer Diseases 0.000 claims description 4
201000010099 disease Diseases 0.000 claims description 4
125000002541 furyl group Chemical group 0.000 claims description 4
125000002883 imidazolyl group Chemical group 0.000 claims description 4
125000001041 indolyl group Chemical group 0.000 claims description 4
125000002911 monocyclic heterocycle group Chemical group 0.000 claims description 4
125000004368 propenyl group Chemical group C(=CC)* 0.000 claims description 4
125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 claims description 4
125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 4
125000001544 thienyl group Chemical group 0.000 claims description 4
230000002792 vascular Effects 0.000 claims description 4
IUUKZAPRHHDBRY-INIZCTEOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-ethylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CC)C(=O)COC1=CC=C(Cl)S1 IUUKZAPRHHDBRY-INIZCTEOSA-N 0.000 claims description 3
XCRUBLJKUBZRPI-SFHVURJKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-3-yl)oxyacetyl]-3-propylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCC)C(=O)COC1=CSC(Cl)=C1 XCRUBLJKUBZRPI-SFHVURJKSA-N 0.000 claims description 3
NWCAWUFBLUEHKZ-IBGZPJMESA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-bromothiophen-2-yl)prop-2-enoyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)C=CC1=CC(Br)=CS1 NWCAWUFBLUEHKZ-IBGZPJMESA-N 0.000 claims description 3
QHFXSHUFIYACNB-FQEVSTJZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-bromothiophen-2-yl)prop-2-enoyl]-3-propylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCC)C(=O)C=CC1=CC(Br)=CS1 QHFXSHUFIYACNB-FQEVSTJZSA-N 0.000 claims description 3
CVYIVXZLCLEKCW-IBGZPJMESA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-chlorothiophen-2-yl)prop-2-enoyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)C=CC1=CC(Cl)=CS1 CVYIVXZLCLEKCW-IBGZPJMESA-N 0.000 claims description 3
CFUCEQZLZAMMLJ-FQEVSTJZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-chlorothiophen-2-yl)prop-2-enoyl]-3-propylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCC)C(=O)C=CC1=CC(Cl)=CS1 CFUCEQZLZAMMLJ-FQEVSTJZSA-N 0.000 claims description 3
HBPADMQHJSODLC-SFHVURJKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-bromofuran-2-yl)prop-2-enoyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)C=CC1=CC=C(Br)O1 HBPADMQHJSODLC-SFHVURJKSA-N 0.000 claims description 3
XUWBFPVCMNOWRB-SFHVURJKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-bromothiophen-2-yl)prop-2-enoyl]-3-ethylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CC)C(=O)C=CC1=CC=C(Br)S1 XUWBFPVCMNOWRB-SFHVURJKSA-N 0.000 claims description 3
MLBCOMHEHVFVSU-PKDNWHCCSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-(methoxymethyl)-6-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)C(C)C1)=O)COC)C(=O)C=CC1=CC=C(Cl)S1 MLBCOMHEHVFVSU-PKDNWHCCSA-N 0.000 claims description 3
JLEJMDXRGFSELX-SFHVURJKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)C=CC1=CC=C(Cl)S1 JLEJMDXRGFSELX-SFHVURJKSA-N 0.000 claims description 3
RMBMHASNSWAOHY-PKDNWHCCSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-ethyl-6-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)C(C)C1)=O)CC)C(=O)C=CC1=CC=C(Cl)S1 RMBMHASNSWAOHY-PKDNWHCCSA-N 0.000 claims description 3
POXQQNYNFKHQDV-IBGZPJMESA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-propylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCC)C(=O)C=CC1=CC=C(Cl)S1 POXQQNYNFKHQDV-IBGZPJMESA-N 0.000 claims description 3
JPTSWNYMUYGSKK-IBGZPJMESA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-3-yl)prop-2-enoyl]-3-propylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCC)C(=O)C=CC1=CSC(Cl)=C1 JPTSWNYMUYGSKK-IBGZPJMESA-N 0.000 claims description 3
ZHXRBHVQTMGURT-DEOSSOPVSA-N (3s)-1-[(4-aminoquinolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]-3-(methoxymethyl)piperazin-2-one Chemical compound NC1=CC=NC2=CC(CN3CCN(CC=4NC5=CC=C(Cl)C=C5C=4)[C@H](C3=O)COC)=CC=C21 ZHXRBHVQTMGURT-DEOSSOPVSA-N 0.000 claims description 3
PLGIBGUEBNPJSD-INIZCTEOSA-N (3s)-1-[(4-aminoquinolin-7-yl)methyl]-4-[(7-chloroisoquinolin-3-yl)methyl]-3-methylpiperazin-2-one Chemical compound NC1=CC=NC2=CC(CN3CCN(CC=4N=CC5=CC(Cl)=CC=C5C=4)[C@H](C3=O)C)=CC=C21 PLGIBGUEBNPJSD-INIZCTEOSA-N 0.000 claims description 3
YNGUIVWXPRQDKT-SFHVURJKSA-N (3s)-1-[(4-aminoquinolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-ethylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CC=C(N)C3=CC=2)CC1)=O)CC)C(=O)COC1=CC=C(Cl)S1 YNGUIVWXPRQDKT-SFHVURJKSA-N 0.000 claims description 3
FUJIFMFKHBAPDZ-AWEZNQCLSA-N (3s)-1-[(4-aminoquinolin-7-yl)methyl]-4-[3-(4-bromothiophen-2-yl)prop-2-enoyl]-3-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CC=C(N)C3=CC=2)CC1)=O)C)C(=O)C=CC1=CC(Br)=CS1 FUJIFMFKHBAPDZ-AWEZNQCLSA-N 0.000 claims description 3
LBSSLHSDLKSISQ-INIZCTEOSA-N (3s)-4-[(5-chloro-1h-indol-2-yl)methyl]-3-methyl-1-[[4-(methylamino)quinolin-7-yl]methyl]piperazin-2-one Chemical compound ClC1=CC=C2NC(CN3CCN(C([C@@H]3C)=O)CC=3C=C4N=CC=C(C4=CC=3)NC)=CC2=C1 LBSSLHSDLKSISQ-INIZCTEOSA-N 0.000 claims description 3
CRBQZAIDKNSNSG-MNOVXSKESA-N (3s,5r)-1-[(4-chloroquinolin-7-yl)methyl]-3,5-dimethylpiperazin-2-one Chemical compound O=C1[C@H](C)N[C@H](C)CN1CC1=CC=C(C(Cl)=CC=N2)C2=C1 CRBQZAIDKNSNSG-MNOVXSKESA-N 0.000 claims description 3
YMVFJGSXZNNUDW-UHFFFAOYSA-N (4-chlorophenyl)methanamine Chemical compound NCC1=CC=C(Cl)C=C1 YMVFJGSXZNNUDW-UHFFFAOYSA-N 0.000 claims description 3
SXJRFJQQWDUBFI-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-oxopiperazine-2-carboxylic acid Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CC(N(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)C(O)=O)=CC2=C1 SXJRFJQQWDUBFI-UHFFFAOYSA-N 0.000 claims description 3
XLAFJOJHGYYPNC-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 XLAFJOJHGYYPNC-UHFFFAOYSA-N 0.000 claims description 3
FSRMNBLCZIURKT-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-benzimidazol-2-yl)sulfonyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2NC(S(=O)(=O)N3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=NC2=C1 FSRMNBLCZIURKT-UHFFFAOYSA-N 0.000 claims description 3
UPMNSSHHEXHKOY-UHFFFAOYSA-N 1-[(4-aminoquinolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-(morpholine-4-carbonyl)piperazin-2-one Chemical compound C=1C=C2C(N)=CC=NC2=CC=1CN(C(CN(C1)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)C1C(=O)N1CCOCC1 UPMNSSHHEXHKOY-UHFFFAOYSA-N 0.000 claims description 3
QOKLSMJVOUCASW-UHFFFAOYSA-N 1-[(4-aminothieno[3,2-d]pyrimidin-6-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]piperazin-2-one Chemical compound S1C=2C(N)=NC=NC=2C=C1CN(C(C1)=O)CCN1S(=O)(=O)C=CC1=CC=C(Cl)S1 QOKLSMJVOUCASW-UHFFFAOYSA-N 0.000 claims description 3
MXBZVUNPPBLGKF-UHFFFAOYSA-N 1-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-oxopiperazine-2-carboxylic acid Chemical compound ClC=1C=CC2=C(SC(=C2)S(=O)(=O)N2C(CNCC2=O)C(=O)O)C=1 MXBZVUNPPBLGKF-UHFFFAOYSA-N 0.000 claims description 3
BFLDFOIEAGGAMA-UHFFFAOYSA-N 1-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]-5-oxo-4-(1H-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazine-2-carboxylic acid Chemical compound ClC1=CC=C(S1)C=CS(=O)(=O)N1C(CN(C(C1)=O)CC1=CC=2C=NC=CC2N1)C(=O)O BFLDFOIEAGGAMA-UHFFFAOYSA-N 0.000 claims description 3
AAFAHCLNAYJKAZ-UHFFFAOYSA-N 2-[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]-n-(pyridin-3-ylmethyl)acetamide Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(=O)NCC1=CC=CN=C1 AAFAHCLNAYJKAZ-UHFFFAOYSA-N 0.000 claims description 3
WCDARHCRCJMTKX-UHFFFAOYSA-N 2-[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]-n-methyl-n-pyridin-4-ylacetamide Chemical compound C1CN(S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)CC(=O)N1CC(=O)N(C)C1=CC=NC=C1 WCDARHCRCJMTKX-UHFFFAOYSA-N 0.000 claims description 3
DRSWLWRQTBEPCM-UHFFFAOYSA-N 2-[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]-n-phenylacetamide Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(=O)NC1=CC=CC=C1 DRSWLWRQTBEPCM-UHFFFAOYSA-N 0.000 claims description 3
BGDPYZVYMATVPO-UHFFFAOYSA-N 2-[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]-n-piperidin-4-ylacetamide Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(=O)NC1CCNCC1 BGDPYZVYMATVPO-UHFFFAOYSA-N 0.000 claims description 3
CSPHWZKKPHVWQX-UHFFFAOYSA-N 2-[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]-n-pyridin-4-ylacetamide Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(=O)NC1=CC=NC=C1 CSPHWZKKPHVWQX-UHFFFAOYSA-N 0.000 claims description 3
125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 3
125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 3
IKAPTTKIZZCVRD-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-(hydroxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CC(N(C(=O)C3)CC=3NC4=CC=NC=C4C=3)CO)=CC2=C1 IKAPTTKIZZCVRD-UHFFFAOYSA-N 0.000 claims description 3
NZCXKVRARHEPLF-UHFFFAOYSA-N 4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]-5-(hydroxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound OCC1CN(CC=2NC3=CC=NC=C3C=2)C(=O)CN1S(=O)(=O)C=CC1=CC=C(Cl)S1 NZCXKVRARHEPLF-UHFFFAOYSA-N 0.000 claims description 3
OKIQEXQUYIVZPS-UHFFFAOYSA-N 4-[[4-(6-chlorothieno[2,3-b]pyridin-2-yl)sulfonyl-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1CN1C(=O)CN(S(=O)(=O)C=2SC3=NC(Cl)=CC=C3C=2)CC1 OKIQEXQUYIVZPS-UHFFFAOYSA-N 0.000 claims description 3
125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims description 3
208000005189 Embolism Diseases 0.000 claims description 3
208000001435 Thromboembolism Diseases 0.000 claims description 3
230000001154 acute effect Effects 0.000 claims description 3
210000004204 blood vessel Anatomy 0.000 claims description 3
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 3
150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 3
238000011161 development Methods 0.000 claims description 3
239000003937 drug carrier Substances 0.000 claims description 3
238000001631 haemodialysis Methods 0.000 claims description 3
230000000322 hemodialysis Effects 0.000 claims description 3
210000003127 knee Anatomy 0.000 claims description 3
YPHRCQHMSQLRIC-UHFFFAOYSA-N methyl 6-oxopiperazine-2-carboxylate Chemical compound COC(=O)C1CNCC(=O)N1 YPHRCQHMSQLRIC-UHFFFAOYSA-N 0.000 claims description 3
MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 claims description 3
AQPZTRKKAFBMPN-UHFFFAOYSA-N n-[(4-amino-2-methylpyrimidin-5-yl)methyl]-2-[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]acetamide Chemical compound NC1=NC(C)=NC=C1CNC(=O)CN1C(=O)CN(S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)CC1 AQPZTRKKAFBMPN-UHFFFAOYSA-N 0.000 claims description 3
YEEFWWDMOPQODK-UHFFFAOYSA-N n-[2-(2-amino-1,3-thiazol-4-yl)ethyl]-2-[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]acetamide Chemical compound S1C(N)=NC(CCNC(=O)CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=C1 YEEFWWDMOPQODK-UHFFFAOYSA-N 0.000 claims description 3
LDRITHUEJKBDDB-UHFFFAOYSA-N n-[2-(2-aminopyridin-4-yl)ethyl]-2-[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]acetamide Chemical compound C1=NC(N)=CC(CCNC(=O)CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=C1 LDRITHUEJKBDDB-UHFFFAOYSA-N 0.000 claims description 3
125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 claims description 3
VOWUGYAENFWGMB-UHFFFAOYSA-N pyrrolo[3,2-c]pyridine-1-carboxylic acid Chemical compound N1=CC=C2N(C(=O)O)C=CC2=C1 VOWUGYAENFWGMB-UHFFFAOYSA-N 0.000 claims description 3
DRYRBWIFRVMRPV-UHFFFAOYSA-N quinazolin-4-amine Chemical compound C1=CC=C2C(N)=NC=NC2=C1 DRYRBWIFRVMRPV-UHFFFAOYSA-N 0.000 claims description 3
230000009885 systemic effect Effects 0.000 claims description 3
230000002537 thrombolytic effect Effects 0.000 claims description 3
210000003462 vein Anatomy 0.000 claims description 3
GHQRGLKRCADPHG-IBGZPJMESA-N (2s)-n-(4-chlorophenyl)-2-(methoxymethyl)-3-oxo-4-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazine-1-carboxamide Chemical compound N1([C@H](C(N(CC=2NC3=CC=NC=C3C=2)CC1)=O)COC)C(=O)NC1=CC=C(Cl)C=C1 GHQRGLKRCADPHG-IBGZPJMESA-N 0.000 claims description 2
OGSMMTQXQFMXBW-CQSZACIVSA-N (3r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1-benzothiophen-2-yl)methyl]-3-methylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4SC5=CC=C(Cl)C=C5C=4)[C@@H](C3=O)C)=CC=C21 OGSMMTQXQFMXBW-CQSZACIVSA-N 0.000 claims description 2
PQRXCNSYCYYVPW-CQSZACIVSA-N (3r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)methyl]-3-methylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4SC5=CC(Cl)=CC=C5C=4)[C@@H](C3=O)C)=CC=C21 PQRXCNSYCYYVPW-CQSZACIVSA-N 0.000 claims description 2
UTMMYPUCOXYXLL-NRFANRHFSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-3-(ethoxymethyl)-4-[2-(3-fluorophenoxy)acetyl]piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COCC)C(=O)COC1=CC=CC(F)=C1 UTMMYPUCOXYXLL-NRFANRHFSA-N 0.000 claims description 2
YXAPPUAOECRZCR-LJAQVGFWSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-3-benzyl-4-[(6-chloronaphthalen-2-yl)methyl]piperazin-2-one Chemical compound C([C@@H]1N(CC=2C=C3C=CC(Cl)=CC3=CC=2)CCN(C1=O)CC=1C=C2N=CN=C(C2=CC=1)N)C1=CC=CC=C1 YXAPPUAOECRZCR-LJAQVGFWSA-N 0.000 claims description 2
XPCVPCWAXOPYLW-VWLOTQADSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-3-benzyl-4-[2-(4-chlorophenoxy)acetyl]piperazin-2-one Chemical compound C([C@@H]1N(CCN(C1=O)CC=1C=C2N=CN=C(C2=CC=1)N)C(=O)COC=1C=CC(Cl)=CC=1)C1=CC=CC=C1 XPCVPCWAXOPYLW-VWLOTQADSA-N 0.000 claims description 2
OPOITKPALPAVQE-QHCPKHFHSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-3-benzyl-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]piperazin-2-one Chemical compound C([C@@H]1N(CCN(C1=O)CC=1C=C2N=CN=C(C2=CC=1)N)C(=O)C=CC=1SC(Cl)=CC=1)C1=CC=CC=C1 OPOITKPALPAVQE-QHCPKHFHSA-N 0.000 claims description 2
BAMWXBZHSKFVFW-DEOSSOPVSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-3-benzyl-4-[3-(5-chlorothiophen-2-yl)propyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C([C@@H]1CC=2C=CC=CC=2)=O)CCN1CCCC1=CC=C(Cl)S1 BAMWXBZHSKFVFW-DEOSSOPVSA-N 0.000 claims description 2
QKBOGKQGZZXLPN-IBGZPJMESA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-3-butyl-4-[2-(5-chlorothiophen-3-yl)oxyacetyl]piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCCC)C(=O)COC1=CSC(Cl)=C1 QKBOGKQGZZXLPN-IBGZPJMESA-N 0.000 claims description 2
NVKLSNIQCKIEJP-QFIPXVFZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-3-ethyl-4-[3-(4-methoxyphenyl)propanoyl]piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CC)C(=O)CCC1=CC=C(OC)C=C1 NVKLSNIQCKIEJP-QFIPXVFZSA-N 0.000 claims description 2
CGRRXTZMFZVYAU-IBGZPJMESA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-(2-chloro-1-benzothiophene-6-carbonyl)-3-ethylpiperazin-2-one Chemical compound C1=C2C=C(Cl)SC2=CC(C(=O)N2[C@H](C(N(CC=3C=C4N=CN=C(N)C4=CC=3)CC2)=O)CC)=C1 CGRRXTZMFZVYAU-IBGZPJMESA-N 0.000 claims description 2
YADMRFPADJSAPB-ZDUSSCGKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-(3-chloro-1h-indole-6-carbonyl)-3-methylpiperazin-2-one Chemical compound C1=C2C(Cl)=CNC2=CC(C(=O)N2[C@H](C(N(CC=3C=C4N=CN=C(N)C4=CC=3)CC2)=O)C)=C1 YADMRFPADJSAPB-ZDUSSCGKSA-N 0.000 claims description 2
WCBWFWMJBQITHV-FQEVSTJZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-(6-chloro-1-benzothiophene-2-carbonyl)-3-(2-methoxyethyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(C(=O)N3[C@H](C(N(CC=4C=C5N=CN=C(N)C5=CC=4)CC3)=O)CCOC)=CC2=C1 WCBWFWMJBQITHV-FQEVSTJZSA-N 0.000 claims description 2
FKGQZKAWLZQDND-IBGZPJMESA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-(6-chloro-1-benzothiophene-2-carbonyl)-3-ethylpiperazin-2-one Chemical compound C1=C(Cl)C=C2SC(C(=O)N3[C@H](C(N(CC=4C=C5N=CN=C(N)C5=CC=4)CC3)=O)CC)=CC2=C1 FKGQZKAWLZQDND-IBGZPJMESA-N 0.000 claims description 2
NLCHLWSZCGOECC-ZDUSSCGKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-(6-chloro-1-benzothiophene-2-carbonyl)-3-methylpiperazin-2-one Chemical compound C1=C(Cl)C=C2SC(C(=O)N3[C@H](C(N(CC=4C=C5N=CN=C(N)C5=CC=4)CC3)=O)C)=CC2=C1 NLCHLWSZCGOECC-ZDUSSCGKSA-N 0.000 claims description 2
SXVUEJCFPMQQDF-AWEZNQCLSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-(7-chloroisoquinoline-3-carbonyl)-3-methylpiperazin-2-one Chemical compound C1=C(Cl)C=C2C=NC(C(=O)N3[C@H](C(N(CC=4C=C5N=CN=C(N)C5=CC=4)CC3)=O)C)=CC2=C1 SXVUEJCFPMQQDF-AWEZNQCLSA-N 0.000 claims description 2
ONWUZTDBOWSXFS-AWEZNQCLSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(3-chloro-1h-indol-6-yl)methyl]-3-methylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4C=C5NC=C(Cl)C5=CC=4)[C@H](C3=O)C)=CC=C21 ONWUZTDBOWSXFS-AWEZNQCLSA-N 0.000 claims description 2
GIMYOOBUEHLNSZ-AWEZNQCLSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]-3-methylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4NC5=CC=C(Cl)C=C5C=4)[C@H](C3=O)C)=CC=C21 GIMYOOBUEHLNSZ-AWEZNQCLSA-N 0.000 claims description 2
PQRXCNSYCYYVPW-AWEZNQCLSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)methyl]-3-methylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4SC5=CC(Cl)=CC=C5C=4)[C@H](C3=O)C)=CC=C21 PQRXCNSYCYYVPW-AWEZNQCLSA-N 0.000 claims description 2
FCBCOTPFDAUCKI-ZDUSSCGKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-3-methylpiperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3[C@H](C(N(CC=4C=C5N=CN=C(N)C5=CC=4)CC3)=O)C)=CC2=C1 FCBCOTPFDAUCKI-ZDUSSCGKSA-N 0.000 claims description 2
ZLHXWILVUVCHFU-ZDUSSCGKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-benzimidazol-2-yl)methyl]-3-methylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4NC5=CC=C(Cl)C=C5N=4)[C@H](C3=O)C)=CC=C21 ZLHXWILVUVCHFU-ZDUSSCGKSA-N 0.000 claims description 2
OCMQMXOWCUTTLQ-INIZCTEOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloronaphthalen-2-yl)methyl]-3-methylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4C=C5C=CC(Cl)=CC5=CC=4)[C@H](C3=O)C)=CC=C21 OCMQMXOWCUTTLQ-INIZCTEOSA-N 0.000 claims description 2
XPKQDJGCWRNWIX-ZDUSSCGKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chlorothieno[2,3-b]pyridin-2-yl)methyl]-3-methylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4SC5=NC(Cl)=CC=C5C=4)[C@H](C3=O)C)=CC=C21 XPKQDJGCWRNWIX-ZDUSSCGKSA-N 0.000 claims description 2
BABMVDQHQYVJLN-GYCJOSAFSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(7-chloroisoquinolin-3-yl)methyl]-3-[(1r)-1-methoxyethyl]piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4N=CC5=CC(Cl)=CC=C5C=4)[C@H](C3=O)[C@@H](C)OC)=CC=C21 BABMVDQHQYVJLN-GYCJOSAFSA-N 0.000 claims description 2
YTZUCGFEWLFGNZ-LGTGAQBVSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(2,5-dichlorophenoxy)acetyl]-3-(methoxymethyl)-6-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)C(C)C1)=O)COC)C(=O)COC1=CC(Cl)=CC=C1Cl YTZUCGFEWLFGNZ-LGTGAQBVSA-N 0.000 claims description 2
BATUUIIGKBEHGI-YNNZGITBSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(3,5-dichlorophenoxy)acetyl]-3-(methoxymethyl)-6-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)C(C)C1)=O)COC)C(=O)COC1=CC(Cl)=CC(Cl)=C1 BATUUIIGKBEHGI-YNNZGITBSA-N 0.000 claims description 2
MVAKMVXXKKYEKL-YNNZGITBSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(3-chloro-4-fluorophenoxy)acetyl]-3-(methoxymethyl)-6-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)C(C)C1)=O)COC)C(=O)COC1=CC=C(F)C(Cl)=C1 MVAKMVXXKKYEKL-YNNZGITBSA-N 0.000 claims description 2
XRQOAAVQXKNQTP-NRFANRHFSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(3-chloro-5-methoxyphenoxy)acetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC1=CC(Cl)=CC(OC)=C1 XRQOAAVQXKNQTP-NRFANRHFSA-N 0.000 claims description 2
WIXGFFANUNUPPC-FQEVSTJZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(3-chlorophenoxy)acetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC1=CC=CC(Cl)=C1 WIXGFFANUNUPPC-FQEVSTJZSA-N 0.000 claims description 2
VSWCUNILQIMCDD-FQEVSTJZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(4-chloro-2-methylphenoxy)acetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC1=CC=C(Cl)C=C1C VSWCUNILQIMCDD-FQEVSTJZSA-N 0.000 claims description 2
DNKBVLUYSVHQIU-AWEZNQCLSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(4-chlorophenoxy)acetyl]-3-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)C)C(=O)COC1=CC=C(Cl)C=C1 DNKBVLUYSVHQIU-AWEZNQCLSA-N 0.000 claims description 2
OOFKXVRAOJTQHF-KRWDZBQOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-ethylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CC)C(=O)COC1=CC(Cl)=CS1 OOFKXVRAOJTQHF-KRWDZBQOSA-N 0.000 claims description 2
BLOMVHIDQQPOQR-LBPRGKRZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)C)C(=O)COC1=CC(Cl)=CS1 BLOMVHIDQQPOQR-LBPRGKRZSA-N 0.000 claims description 2
MZSDIUXRVMTHPY-SFHVURJKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-propylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCC)C(=O)COC1=CC(Cl)=CS1 MZSDIUXRVMTHPY-SFHVURJKSA-N 0.000 claims description 2
RVUOCBNDWAVGSG-MRNPHLECSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chloro-2-methylphenoxy)acetyl]-3-(methoxymethyl)-6-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)C(C)C1)=O)COC)C(=O)COC1=CC(Cl)=CC=C1C RVUOCBNDWAVGSG-MRNPHLECSA-N 0.000 claims description 2
HDXIXQGVVFWHOU-IBGZPJMESA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chloropyridin-3-yl)oxyacetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC1=CN=CC(Cl)=C1 HDXIXQGVVFWHOU-IBGZPJMESA-N 0.000 claims description 2
IKHSESRTYOUGAI-KRWDZBQOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-(2-methoxyethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCOC)C(=O)COC1=CC=C(Cl)S1 IKHSESRTYOUGAI-KRWDZBQOSA-N 0.000 claims description 2
NSQHSFPQJAOGFI-XCLFUZPHSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-[(1r)-1-methoxyethyl]piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)[C@@H](C)OC)C(=O)COC1=CC=C(Cl)S1 NSQHSFPQJAOGFI-XCLFUZPHSA-N 0.000 claims description 2
ZWIVYFALKIOQLP-LBPRGKRZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)C)C(=O)COC1=CC=C(Cl)S1 ZWIVYFALKIOQLP-LBPRGKRZSA-N 0.000 claims description 2
PDZBZJIOBNYCCF-KRWDZBQOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-propylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCC)C(=O)COC1=CC=C(Cl)S1 PDZBZJIOBNYCCF-KRWDZBQOSA-N 0.000 claims description 2
XXKRYBARDAEDSM-SFHVURJKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-3-yl)oxyacetyl]-3-(2-methoxyethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCOC)C(=O)COC1=CSC(Cl)=C1 XXKRYBARDAEDSM-SFHVURJKSA-N 0.000 claims description 2
CBHRYPCDPQMWRT-KRWDZBQOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-3-yl)oxyacetyl]-3-ethylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CC)C(=O)COC1=CSC(Cl)=C1 CBHRYPCDPQMWRT-KRWDZBQOSA-N 0.000 claims description 2
PFSTYVMXTWGWGT-INIZCTEOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-fluorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC1=CC=C(F)S1 PFSTYVMXTWGWGT-INIZCTEOSA-N 0.000 claims description 2
DIJYSOSJXAPYLC-KRWDZBQOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(6-chloropyridin-2-yl)oxyacetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC1=CC=CC(Cl)=N1 DIJYSOSJXAPYLC-KRWDZBQOSA-N 0.000 claims description 2
LUGUTJIMCGLPIZ-IBGZPJMESA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(6-chloropyridin-3-yl)oxyacetyl]-3-(ethoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COCC)C(=O)COC1=CC=C(Cl)N=C1 LUGUTJIMCGLPIZ-IBGZPJMESA-N 0.000 claims description 2
BFFNMFFIRWERJS-CEISFSOZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(2,5-dichlorophenyl)prop-2-enoyl]-3-(methoxymethyl)-6-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)C(C)C1)=O)COC)C(=O)C=CC1=CC(Cl)=CC=C1Cl BFFNMFFIRWERJS-CEISFSOZSA-N 0.000 claims description 2
FOTJKXPTWBLCIX-LGTGAQBVSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-bromothiophen-2-yl)prop-2-enoyl]-3-(methoxymethyl)-6-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)C(C)C1)=O)COC)C(=O)C=CC1=CC(Br)=CS1 FOTJKXPTWBLCIX-LGTGAQBVSA-N 0.000 claims description 2
AGWUXMPCRAFHAO-SZNDQCEHSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-bromothiophen-2-yl)prop-2-enoyl]-3-[(1r)-1-methoxyethyl]piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)[C@@H](C)OC)C(=O)C=CC1=CC(Br)=CS1 AGWUXMPCRAFHAO-SZNDQCEHSA-N 0.000 claims description 2
CBNYJEJZYPVVJO-LGTGAQBVSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-bromothiophen-2-yl)prop-2-enoyl]-3-ethyl-6-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)C(C)C1)=O)CC)C(=O)C=CC1=CC(Br)=CS1 CBNYJEJZYPVVJO-LGTGAQBVSA-N 0.000 claims description 2
VLSKWHGHQDUMMC-IBGZPJMESA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-bromothiophen-2-yl)prop-2-enoyl]-3-ethylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CC)C(=O)C=CC1=CC(Br)=CS1 VLSKWHGHQDUMMC-IBGZPJMESA-N 0.000 claims description 2
BRLIDOSZZOYYBZ-ZDUSSCGKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-bromothiophen-2-yl)prop-2-enoyl]-3-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)C)C(=O)C=CC1=CC(Br)=CS1 BRLIDOSZZOYYBZ-ZDUSSCGKSA-N 0.000 claims description 2
JGPUUXNCEMSQHF-ZDUSSCGKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-bromothiophen-2-yl)prop-2-enoyl]-3-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)C)C(=O)C=CC1=CC=C(Br)S1 JGPUUXNCEMSQHF-ZDUSSCGKSA-N 0.000 claims description 2
GRMJYCFPEXLVHM-AWEZNQCLSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)but-2-enoyl]-3-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)C)C(=O)C=C(C)C1=CC=C(Cl)S1 GRMJYCFPEXLVHM-AWEZNQCLSA-N 0.000 claims description 2
BVHQPYVSEXRFIJ-HNNXBMFYSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)but-2-enyl]-3-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)C)CC=C(C)C1=CC=C(Cl)S1 BVHQPYVSEXRFIJ-HNNXBMFYSA-N 0.000 claims description 2
QQQHNJGTKOJFDI-IBGZPJMESA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-(ethoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COCC)C(=O)C=CC1=CC=C(Cl)S1 QQQHNJGTKOJFDI-IBGZPJMESA-N 0.000 claims description 2
DXYCFQASODUPMW-SZNDQCEHSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-[(1r)-1-methoxyethyl]piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)[C@@H](C)OC)C(=O)C=CC1=CC=C(Cl)S1 DXYCFQASODUPMW-SZNDQCEHSA-N 0.000 claims description 2
HEODAYIDJROIDD-ZDUSSCGKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)C)C(=O)C=CC1=CC=C(Cl)S1 HEODAYIDJROIDD-ZDUSSCGKSA-N 0.000 claims description 2
HJUMCXQVYCNSMB-MBABXSBOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)propyl]-3-ethyl-6-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)C(C)C1)=O)CC)CCCC1=CC=C(Cl)S1 HJUMCXQVYCNSMB-MBABXSBOSA-N 0.000 claims description 2
BZDOUZIDMFNRHN-AWEZNQCLSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)propyl]-3-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)C)CCCC1=CC=C(Cl)S1 BZDOUZIDMFNRHN-AWEZNQCLSA-N 0.000 claims description 2
PPQAUEYZXKIYNI-SFHVURJKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-3-yl)prop-2-enoyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)C=CC1=CSC(Cl)=C1 PPQAUEYZXKIYNI-SFHVURJKSA-N 0.000 claims description 2
BSSQYTLAFHGVAR-SFHVURJKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-3-yl)prop-2-enoyl]-3-ethylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CC)C(=O)C=CC1=CSC(Cl)=C1 BSSQYTLAFHGVAR-SFHVURJKSA-N 0.000 claims description 2
ROBQZXSQLBIJPA-SANMLTNESA-N (3s)-1-[(4-aminoquinolin-7-yl)methyl]-4-[(6-chloronaphthalen-2-yl)methyl]-3-ethylpiperazin-2-one Chemical compound NC1=CC=NC2=CC(CN3CCN(CC=4C=C5C=CC(Cl)=CC5=CC=4)[C@H](C3=O)CC)=CC=C21 ROBQZXSQLBIJPA-SANMLTNESA-N 0.000 claims description 2
FPKHGUBTMCBSHO-WUTOIGTNSA-N (3s)-1-[(4-aminoquinolin-7-yl)methyl]-4-[3-(4-bromothiophen-2-yl)prop-2-enoyl]-3-[(1r)-1-methoxyethyl]piperazin-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1([C@H](C(N(CC=2C=C3N=CC=C(N)C3=CC=2)CC1)=O)[C@@H](C)OC)C(=O)C=CC1=CC(Br)=CS1 FPKHGUBTMCBSHO-WUTOIGTNSA-N 0.000 claims description 2
FPUMBAUAQAVAQQ-FQEVSTJZSA-N (3s)-1-[(4-aminoquinolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CC=C(N)C3=CC=2)CC1)=O)COC)C(=O)C=CC1=CC=C(Cl)S1 FPUMBAUAQAVAQQ-FQEVSTJZSA-N 0.000 claims description 2
QUFVGWBUWMPEME-CMJOXMDJSA-N (3s)-1-[(4-aminoquinolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-[(1r)-1-methoxyethyl]piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CC=C(N)C3=CC=2)CC1)=O)[C@@H](C)OC)C(=O)C=CC1=CC=C(Cl)S1 QUFVGWBUWMPEME-CMJOXMDJSA-N 0.000 claims description 2
CRBQZAIDKNSNSG-DTIOYNMSSA-N (3s)-1-[(4-chloroquinolin-7-yl)methyl]-3,5-dimethylpiperazin-2-one Chemical compound O=C1[C@H](C)NC(C)CN1CC1=CC=C(C(Cl)=CC=N2)C2=C1 CRBQZAIDKNSNSG-DTIOYNMSSA-N 0.000 claims description 2
CSNBZVUJZDWSRS-JTQLQIEISA-N (3s)-1-[(4-chloroquinolin-7-yl)methyl]-3-methylpiperazin-2-one Chemical compound O=C1[C@H](C)NCCN1CC1=CC=C(C(Cl)=CC=N2)C2=C1 CSNBZVUJZDWSRS-JTQLQIEISA-N 0.000 claims description 2
AWWPRJSAXAOEDN-CYXJOQHWSA-N (3s)-1-[(7-chloroisoquinolin-3-yl)methyl]-4-[(e)-3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2N=CC3=CC(Cl)=CC=C3C=2)CC1)=O)COC)C(=O)\C=C\C1=CC=C(Cl)S1 AWWPRJSAXAOEDN-CYXJOQHWSA-N 0.000 claims description 2
QNFASEFJRMIJKK-DEOSSOPVSA-N (3s)-4-[(5-chloro-1h-indol-2-yl)methyl]-1-[(4-chloroquinolin-7-yl)methyl]-3-(methoxymethyl)piperazin-2-one Chemical compound ClC1=CC=NC2=CC(CN3CCN(CC=4NC5=CC=C(Cl)C=C5C=4)[C@H](C3=O)COC)=CC=C21 QNFASEFJRMIJKK-DEOSSOPVSA-N 0.000 claims description 2
BFLDPLPFCJQHRA-QFIPXVFZSA-N (3s)-4-[(5-chloro-1h-indol-2-yl)methyl]-3-(methoxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC=4NC5=CC=C(Cl)C=C5C=4)[C@H](C3=O)COC)=CC2=C1 BFLDPLPFCJQHRA-QFIPXVFZSA-N 0.000 claims description 2
QPMDRTXSMAQJQN-XBGMYJNYSA-N (3s)-4-[(e)-3-(4-chlorophenyl)prop-2-enoyl]-3-(methoxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2NC3=CC=NC=C3C=2)CC1)=O)COC)C(=O)\C=C\C1=CC=C(Cl)C=C1 QPMDRTXSMAQJQN-XBGMYJNYSA-N 0.000 claims description 2
OPPJHIHBJIDVQV-KQPPXVQYSA-N (3s)-4-[(e)-3-(5-chlorothiophen-2-yl)prop-2-enoyl]-1-[[4-(6-methoxypyridin-3-yl)phenyl]methyl]-3-methylpiperazin-2-one Chemical compound C1=NC(OC)=CC=C1C(C=C1)=CC=C1CN1C(=O)[C@H](C)N(C(=O)\C=C\C=2SC(Cl)=CC=2)CC1 OPPJHIHBJIDVQV-KQPPXVQYSA-N 0.000 claims description 2
XQAOVSSCYCZVOJ-YZTRRJNXSA-N (3s)-4-[(e)-3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-(methoxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2NC3=CC=NC=C3C=2)CC1)=O)COC)C(=O)\C=C\C1=CC=C(Cl)S1 XQAOVSSCYCZVOJ-YZTRRJNXSA-N 0.000 claims description 2
CTOJTNFXJHUNGS-FQTAANOTSA-N (3s)-4-[(e)-3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-(methoxymethyl)-1-[[4-(6-methoxypyridin-3-yl)phenyl]methyl]piperazin-2-one Chemical compound C=1C=C(Cl)SC=1/C=C/C(=O)N([C@H](C1=O)COC)CCN1CC(C=C1)=CC=C1C1=CC=C(OC)N=C1 CTOJTNFXJHUNGS-FQTAANOTSA-N 0.000 claims description 2
CSBOZDOLFWPELI-CTMGSCHOSA-N (3s)-4-[(e)-3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-ethyl-6-methyl-1-[(4-phenylphenyl)methyl]piperazin-2-one Chemical compound C=1C=C(Cl)SC=1/C=C/C(=O)N([C@H](C1=O)CC)CC(C)N1CC(C=C1)=CC=C1C1=CC=CC=C1 CSBOZDOLFWPELI-CTMGSCHOSA-N 0.000 claims description 2
IQNASPLCFQXXHR-KXKDPZRNSA-N (3s)-4-[(e)-3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-methyl-1-[[4-(6-oxo-1h-pyridin-3-yl)phenyl]methyl]piperazin-2-one Chemical compound C=1C=C(Cl)SC=1/C=C/C(=O)N([C@H](C1=O)C)CCN1CC(C=C1)=CC=C1C=1C=CC(=O)NC=1 IQNASPLCFQXXHR-KXKDPZRNSA-N 0.000 claims description 2
MRJYWARTPLUSST-NRFANRHFSA-N (3s)-4-[2-(4-chlorophenyl)ethenylsulfonyl]-3-(methoxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2NC3=CC=NC=C3C=2)CC1)=O)COC)S(=O)(=O)C=CC1=CC=C(Cl)C=C1 MRJYWARTPLUSST-NRFANRHFSA-N 0.000 claims description 2
ISAAXJOTMHQBEZ-NRFANRHFSA-N (3s)-4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxypyridin-3-yl)phenyl]methyl]piperazin-2-one Chemical compound C=1C(Cl)=CSC=1OCC(=O)N([C@H](C1=O)COC)CCN1CC(C=C1)=CC=C1C1=CC=C(OC)N=C1 ISAAXJOTMHQBEZ-NRFANRHFSA-N 0.000 claims description 2
RGPAZBWNCODDDQ-FQEVSTJZSA-N (3s)-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-1-[[4-(6-methoxypyridin-3-yl)phenyl]methyl]piperazin-2-one Chemical compound C=1C=C(Cl)SC=1OCC(=O)N([C@H](C1=O)COC)CCN1CC(C=C1)=CC=C1C1=CC=C(OC)N=C1 RGPAZBWNCODDDQ-FQEVSTJZSA-N 0.000 claims description 2
UHIVURXWDCNWGB-NRFANRHFSA-N (3s)-4-[3-(4-aminophenyl)prop-2-enoyl]-1-[(4-aminoquinazolin-7-yl)methyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)C=CC1=CC=C(N)C=C1 UHIVURXWDCNWGB-NRFANRHFSA-N 0.000 claims description 2
VSPQQTPTCVEGPW-FQEVSTJZSA-N (3s)-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-ethyl-1-[[4-(hydroxyamino)quinolin-7-yl]methyl]piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CC=C(NO)C3=CC=2)CC1)=O)CC)C(=O)C=CC1=CC=C(Cl)S1 VSPQQTPTCVEGPW-FQEVSTJZSA-N 0.000 claims description 2
RHJMEECUWIXNDR-IBGZPJMESA-N (3s)-4-[3-(6-aminopyridin-3-yl)prop-2-enoyl]-1-[(4-aminoquinazolin-7-yl)methyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)C=CC1=CC=C(N)N=C1 RHJMEECUWIXNDR-IBGZPJMESA-N 0.000 claims description 2
KBIRRSHMTNLPFD-KBPBESRZSA-N (3s,5s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-3,5-dimethylpiperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3[C@@H](C)C(=O)N(CC=4C=C5N=CN=C(N)C5=CC=4)C[C@@H]3C)=CC2=C1 KBIRRSHMTNLPFD-KBPBESRZSA-N 0.000 claims description 2
GPRVEWOEFMIGDL-GKVSMKOHSA-N (3s,6s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloronaphthalen-2-yl)methyl]-3-(methoxymethyl)-6-methylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3[C@@H](C)CN(CC=4C=C5C=CC(Cl)=CC5=CC=4)[C@H](C3=O)COC)=CC=C21 GPRVEWOEFMIGDL-GKVSMKOHSA-N 0.000 claims description 2
OTHALGYTOCLXDJ-UHFFFAOYSA-N (5-chlorothiophen-2-yl)methyl 4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazine-1-carboxylate Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)OCC1=CC=C(Cl)S1 OTHALGYTOCLXDJ-UHFFFAOYSA-N 0.000 claims description 2
XYBHRHQACINKPY-UHFFFAOYSA-N 1,4-bis[(4-aminoquinazolin-7-yl)methyl]piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC3=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC=C21 XYBHRHQACINKPY-UHFFFAOYSA-N 0.000 claims description 2
OPXMLUXDXOHAGV-UHFFFAOYSA-N 1,4-bis[(5-chloro-1h-indol-2-yl)methyl]piperazin-2-one Chemical compound ClC1=CC=C2NC(CN3CCN(CC3=O)CC=3NC4=CC=C(C=C4C=3)Cl)=CC2=C1 OPXMLUXDXOHAGV-UHFFFAOYSA-N 0.000 claims description 2
UXHXBUCYFWISAA-UHFFFAOYSA-N 1-(1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinolin-6-ylmethyl)-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1CC2CNCCC2CC1CN(C(=O)C1)CCN1S(=O)(=O)C1=CC2=CC=C(Cl)C=C2S1 UXHXBUCYFWISAA-UHFFFAOYSA-N 0.000 claims description 2
LBCLWZQZJYVFRN-UHFFFAOYSA-N 1-(1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinolin-7-ylmethyl)-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1CC2CCNCC2CC1CN(C(=O)C1)CCN1S(=O)(=O)C1=CC2=CC=C(Cl)C=C2S1 LBCLWZQZJYVFRN-UHFFFAOYSA-N 0.000 claims description 2
OTVJALKAUIMVDT-UHFFFAOYSA-N 1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)-4-thieno[2,3-b]pyridin-2-ylsulfonylpiperazin-2-one Chemical compound C1=CN=C2SC(S(=O)(=O)N3CC(N(CC3)CC=3NC4=CC=NC=C4C=3)=O)=CC2=C1 OTVJALKAUIMVDT-UHFFFAOYSA-N 0.000 claims description 2
YIQKAPCYLQPOKQ-UHFFFAOYSA-N 1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)-4-thieno[3,2-b]pyridin-2-ylsulfonylpiperazin-2-one Chemical compound C1=CC=C2SC(S(=O)(=O)N3CC(N(CC3)CC=3NC4=CC=NC=C4C=3)=O)=CC2=N1 YIQKAPCYLQPOKQ-UHFFFAOYSA-N 0.000 claims description 2
IFGCMKFNHKDDJW-UHFFFAOYSA-N 1-[(1-aminoisoquinolin-6-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(CN3CCN(C(C3)=O)CC=3C=C4C=CN=C(C4=CC=3)N)=CC2=C1 IFGCMKFNHKDDJW-UHFFFAOYSA-N 0.000 claims description 2
XAZGAXWLOJNGNB-UHFFFAOYSA-N 1-[(1-aminoisoquinolin-6-yl)methyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=CC2=CC=1CN1CCNCC1=O XAZGAXWLOJNGNB-UHFFFAOYSA-N 0.000 claims description 2
VAJHDXWBJMGSQJ-UHFFFAOYSA-N 1-[(2-aminoquinolin-6-yl)methyl]-4-[(4-methoxyphenyl)methyl]piperazin-2-one Chemical compound C1=CC(OC)=CC=C1CN1CC(=O)N(CC=2C=C3C=CC(N)=NC3=CC=2)CC1 VAJHDXWBJMGSQJ-UHFFFAOYSA-N 0.000 claims description 2
NNHTYOYEVGEYDN-UHFFFAOYSA-N 1-[(2-aminoquinolin-6-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC3=CC4=CC=C(N=C4C=C3)N)=CC2=C1 NNHTYOYEVGEYDN-UHFFFAOYSA-N 0.000 claims description 2
FRLLINYESBSQQN-UHFFFAOYSA-N 1-[(2-aminoquinolin-6-yl)methyl]-4-[(6-chloronaphthalen-2-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=CC2=CC(CN3CCN(C(C3)=O)CC3=CC4=CC=C(N=C4C=C3)N)=CC=C21 FRLLINYESBSQQN-UHFFFAOYSA-N 0.000 claims description 2
PLHOOQVSQVOUFX-UHFFFAOYSA-N 1-[(2-aminoquinolin-6-yl)methyl]-4-[(6-methoxy-1h-benzimidazol-2-yl)methyl]piperazin-2-one Chemical compound N1=C(N)C=CC2=CC(CN3CCN(CC3=O)CC=3NC4=CC=C(C=C4N=3)OC)=CC=C21 PLHOOQVSQVOUFX-UHFFFAOYSA-N 0.000 claims description 2
NDFNUQOROBVJAA-XBXARRHUSA-N 1-[(2-aminoquinolin-6-yl)methyl]-4-[(e)-3-(5-chlorothiophen-2-yl)prop-2-enoyl]piperazin-2-one Chemical compound C1=CC2=NC(N)=CC=C2C=C1CN(C(C1)=O)CCN1C(=O)\C=C\C1=CC=C(Cl)S1 NDFNUQOROBVJAA-XBXARRHUSA-N 0.000 claims description 2
MSFDOYADHIZDCR-UHFFFAOYSA-N 1-[(2-aminoquinolin-6-yl)methyl]-4-[5-(5-chlorothiophen-2-yl)thiophen-2-yl]sulfonylpiperazin-2-one Chemical compound C1=CC2=NC(N)=CC=C2C=C1CN(C(C1)=O)CCN1S(=O)(=O)C(S1)=CC=C1C1=CC=C(Cl)S1 MSFDOYADHIZDCR-UHFFFAOYSA-N 0.000 claims description 2
BWCPGQKVUMWCEZ-UHFFFAOYSA-N 1-[(2-aminoquinolin-6-yl)methyl]piperazin-2-one Chemical compound C1=CC2=NC(N)=CC=C2C=C1CN1CCNCC1=O BWCPGQKVUMWCEZ-UHFFFAOYSA-N 0.000 claims description 2
QNLCTWFFEQSBLF-UHFFFAOYSA-N 1-[(2-aminoquinoxalin-6-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC3=CC4=NC=C(N=C4C=C3)N)=CC2=C1 QNLCTWFFEQSBLF-UHFFFAOYSA-N 0.000 claims description 2
JSTUBAABZKIAAC-UHFFFAOYSA-N 1-[(3-amino-1h-indazol-6-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC=3C=C4NN=C(C4=CC=3)N)=CC2=C1 JSTUBAABZKIAAC-UHFFFAOYSA-N 0.000 claims description 2
LMSGORFMUOAKFM-UHFFFAOYSA-N 1-[(3-amino-4-cyanophenyl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-oxopiperazine-2-carboxylic acid Chemical compound C1=C(C#N)C(N)=CC(CN2C(CN(CC2C(O)=O)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=C1 LMSGORFMUOAKFM-UHFFFAOYSA-N 0.000 claims description 2
PJTCXZKNDPPAQB-UHFFFAOYSA-N 1-[(4-amino-1h-pyrrolo[3,2-c]pyridin-2-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC=3NC=4C=CN=C(C=4C=3)N)=CC2=C1 PJTCXZKNDPPAQB-UHFFFAOYSA-N 0.000 claims description 2
NAKLAFVYFZJFGH-UHFFFAOYSA-N 1-[(4-amino-2-methylquinazolin-7-yl)methyl]-4-[(6-chloro-1h-benzimidazol-2-yl)methyl]piperidin-2-one Chemical compound C1=C(Cl)C=C2NC(CC3CCN(C(C3)=O)CC=3C=CC4=C(N)N=C(N=C4C=3)C)=NC2=C1 NAKLAFVYFZJFGH-UHFFFAOYSA-N 0.000 claims description 2
YZSXYJQTPMAQHU-UHFFFAOYSA-N 1-[(4-aminoquinazolin-6-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC3=CC=C4N=CN=C(C4=C3)N)=CC2=C1 YZSXYJQTPMAQHU-UHFFFAOYSA-N 0.000 claims description 2
UAMYABDFIMIBPC-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-3,3-dimethylpiperazin-2-one Chemical compound O=C1C(C)(C)NCCN1CC1=CC=C(C(N)=NC=N2)C2=C1 UAMYABDFIMIBPC-UHFFFAOYSA-N 0.000 claims description 2
UCGMUNYQWRKBOE-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-3-(1-methoxyethyl)piperazin-2-one Chemical compound O=C1C(C(C)OC)NCCN1CC1=CC=C(C(N)=NC=N2)C2=C1 UCGMUNYQWRKBOE-UHFFFAOYSA-N 0.000 claims description 2
MQPPDURTNZUCEJ-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-3-(methoxymethyl)-6-methylpiperazin-2-one Chemical compound O=C1C(COC)NCC(C)N1CC1=CC=C(C(N)=NC=N2)C2=C1 MQPPDURTNZUCEJ-UHFFFAOYSA-N 0.000 claims description 2
RGKINQODOCLLDW-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-3-ethylpiperazin-2-one Chemical compound O=C1C(CC)NCCN1CC1=CC=C(C(N)=NC=N2)C2=C1 RGKINQODOCLLDW-UHFFFAOYSA-N 0.000 claims description 2
NMUOQCRCNSXVLC-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-3-methylpiperazin-2-one Chemical compound O=C1C(C)NCCN1CC1=CC=C(C(N)=NC=N2)C2=C1 NMUOQCRCNSXVLC-UHFFFAOYSA-N 0.000 claims description 2
MKGCGHVUNHUNTJ-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-3-propan-2-ylpiperazin-2-one Chemical compound O=C1C(C(C)C)NCCN1CC1=CC=C(C(N)=NC=N2)C2=C1 MKGCGHVUNHUNTJ-UHFFFAOYSA-N 0.000 claims description 2
XKSPVFNZBIDNPC-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-3-propylpiperazin-2-one Chemical compound O=C1C(CCC)NCCN1CC1=CC=C(C(N)=NC=N2)C2=C1 XKSPVFNZBIDNPC-UHFFFAOYSA-N 0.000 claims description 2
CCSLCNQMXYITAS-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-(1-benzothiophen-2-ylmethyl)piperazin-2-one Chemical compound C1=CC=C2SC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 CCSLCNQMXYITAS-UHFFFAOYSA-N 0.000 claims description 2
UXMSIRHWNBNVRZ-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-(1h-benzimidazol-2-ylmethyl)piperazin-2-one Chemical compound C1=CC=C2NC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=NC2=C1 UXMSIRHWNBNVRZ-UHFFFAOYSA-N 0.000 claims description 2
DEPKQAACNKYEPW-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-(1h-pyrrolo[2,3-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=NC=C2NC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 DEPKQAACNKYEPW-UHFFFAOYSA-N 0.000 claims description 2
RLHZDEXEVGRRTQ-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-(3-chloro-1h-indole-6-carbonyl)piperazin-2-one Chemical compound C1=C2C(Cl)=CNC2=CC(C(=O)N2CCN(C(C2)=O)CC=2C=C3N=CN=C(C3=CC=2)N)=C1 RLHZDEXEVGRRTQ-UHFFFAOYSA-N 0.000 claims description 2
LKBZSOWDIKEINH-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-(3-thiophen-2-ylpropyl)piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CCCC1=CC=CS1 LKBZSOWDIKEINH-UHFFFAOYSA-N 0.000 claims description 2
RLBIRWITDOZLPI-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-(4-chlorothiophene-2-carbonyl)piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)C1=CC(Cl)=CS1 RLBIRWITDOZLPI-UHFFFAOYSA-N 0.000 claims description 2
FDZOADKTORPTMU-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-(5-chloro-1h-indole-2-carbonyl)piperazin-2-one Chemical compound ClC1=CC=C2NC(C(=O)N3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 FDZOADKTORPTMU-UHFFFAOYSA-N 0.000 claims description 2
VHRDVZXDJPMINC-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-(6-chloro-1-benzothiophene-2-carbonyl)-3,3-dimethylpiperazin-2-one Chemical compound C1=C(Cl)C=C2SC(C(=O)N3C(C(N(CC=4C=C5N=CN=C(N)C5=CC=4)CC3)=O)(C)C)=CC2=C1 VHRDVZXDJPMINC-UHFFFAOYSA-N 0.000 claims description 2
AQNNNQSAAQVRGB-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-(6-chloro-1-benzothiophene-2-carbonyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(C(=O)N3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 AQNNNQSAAQVRGB-UHFFFAOYSA-N 0.000 claims description 2
NOZJUJSZVAGSPE-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-(isoquinolin-3-ylmethyl)piperazin-2-one Chemical compound C1=CC=C2C=NC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 NOZJUJSZVAGSPE-UHFFFAOYSA-N 0.000 claims description 2
NRHFSPSKSAMWGO-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-(naphthalen-2-ylmethyl)piperazin-2-one Chemical compound C1=CC=CC2=CC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC=C21 NRHFSPSKSAMWGO-UHFFFAOYSA-N 0.000 claims description 2
BVMZDXWSLYCDIM-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(1,7-dichloroisoquinolin-3-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2C(Cl)=NC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 BVMZDXWSLYCDIM-UHFFFAOYSA-N 0.000 claims description 2
DTSRPYBFMWJQHH-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(2,7-dichloroquinolin-3-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2N=C(Cl)C(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 DTSRPYBFMWJQHH-UHFFFAOYSA-N 0.000 claims description 2
MHEBCWMMESGDGD-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(2-chloro-1-benzothiophen-5-yl)methyl]piperazin-2-one Chemical compound C1=C2SC(Cl)=CC2=CC(CN2CCN(C(C2)=O)CC=2C=C3N=CN=C(C3=CC=2)N)=C1 MHEBCWMMESGDGD-UHFFFAOYSA-N 0.000 claims description 2
OBUJUXVRZCVVMK-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(2-chloro-1-benzothiophen-6-yl)methyl]piperazin-2-one Chemical compound C1=C2C=C(Cl)SC2=CC(CN2CCN(C(C2)=O)CC=2C=C3N=CN=C(C3=CC=2)N)=C1 OBUJUXVRZCVVMK-UHFFFAOYSA-N 0.000 claims description 2
YNXIFJLNKTZBDT-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(2-chloroquinolin-6-yl)methyl]piperazin-2-one Chemical compound N1=C(Cl)C=CC2=CC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC=C21 YNXIFJLNKTZBDT-UHFFFAOYSA-N 0.000 claims description 2
FPSZBDQXWSBHLZ-LJQANCHMSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(2s)-2-(3-chlorophenyl)-2-hydroxyethyl]piperazin-2-one Chemical compound C1([C@H](O)CN2CCN(C(C2)=O)CC=2C=C3N=CN=C(C3=CC=2)N)=CC=CC(Cl)=C1 FPSZBDQXWSBHLZ-LJQANCHMSA-N 0.000 claims description 2
AZTRFXUTDHEZKS-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(3,4-dimethylthieno[2,3-b]thiophen-5-yl)methyl]piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC3=O)CC=3SC=4SC=C(C=4C=3C)C)=CC=C21 AZTRFXUTDHEZKS-UHFFFAOYSA-N 0.000 claims description 2
UXJAFPIQLXWADF-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(4,5-dichloro-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound ClC1=CC=C2SC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1Cl UXJAFPIQLXWADF-UHFFFAOYSA-N 0.000 claims description 2
DTEUPHVUIJZJNX-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(4-chloro-3-methyl-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound S1C2=CC=CC(Cl)=C2C(C)=C1CN1CC(=O)N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1 DTEUPHVUIJZJNX-UHFFFAOYSA-N 0.000 claims description 2
HVOZJLGSIKONOC-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(4-fluoro-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound C1=CC=C2SC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1F HVOZJLGSIKONOC-UHFFFAOYSA-N 0.000 claims description 2
AYIRDMGAXISONP-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(4-methyl-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC3=O)CC=3SC=4C=CC=C(C=4C=3)C)=CC=C21 AYIRDMGAXISONP-UHFFFAOYSA-N 0.000 claims description 2
IRNWUZPSNPPVRG-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(4-phenylphenyl)methyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC(C=C1)=CC=C1C1=CC=CC=C1 IRNWUZPSNPPVRG-UHFFFAOYSA-N 0.000 claims description 2
NXQLRMYNKIGQDG-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5,6-dichloro-1h-benzimidazol-2-yl)methyl]piperazin-2-one Chemical compound ClC1=C(Cl)C=C2NC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=NC2=C1 NXQLRMYNKIGQDG-UHFFFAOYSA-N 0.000 claims description 2
FNPPUJYNBUXLTI-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1,3-benzoxazol-2-yl)methyl]piperazin-2-one Chemical compound ClC1=CC=C2OC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=NC2=C1 FNPPUJYNBUXLTI-UHFFFAOYSA-N 0.000 claims description 2
QGEVNJHZJNTIEF-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound ClC1=CC=C2SC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 QGEVNJHZJNTIEF-UHFFFAOYSA-N 0.000 claims description 2
IZQSKKKJNSCTDL-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1-benzothiophen-3-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2C(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CSC2=C1 IZQSKKKJNSCTDL-UHFFFAOYSA-N 0.000 claims description 2
SUIFBIAETMEQJY-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1-methylbenzimidazol-2-yl)methyl]piperazin-2-one Chemical compound ClC1=CC=C2N(C)C(CN3CC(=O)N(CC=4C=C5N=CN=C(N)C5=CC=4)CC3)=NC2=C1 SUIFBIAETMEQJY-UHFFFAOYSA-N 0.000 claims description 2
YABSNUIIRRNMFB-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chlorothieno[3,2-b]pyridin-2-yl)methyl]piperazin-2-one Chemical compound ClC1=CC=C2SC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=N1 YABSNUIIRRNMFB-UHFFFAOYSA-N 0.000 claims description 2
IKMAHZVWCMTIME-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chlorothieno[3,2-b]pyridin-6-yl)methyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC(C(=N1)Cl)=CC2=C1C=CS2 IKMAHZVWCMTIME-UHFFFAOYSA-N 0.000 claims description 2
JEFIEWYLBMPPMR-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-methyl-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC3=O)CC=3SC4=CC=C(C=C4C=3)C)=CC=C21 JEFIEWYLBMPPMR-UHFFFAOYSA-N 0.000 claims description 2
VPZLWZLCESJIJL-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6,7-dichloro-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C(Cl)=C2SC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 VPZLWZLCESJIJL-UHFFFAOYSA-N 0.000 claims description 2
LGFBSAGHXQZUFW-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-bromo-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound C1=C(Br)C=C2SC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 LGFBSAGHXQZUFW-UHFFFAOYSA-N 0.000 claims description 2
RHNOCRDXDQOBDB-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1,3-benzoxazol-2-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2OC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=NC2=C1 RHNOCRDXDQOBDB-UHFFFAOYSA-N 0.000 claims description 2
CTZNQHPESGPAMJ-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)methyl]-3,3-dimethylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4SC5=CC(Cl)=CC=C5C=4)C(C3=O)(C)C)=CC=C21 CTZNQHPESGPAMJ-UHFFFAOYSA-N 0.000 claims description 2
JDYHHQBKBCKVIJ-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-methylpiperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CC(N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C)=CC2=C1 JDYHHQBKBCKVIJ-UHFFFAOYSA-N 0.000 claims description 2
WUHYZYSAFCOLES-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-oxopiperazine-2-carboxamide Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CC(N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C(=O)N)=CC2=C1 WUHYZYSAFCOLES-UHFFFAOYSA-N 0.000 claims description 2
CUTVFASIFHSGRE-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-benzimidazol-2-yl)methyl]piperidin-2-one Chemical compound C1=C(Cl)C=C2NC(CC3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=NC2=C1 CUTVFASIFHSGRE-UHFFFAOYSA-N 0.000 claims description 2
IZOICTLWHVVKJQ-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1h-indol-2-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2NC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 IZOICTLWHVVKJQ-UHFFFAOYSA-N 0.000 claims description 2
VRGCDXCWSZXXLR-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-3-methoxy-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C(OC)=C1CN1CC(=O)N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1 VRGCDXCWSZXXLR-UHFFFAOYSA-N 0.000 claims description 2
GRMZPRYXICSWQX-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-3-methyl-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C(C)=C1CN1CC(=O)N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1 GRMZPRYXICSWQX-UHFFFAOYSA-N 0.000 claims description 2
ZINIRCLOOSOCLA-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-5-fluoro-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound FC1=C(Cl)C=C2SC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 ZINIRCLOOSOCLA-UHFFFAOYSA-N 0.000 claims description 2
XXBXTBPJZVVKKX-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloronaphthalen-2-yl)methyl]-6-methylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3C(=O)CN(CC=4C=C5C=CC(Cl)=CC5=CC=4)CC3C)=CC=C21 XXBXTBPJZVVKKX-UHFFFAOYSA-N 0.000 claims description 2
WLSOQGLQOAFVHW-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloronaphthalen-2-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=CC2=CC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC=C21 WLSOQGLQOAFVHW-UHFFFAOYSA-N 0.000 claims description 2
MZAMTBZXDVWXED-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chlorothieno[2,3-b]pyridin-2-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)N=C2SC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 MZAMTBZXDVWXED-UHFFFAOYSA-N 0.000 claims description 2
STZUOWDKZKRXOP-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-fluoro-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound C1=C(F)C=C2SC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 STZUOWDKZKRXOP-UHFFFAOYSA-N 0.000 claims description 2
RJTCYARNUWJSCC-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-methyl-1h-benzimidazol-2-yl)methyl]piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC3=O)CC3=NC4=CC=C(C=C4N3)C)=CC=C21 RJTCYARNUWJSCC-UHFFFAOYSA-N 0.000 claims description 2
LRGJRTFOBUQNFP-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-nitro-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound C1=C([N+]([O-])=O)C=C2SC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 LRGJRTFOBUQNFP-UHFFFAOYSA-N 0.000 claims description 2
WUZXNJKSNUZUMV-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(7-chloro-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound C1=CC(Cl)=C2SC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 WUZXNJKSNUZUMV-UHFFFAOYSA-N 0.000 claims description 2
MELLWKWWNBDFBM-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(7-chloroquinolin-3-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=CC2=CC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CN=C21 MELLWKWWNBDFBM-UHFFFAOYSA-N 0.000 claims description 2
PREJTWSQVQTPDC-FNORWQNLSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(e)-3-(3-chlorophenyl)prop-2-enoyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)\C=C\C1=CC=CC(Cl)=C1 PREJTWSQVQTPDC-FNORWQNLSA-N 0.000 claims description 2
XTEXXVSSPNENQM-DUXPYHPUSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(e)-3-(4-bromothiophen-2-yl)prop-2-enoyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)\C=C\C1=CC(Br)=CS1 XTEXXVSSPNENQM-DUXPYHPUSA-N 0.000 claims description 2
UWDFJRDNTMENIR-XBXARRHUSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(e)-3-(4-chlorophenyl)prop-2-enoyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)\C=C\C1=CC=C(Cl)C=C1 UWDFJRDNTMENIR-XBXARRHUSA-N 0.000 claims description 2
AUJGNFAMGLGVTO-ZZXKWVIFSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(e)-3-(5-bromothiophen-2-yl)prop-2-enoyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)\C=C\C1=CC=C(Br)S1 AUJGNFAMGLGVTO-ZZXKWVIFSA-N 0.000 claims description 2
SZLJRSQDUPBXJX-ZZXKWVIFSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(e)-3-(5-chlorothiophen-2-yl)prop-2-enoyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)\C=C\C1=CC=C(Cl)S1 SZLJRSQDUPBXJX-ZZXKWVIFSA-N 0.000 claims description 2
ZIIAZSFBEODGMB-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[1-(3-chlorophenyl)pyrrolidin-3-yl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(C1)CCN1C1=CC=CC(Cl)=C1 ZIIAZSFBEODGMB-UHFFFAOYSA-N 0.000 claims description 2
RJEYKQFPMKPJSM-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[1-(4-chlorophenyl)pyrrolidin-3-yl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(C1)CCN1C1=CC=C(Cl)C=C1 RJEYKQFPMKPJSM-UHFFFAOYSA-N 0.000 claims description 2
TVBOGYVJJIRWCA-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(4-chloro-2-methylphenoxy)acetyl]piperazin-2-one Chemical compound CC1=CC(Cl)=CC=C1OCC(=O)N1CC(=O)N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1 TVBOGYVJJIRWCA-UHFFFAOYSA-N 0.000 claims description 2
QVZCJXBOSACUCI-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(4-chlorophenoxy)acetyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)COC1=CC=C(Cl)C=C1 QVZCJXBOSACUCI-UHFFFAOYSA-N 0.000 claims description 2
JPXXIJSKCQZARD-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(4-chlorophenyl)sulfanylethyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CCSC1=CC=C(Cl)C=C1 JPXXIJSKCQZARD-UHFFFAOYSA-N 0.000 claims description 2
RWIVSPMXHGEMNF-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)acetyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)CC1=CC=C(Cl)S1 RWIVSPMXHGEMNF-UHFFFAOYSA-N 0.000 claims description 2
RAJCZWNZAIZTQY-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1S(=O)(=O)C=CC1=CC=C(Cl)S1 RAJCZWNZAIZTQY-UHFFFAOYSA-N 0.000 claims description 2
QJWJIEXQRAIBQD-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)ethyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CCC1=CC=C(Cl)S1 QJWJIEXQRAIBQD-UHFFFAOYSA-N 0.000 claims description 2
AEHIJBOZNXHLFF-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-6-oxopiperazine-2-carboxylic acid Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)C(C(O)=O)CN1C(=O)COC1=CC=C(Cl)S1 AEHIJBOZNXHLFF-UHFFFAOYSA-N 0.000 claims description 2
VRFJPBDEXLTGGM-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)COC1=CC=C(Cl)S1 VRFJPBDEXLTGGM-UHFFFAOYSA-N 0.000 claims description 2
PUXODIWPXYYGRL-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(6-chloro-1-benzothiophen-2-yl)ethyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(CCN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 PUXODIWPXYYGRL-UHFFFAOYSA-N 0.000 claims description 2
XAWXWRJUYRSRHX-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(2,5-dichlorothiophen-3-yl)prop-2-ynyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC#CC=1C=C(Cl)SC=1Cl XAWXWRJUYRSRHX-UHFFFAOYSA-N 0.000 claims description 2
OGGIAPDLOVLXSZ-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(2-chlorophenyl)prop-2-ynyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC#CC1=CC=CC=C1Cl OGGIAPDLOVLXSZ-UHFFFAOYSA-N 0.000 claims description 2
RVQWAWZXNNMTOA-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(3-chlorophenyl)prop-2-ynyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC#CC1=CC=CC(Cl)=C1 RVQWAWZXNNMTOA-UHFFFAOYSA-N 0.000 claims description 2
BEDRVIRGMCJGBM-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(3-chlorophenyl)propyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CCCC1=CC=CC(Cl)=C1 BEDRVIRGMCJGBM-UHFFFAOYSA-N 0.000 claims description 2
OZQAYRYMHQRQSI-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(3-methylphenyl)prop-2-ynyl]piperazin-2-one Chemical compound CC1=CC=CC(C#CCN2CC(=O)N(CC=3C=C4N=CN=C(N)C4=CC=3)CC2)=C1 OZQAYRYMHQRQSI-UHFFFAOYSA-N 0.000 claims description 2
LUMULQIYXABLTQ-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(3-phenylphenyl)prop-2-ynyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC#CC(C=1)=CC=CC=1C1=CC=CC=C1 LUMULQIYXABLTQ-UHFFFAOYSA-N 0.000 claims description 2
CHBYJJHCWKUQHQ-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-chlorophenyl)prop-2-ynyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC#CC1=CC=C(Cl)C=C1 CHBYJJHCWKUQHQ-UHFFFAOYSA-N 0.000 claims description 2
JYOHXMSDHLHLGD-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-chlorophenyl)propyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CCCC1=CC=C(Cl)C=C1 JYOHXMSDHLHLGD-UHFFFAOYSA-N 0.000 claims description 2
NEJCXVWBNBCQPO-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-methylphenyl)prop-2-ynyl]piperazin-2-one Chemical compound C1=CC(C)=CC=C1C#CCN1CC(=O)N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1 NEJCXVWBNBCQPO-UHFFFAOYSA-N 0.000 claims description 2
IPSHUAIHILKQKU-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-phenylphenyl)prop-2-ynyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC#CC(C=C1)=CC=C1C1=CC=CC=C1 IPSHUAIHILKQKU-UHFFFAOYSA-N 0.000 claims description 2
SMPHVPLIQJYCMS-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3,3-dimethylpiperazin-2-one Chemical compound C1CN(CC=2C=C3N=CN=C(N)C3=CC=2)C(=O)C(C)(C)N1C(=O)C=CC1=CC=C(Cl)S1 SMPHVPLIQJYCMS-UHFFFAOYSA-N 0.000 claims description 2
QJKGTSXSFUEUJP-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)propanoyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)CCC1=CC=C(Cl)S1 QJKGTSXSFUEUJP-UHFFFAOYSA-N 0.000 claims description 2
FOMGIDMGPTYDOQ-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[5-(1,2-oxazol-3-yl)thiophen-2-yl]sulfonylpiperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1S(=O)(=O)C(S1)=CC=C1C=1C=CON=1 FOMGIDMGPTYDOQ-UHFFFAOYSA-N 0.000 claims description 2
CTECOCZYUFJLEB-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[5-(5-methylthiophen-2-yl)penta-2,4-dienyl]piperazin-2-one Chemical compound S1C(C)=CC=C1C=CC=CCN1CC(=O)N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1 CTECOCZYUFJLEB-UHFFFAOYSA-N 0.000 claims description 2
VABWDILJHVGISM-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC(N=1)=CSC=1C1=CC=C(Cl)C=C1 VABWDILJHVGISM-UHFFFAOYSA-N 0.000 claims description 2
ASWKUECSFCYFHI-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[3,5-bis(trifluoromethyl)phenyl]methyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 ASWKUECSFCYFHI-UHFFFAOYSA-N 0.000 claims description 2
NYZKQGSWOKTZGC-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[3-(1,3-benzoxazol-2-yl)phenyl]methyl]piperazin-2-one Chemical compound C1=CC=C2OC(C=3C=CC=C(C=3)CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=NC2=C1 NYZKQGSWOKTZGC-UHFFFAOYSA-N 0.000 claims description 2
VBTAXBQWEZHFSU-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[3-(4-fluorophenoxy)phenyl]methyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC(C=1)=CC=CC=1OC1=CC=C(F)C=C1 VBTAXBQWEZHFSU-UHFFFAOYSA-N 0.000 claims description 2
PZOLCTVUJSGXHT-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[5-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,3-oxazol-2-yl]methyl]piperazin-2-one Chemical compound O1CCOC2=CC(C3=CN=C(O3)CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC=C21 PZOLCTVUJSGXHT-UHFFFAOYSA-N 0.000 claims description 2
WDFOHEDPLQUVDU-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[5-(3-chlorophenyl)thiophen-2-yl]methyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC(S1)=CC=C1C1=CC=CC(Cl)=C1 WDFOHEDPLQUVDU-UHFFFAOYSA-N 0.000 claims description 2
WGNYAXSXIRVNJE-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[5-(3-nitrophenyl)furan-2-yl]methyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC(O1)=CC=C1C1=CC=CC([N+]([O-])=O)=C1 WGNYAXSXIRVNJE-UHFFFAOYSA-N 0.000 claims description 2
BNDUKDAMOVXTDE-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[5-(4-chlorophenyl)thiophen-2-yl]methyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC(S1)=CC=C1C1=CC=C(Cl)C=C1 BNDUKDAMOVXTDE-UHFFFAOYSA-N 0.000 claims description 2
OFGRRWOUXANCCE-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[5-(4-methoxyphenyl)thiophen-2-yl]methyl]piperazin-2-one Chemical compound C1=CC(OC)=CC=C1C(S1)=CC=C1CN1CC(=O)N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1 OFGRRWOUXANCCE-UHFFFAOYSA-N 0.000 claims description 2
PNOGJQLRMQXRMT-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[5-[1-methyl-5-(trifluoromethyl)pyrazol-3-yl]thiophen-2-yl]methyl]piperazin-2-one Chemical compound C1=C(C(F)(F)F)N(C)N=C1C(S1)=CC=C1CN1CC(=O)N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1 PNOGJQLRMQXRMT-UHFFFAOYSA-N 0.000 claims description 2
PNRTXGXLSDZDTN-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN1CCNCC1=O PNRTXGXLSDZDTN-UHFFFAOYSA-N 0.000 claims description 2
CIRPVOWZXKBAQV-UHFFFAOYSA-N 1-[(4-aminoquinolin-7-yl)methyl]-4-[3-(4-bromothiophen-2-yl)prop-2-enoyl]piperazin-2-one Chemical compound C=1C=C2C(N)=CC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)C=CC1=CC(Br)=CS1 CIRPVOWZXKBAQV-UHFFFAOYSA-N 0.000 claims description 2
HOKVDVWDNLPHCS-UHFFFAOYSA-N 1-[(4-aminoquinolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]piperazin-2-one Chemical compound C=1C=C2C(N)=CC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)C=CC1=CC=C(Cl)S1 HOKVDVWDNLPHCS-UHFFFAOYSA-N 0.000 claims description 2
KRZZLDPDBPYJCI-UHFFFAOYSA-N 1-[(4-aminothieno[2,3-d]pyrimidin-6-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(CN3CCN(C(C3)=O)CC=3SC=4N=CN=C(C=4C=3)N)=CC2=C1 KRZZLDPDBPYJCI-UHFFFAOYSA-N 0.000 claims description 2
LXAREMWKFSQBLI-UHFFFAOYSA-N 1-[(4-aminothieno[2,3-d]pyrimidin-6-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC=3SC=4N=CN=C(C=4C=3)N)=CC2=C1 LXAREMWKFSQBLI-UHFFFAOYSA-N 0.000 claims description 2
YQMKOMRTVGHVTH-UHFFFAOYSA-N 1-[(4-aminothieno[3,2-c]pyridin-2-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC=3SC=4C=CN=C(C=4C=3)N)=CC2=C1 YQMKOMRTVGHVTH-UHFFFAOYSA-N 0.000 claims description 2
DQYSLHYVAVEKEN-UHFFFAOYSA-N 1-[(4-aminothieno[3,2-c]pyridin-3-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC3=CSC=4C=CN=C(C3=4)N)=CC2=C1 DQYSLHYVAVEKEN-UHFFFAOYSA-N 0.000 claims description 2
AESJULZFAITDSG-UHFFFAOYSA-N 1-[(4-aminothieno[3,2-d]pyrimidin-6-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(CN3CCN(C(C3)=O)CC3=CC=4N=CN=C(C=4S3)N)=CC2=C1 AESJULZFAITDSG-UHFFFAOYSA-N 0.000 claims description 2
PMDVILVEJYXQSD-UHFFFAOYSA-N 1-[(4-aminothieno[3,2-d]pyrimidin-6-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC3=CC=4N=CN=C(C=4S3)N)=CC2=C1 PMDVILVEJYXQSD-UHFFFAOYSA-N 0.000 claims description 2
RAWVFSFXCQMSRQ-UHFFFAOYSA-N 1-[(4-aminothieno[3,2-d]pyrimidin-6-yl)methyl]-4-[(7-chloroisoquinolin-3-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2C=NC(CN3CCN(C(C3)=O)CC3=CC=4N=CN=C(C=4S3)N)=CC2=C1 RAWVFSFXCQMSRQ-UHFFFAOYSA-N 0.000 claims description 2
YCTMZOVIZSALLK-UHFFFAOYSA-N 1-[(4-aminothieno[3,2-d]pyrimidin-6-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]piperazin-2-one Chemical compound S1C=2C(N)=NC=NC=2C=C1CN(C(C1)=O)CCN1C(=O)C=CC1=CC=C(Cl)S1 YCTMZOVIZSALLK-UHFFFAOYSA-N 0.000 claims description 2
KVKJYYYQVZHPAU-UHFFFAOYSA-N 1-[(4-aminothieno[3,2-d]pyrimidin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC=3C=4N=CN=C(C=4SC=3)N)=CC2=C1 KVKJYYYQVZHPAU-UHFFFAOYSA-N 0.000 claims description 2
WLPDEDJVUXTZSY-UHFFFAOYSA-N 1-[(4-chlorocinnolin-7-yl)methyl]piperazin-2-one Chemical compound C=1C=C2C(Cl)=CN=NC2=CC=1CN1CCNCC1=O WLPDEDJVUXTZSY-UHFFFAOYSA-N 0.000 claims description 2
CMIXLUFBQPQJIC-UHFFFAOYSA-N 1-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-5-oxo-4-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazine-2-carboxylic acid Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CC(=O)N(CC=4NC5=CC=NC=C5C=4)CC3C(=O)O)=CC2=C1 CMIXLUFBQPQJIC-UHFFFAOYSA-N 0.000 claims description 2
CRYKWXSMGAAYGH-UHFFFAOYSA-N 1-[(7-aminothieno[2,3-c]pyridin-2-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC3=CC=4C=CN=C(C=4S3)N)=CC2=C1 CRYKWXSMGAAYGH-UHFFFAOYSA-N 0.000 claims description 2
KIZVHBMKOLDMOZ-UHFFFAOYSA-N 1-[2-(pyridazin-4-ylamino)ethyl]piperazin-2-one Chemical compound O=C1CNCCN1CCNC1=CC=NN=C1 KIZVHBMKOLDMOZ-UHFFFAOYSA-N 0.000 claims description 2
JZJQEMMSTBRCLW-UHFFFAOYSA-N 1-[2-(pyridin-4-ylamino)ethyl]-4-thieno[2,3-b]pyridin-2-ylsulfonylpiperazin-2-one Chemical compound O=C1CN(S(=O)(=O)C=2SC3=NC=CC=C3C=2)CCN1CCNC1=CC=NC=C1 JZJQEMMSTBRCLW-UHFFFAOYSA-N 0.000 claims description 2
LJZIZLNUGIZUHY-UHFFFAOYSA-N 1-[2-(pyridin-4-ylamino)ethyl]-4-thieno[3,2-b]pyridin-2-ylsulfonylpiperazin-2-one Chemical compound O=C1CN(S(=O)(=O)C=2SC3=CC=CN=C3C=2)CCN1CCNC1=CC=NC=C1 LJZIZLNUGIZUHY-UHFFFAOYSA-N 0.000 claims description 2
VWGALLSZEUGDHF-UHFFFAOYSA-N 1-[2-(pyridin-4-ylamino)ethyl]piperazin-2-one Chemical compound O=C1CNCCN1CCNC1=CC=NC=C1 VWGALLSZEUGDHF-UHFFFAOYSA-N 0.000 claims description 2
WUCQVCASJDWMHL-UHFFFAOYSA-N 1-[2-[(2-amino-3-chloropyridin-4-yl)amino]ethyl]-4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]piperazin-2-one Chemical compound NC1=NC=CC(NCCN2C(CN(CC2)S(=O)(=O)C=CC=2SC(Cl)=CC=2)=O)=C1Cl WUCQVCASJDWMHL-UHFFFAOYSA-N 0.000 claims description 2
QOMRBIOVACKYLQ-UHFFFAOYSA-N 1-[2-[(3-methylpyridin-4-yl)amino]ethyl]piperazin-2-one Chemical compound CC1=CN=CC=C1NCCN1C(=O)CNCC1 QOMRBIOVACKYLQ-UHFFFAOYSA-N 0.000 claims description 2
BAYNIUKFHHWSFU-UHFFFAOYSA-N 1-[2-[methyl(pyridin-4-yl)amino]ethyl]piperazin-2-one 2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C=1C=NC=CC=1N(C)CCN1CCNCC1=O BAYNIUKFHHWSFU-UHFFFAOYSA-N 0.000 claims description 2
SMKHDFNCCGCJSL-UHFFFAOYSA-N 1-[3-(4-aminopyridin-3-yl)prop-1-enyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound NC1=CC=NC=C1CC=CN1C(=O)CN(S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)CC1 SMKHDFNCCGCJSL-UHFFFAOYSA-N 0.000 claims description 2
SUYXAMALHLYLGO-UHFFFAOYSA-N 1-[3-(4-aminopyridin-3-yl)propyl]-4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]piperazin-2-one Chemical compound NC1=CC=NC=C1CCCN1C(=O)CN(S(=O)(=O)C=CC=2SC(Cl)=CC=2)CC1 SUYXAMALHLYLGO-UHFFFAOYSA-N 0.000 claims description 2
PEUXZGBCAOQGRK-UHFFFAOYSA-N 1-benzyl-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC1=CC=CC=C1 PEUXZGBCAOQGRK-UHFFFAOYSA-N 0.000 claims description 2
QDKWLJJOYIFEBS-UHFFFAOYSA-N 1-fluoro-4-$l^{1}-oxidanylbenzene Chemical group [O]C1=CC=C(F)C=C1 QDKWLJJOYIFEBS-UHFFFAOYSA-N 0.000 claims description 2
NVNOZTZNKBRSDF-UHFFFAOYSA-N 2-[2-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]pyrrolo[3,2-c]pyridin-1-yl]acetic acid Chemical compound N1=CC=C2N(CC(=O)O)C(CN3C(CN(CC3)S(=O)(=O)C=3SC4=CC(Cl)=CC=C4C=3)=O)=CC2=C1 NVNOZTZNKBRSDF-UHFFFAOYSA-N 0.000 claims description 2
GYZLGQMZRBYZNZ-UHFFFAOYSA-N 2-[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazine-1-carbonyl]-6-chloro-4h-1,4-benzothiazin-3-one Chemical compound S1C2=CC=C(Cl)C=C2NC(=O)C1C(=O)N(CC1=O)CCN1CC1=CC=C2C(N)=NC=NC2=C1 GYZLGQMZRBYZNZ-UHFFFAOYSA-N 0.000 claims description 2
LYUPMGXLNJDWOT-UHFFFAOYSA-N 2-[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]-n-[2-(1-methylpyrrol-2-yl)ethyl]acetamide Chemical compound CN1C=CC=C1CCNC(=O)CN1C(=O)CN(S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)CC1 LYUPMGXLNJDWOT-UHFFFAOYSA-N 0.000 claims description 2
GFCOASLPAVORJU-UHFFFAOYSA-N 2-[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]-n-pyrimidin-4-ylacetamide Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(=O)NC1=CC=NC=N1 GFCOASLPAVORJU-UHFFFAOYSA-N 0.000 claims description 2
SFBLBGAGMPSGSA-UHFFFAOYSA-N 2-[[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazin-1-yl]methyl]-3-(4-chlorophenyl)prop-2-enoic acid Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC(C(O)=O)=CC1=CC=C(Cl)C=C1 SFBLBGAGMPSGSA-UHFFFAOYSA-N 0.000 claims description 2
PNKLPQGHISAFAX-UHFFFAOYSA-N 2-[[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazin-1-yl]methyl]-6-chloro-1h-quinazolin-4-one Chemical compound C1=C(Cl)C=C2C(=O)NC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=NC2=C1 PNKLPQGHISAFAX-UHFFFAOYSA-N 0.000 claims description 2
BLBHYBAZHKAFNO-UHFFFAOYSA-N 2-[[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazin-1-yl]methyl]-6-chloro-4h-1,4-benzothiazin-3-one Chemical compound S1C2=CC=C(Cl)C=C2NC(=O)C1CN(CC1=O)CCN1CC1=CC=C2C(N)=NC=NC2=C1 BLBHYBAZHKAFNO-UHFFFAOYSA-N 0.000 claims description 2
ZOBJJZIYTREFDZ-UHFFFAOYSA-N 2-amino-4-[[4-[(6-chloro-1h-benzimidazol-2-yl)methyl]-2-oxopiperidin-1-yl]methyl]benzonitrile Chemical compound C1=C(C#N)C(N)=CC(CN2C(CC(CC=3NC4=CC(Cl)=CC=C4N=3)CC2)=O)=C1 ZOBJJZIYTREFDZ-UHFFFAOYSA-N 0.000 claims description 2
125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 claims description 2
125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims description 2
PRMSFVUWLBPPLY-UHFFFAOYSA-N 3-({4-[(6-chloro-1-benzothien-2-yl)sulfonyl]-2-oxopiperazin-1-yl}methyl)benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=C1 PRMSFVUWLBPPLY-UHFFFAOYSA-N 0.000 claims description 2
AVXKXPDUVAYPFZ-UHFFFAOYSA-N 3-[[3-oxo-4-[(3-phenylphenyl)methyl]piperazin-1-yl]methyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(CN2CC(=O)N(CC=3C=C(C=CC=3)C=3C=CC=CC=3)CC2)=C1 AVXKXPDUVAYPFZ-UHFFFAOYSA-N 0.000 claims description 2
VYPYKEMZXWPEMG-UHFFFAOYSA-N 3-[[4-(1-benzothiophen-2-ylsulfonyl)-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC=CC=C3C=2)=O)=C1 VYPYKEMZXWPEMG-UHFFFAOYSA-N 0.000 claims description 2
QQJLQBVAGGTUNE-UHFFFAOYSA-N 3-[[4-(4-methylphenyl)sulfonyl-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CC(=O)N(CC=2C=C(C=CC=2)C(N)=N)CC1 QQJLQBVAGGTUNE-UHFFFAOYSA-N 0.000 claims description 2
YOPHZYJZQZFVGX-UHFFFAOYSA-N 3-[[4-(6-methoxynaphthalen-2-yl)sulfonyl-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C1=CC2=CC(OC)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC1=CC=CC(C(N)=N)=C1 YOPHZYJZQZFVGX-UHFFFAOYSA-N 0.000 claims description 2
LCARCRIPNVHNNF-UHFFFAOYSA-N 3-[[4-[(2-aminoquinolin-6-yl)methyl]-3-oxopiperazin-1-yl]methyl]-7-fluoro-1h-quinolin-2-one Chemical compound C1=C(F)C=C2NC(=O)C(CN3CCN(C(C3)=O)CC3=CC4=CC=C(N=C4C=C3)N)=CC2=C1 LCARCRIPNVHNNF-UHFFFAOYSA-N 0.000 claims description 2
KTPSLHFCCVXGGJ-UHFFFAOYSA-N 3-[[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazin-1-yl]methyl]-7-chloro-2h-isoquinolin-1-one Chemical compound C1=C(Cl)C=C2C(O)=NC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 KTPSLHFCCVXGGJ-UHFFFAOYSA-N 0.000 claims description 2
FADGULQQSCXREE-UHFFFAOYSA-N 3-[[4-[(4-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC=CC(Cl)=C3C=2)=O)=C1 FADGULQQSCXREE-UHFFFAOYSA-N 0.000 claims description 2
WNSTVUABFHOYAE-UHFFFAOYSA-N 3-[[4-[(5-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC=C(Cl)C=C3C=2)=O)=C1 WNSTVUABFHOYAE-UHFFFAOYSA-N 0.000 claims description 2
AETDBVJJAABBTK-UHFFFAOYSA-N 3-[[4-[(6-chloro-1-benzothiophen-2-yl)methyl]-2,5-dioxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(CN2C(CN(CC=3SC4=CC(Cl)=CC=C4C=3)C(=O)C2)=O)=C1 AETDBVJJAABBTK-UHFFFAOYSA-N 0.000 claims description 2
NIJAEPFMFVZVEG-UHFFFAOYSA-N 3-[[4-[(6-chloro-1h-benzimidazol-2-yl)methyl]-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(CN2C(CN(CC=3NC4=CC(Cl)=CC=C4N=3)CC2)=O)=C1 NIJAEPFMFVZVEG-UHFFFAOYSA-N 0.000 claims description 2
GNJLLUNIAFVQMZ-UHFFFAOYSA-N 3-[[4-[(6-fluoro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(F)=CC=C3C=2)=O)=C1 GNJLLUNIAFVQMZ-UHFFFAOYSA-N 0.000 claims description 2
JUUPKGZRLFTNTE-FNORWQNLSA-N 3-[[4-[(e)-3-(5-chlorothiophen-2-yl)prop-2-enoyl]-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(CN2C(CN(CC2)C(=O)\C=C\C=2SC(Cl)=CC=2)=O)=C1 JUUPKGZRLFTNTE-FNORWQNLSA-N 0.000 claims description 2
RXVLPBWBAHNSNX-UHFFFAOYSA-N 3-[[4-[2-(3-chlorophenyl)ethenylsulfonyl]-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(CN2C(CN(CC2)S(=O)(=O)C=CC=2C=C(Cl)C=CC=2)=O)=C1 RXVLPBWBAHNSNX-UHFFFAOYSA-N 0.000 claims description 2
125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 claims description 2
PNPCRKVUWYDDST-UHFFFAOYSA-N 3-chloroaniline Chemical compound NC1=CC=CC(Cl)=C1 PNPCRKVUWYDDST-UHFFFAOYSA-N 0.000 claims description 2
125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 claims description 2
FDYICBIXKAIKOA-UHFFFAOYSA-N 4-(1h-benzimidazol-2-ylsulfonyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=CC=C2NC(S(=O)(=O)N3CC(N(CC3)CC=3NC4=CC=NC=C4C=3)=O)=NC2=C1 FDYICBIXKAIKOA-UHFFFAOYSA-N 0.000 claims description 2
SOLPNUKRJVANFL-UHFFFAOYSA-N 4-(1h-pyrrolo[2,3-c]pyridin-2-ylmethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC=4NC5=CN=CC=C5C=4)CC3=O)=CC2=C1 SOLPNUKRJVANFL-UHFFFAOYSA-N 0.000 claims description 2
GJXURDUUEYEMRQ-UHFFFAOYSA-N 4-(3-aminophenyl)sulfonyl-1-[(4-aminoquinazolin-7-yl)methyl]piperazin-2-one Chemical compound NC1=CC=CC(S(=O)(=O)N2CC(=O)N(CC=3C=C4N=CN=C(N)C4=CC=3)CC2)=C1 GJXURDUUEYEMRQ-UHFFFAOYSA-N 0.000 claims description 2
APZOZGBPRZSDPQ-UHFFFAOYSA-N 4-(3-phenylprop-2-ynyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1CN(CC=2NC3=CC=NC=C3C=2)C(=O)CN1CC#CC1=CC=CC=C1 APZOZGBPRZSDPQ-UHFFFAOYSA-N 0.000 claims description 2
XXXQCWCAJYVSOW-UHFFFAOYSA-N 4-(5-pyridin-4-ylthiophen-2-yl)sulfonyl-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1CN(CC=2NC3=CC=NC=C3C=2)C(=O)CN1S(=O)(=O)C(S1)=CC=C1C1=CC=NC=C1 XXXQCWCAJYVSOW-UHFFFAOYSA-N 0.000 claims description 2
XOEGHPVQJFFHDW-UHFFFAOYSA-N 4-(6-chlorothieno[2,3-b]pyridin-2-yl)sulfonyl-1-(1h-pyrrolo[2,3-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=NC=C2NC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(N=C4S3)Cl)=CC2=C1 XOEGHPVQJFFHDW-UHFFFAOYSA-N 0.000 claims description 2
MMLVQVYPEVEZGN-UHFFFAOYSA-N 4-(6-chlorothieno[2,3-b]pyridin-2-yl)sulfonyl-1-[2-(pyridin-4-ylamino)ethyl]piperazin-2-one Chemical compound S1C2=NC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CCNC1=CC=NC=C1 MMLVQVYPEVEZGN-UHFFFAOYSA-N 0.000 claims description 2
WKCHKYQELWEEMV-UHFFFAOYSA-N 4-(6-chlorothieno[3,2-b]pyridin-2-yl)sulfonyl-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=NC=C(C=C4S3)Cl)=CC2=C1 WKCHKYQELWEEMV-UHFFFAOYSA-N 0.000 claims description 2
WJEHLJQNCZCIDE-UHFFFAOYSA-N 4-[(1-amino-7-chloroisoquinolin-3-yl)methyl]-1-[(4-aminoquinazolin-7-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2C(N)=NC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 WJEHLJQNCZCIDE-UHFFFAOYSA-N 0.000 claims description 2
FPTHROAYCPFNOI-UHFFFAOYSA-N 4-[(2-amino-7-chloroquinolin-3-yl)methyl]-1-[(4-aminoquinazolin-7-yl)methyl]piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC3=O)CC3=CC4=CC=C(Cl)C=C4N=C3N)=CC=C21 FPTHROAYCPFNOI-UHFFFAOYSA-N 0.000 claims description 2
KLZBJNAZJQHBBS-UHFFFAOYSA-N 4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazine-1-carboxylic acid Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN1CCN(C(O)=O)CC1=O KLZBJNAZJQHBBS-UHFFFAOYSA-N 0.000 claims description 2
LZJHFHWEIBYIQE-UHFFFAOYSA-N 4-[(4-aminoquinazolin-7-yl)methyl]-n-(5-chlorothiophen-2-yl)-3-oxopiperazine-1-carboxamide Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)NC1=CC=C(Cl)S1 LZJHFHWEIBYIQE-UHFFFAOYSA-N 0.000 claims description 2
UGSBJCNHXKLQQP-UHFFFAOYSA-N 4-[(4-aminoquinazolin-7-yl)methyl]-n-[(3-chlorophenyl)methyl]-3-oxopiperazine-1-sulfonamide Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1S(=O)(=O)NCC1=CC=CC(Cl)=C1 UGSBJCNHXKLQQP-UHFFFAOYSA-N 0.000 claims description 2
YREXIKMRNAOWEW-UHFFFAOYSA-N 4-[(4-aminoquinazolin-7-yl)methyl]-n-[(4-chlorophenyl)methyl]-3-oxopiperazine-1-sulfonamide Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1S(=O)(=O)NCC1=CC=C(Cl)C=C1 YREXIKMRNAOWEW-UHFFFAOYSA-N 0.000 claims description 2
ZOTCNCNVUBRVOV-UHFFFAOYSA-N 4-[(5-chloro-1h-indol-2-yl)methyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC3=O)CC=3NC4=CC=C(C=C4C=3)Cl)=CC2=C1 ZOTCNCNVUBRVOV-UHFFFAOYSA-N 0.000 claims description 2
SIFRVUXVQGVNGB-UHFFFAOYSA-N 4-[(5-chloro-1h-indol-2-yl)methyl]-1-[(4-chloroquinolin-7-yl)methyl]piperazin-2-one Chemical compound ClC1=CC=NC2=CC(CN3CCN(CC3=O)CC=3NC4=CC=C(C=C4C=3)Cl)=CC=C21 SIFRVUXVQGVNGB-UHFFFAOYSA-N 0.000 claims description 2
FKTOGINWCZSRPX-UHFFFAOYSA-N 4-[(5-chloro-1h-indol-2-yl)methyl]-1-[[4-(2-hydroxyethylamino)quinolin-7-yl]methyl]piperazin-2-one Chemical compound ClC1=CC=C2NC(CN3CCN(C(C3)=O)CC=3C=C4N=CC=C(C4=CC=3)NCCO)=CC2=C1 FKTOGINWCZSRPX-UHFFFAOYSA-N 0.000 claims description 2
SUYSPBVFJVQBSZ-UHFFFAOYSA-N 4-[(6-amino-1-benzothiophen-2-yl)methyl]-1-[(4-aminoquinazolin-7-yl)methyl]piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC3=O)CC3=CC4=CC=C(C=C4S3)N)=CC=C21 SUYSPBVFJVQBSZ-UHFFFAOYSA-N 0.000 claims description 2
FTDXWBPXALILLG-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(1,2,3,4-tetrahydroisoquinolin-6-ylmethyl)piperazin-2-one Chemical compound C1NCCC2=CC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)Cl)=CC=C21 FTDXWBPXALILLG-UHFFFAOYSA-N 0.000 claims description 2
RBJGVOFWIYFBMK-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(1h-pyrrolo[2,3-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=NC=C2NC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)Cl)=CC2=C1 RBJGVOFWIYFBMK-UHFFFAOYSA-N 0.000 claims description 2
SZWQUBUUZPTTEK-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(1h-pyrrolo[3,2-b]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=CC=C2NC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)Cl)=CC2=N1 SZWQUBUUZPTTEK-UHFFFAOYSA-N 0.000 claims description 2
XAGDUHBFFVIFGV-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(2-piperidin-4-ylethyl)piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CCC1CCNCC1 XAGDUHBFFVIFGV-UHFFFAOYSA-N 0.000 claims description 2
WCTNNHMFXZEAAH-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(3-piperidin-4-ylpropyl)piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CCCC1CCNCC1 WCTNNHMFXZEAAH-UHFFFAOYSA-N 0.000 claims description 2
HNPAYUJPXXLQAT-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(3-pyridin-4-ylpropyl)piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CCCC1=CC=NC=C1 HNPAYUJPXXLQAT-UHFFFAOYSA-N 0.000 claims description 2
RQMJISHIMYUXOX-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(4-piperidin-4-ylbutyl)piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CCCCC1CCNCC1 RQMJISHIMYUXOX-UHFFFAOYSA-N 0.000 claims description 2
JHKADIBGGLFWIN-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(isoquinolin-6-ylmethyl)piperazin-2-one Chemical compound C1=NC=CC2=CC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)Cl)=CC=C21 JHKADIBGGLFWIN-UHFFFAOYSA-N 0.000 claims description 2
YYSHYQCBLKQDPI-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(quinolin-6-ylmethyl)piperazin-2-one Chemical compound N1=CC=CC2=CC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)Cl)=CC=C21 YYSHYQCBLKQDPI-UHFFFAOYSA-N 0.000 claims description 2
NVQALUJXUKUUGD-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(thieno[2,3-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=NC=C2SC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)Cl)=CC2=C1 NVQALUJXUKUUGD-UHFFFAOYSA-N 0.000 claims description 2
IOYOXXDRTFYBEV-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(thieno[2,3-c]pyridin-3-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2C(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)Cl)=CSC2=C1 IOYOXXDRTFYBEV-UHFFFAOYSA-N 0.000 claims description 2
ZFEMZURPEYWMCK-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(thieno[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2SC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)Cl)=CC2=C1 ZFEMZURPEYWMCK-UHFFFAOYSA-N 0.000 claims description 2
CBSMNZBRWBTDDH-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[(1-chloroisoquinolin-6-yl)methyl]piperazin-2-one Chemical compound ClC1=NC=CC2=CC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)Cl)=CC=C21 CBSMNZBRWBTDDH-UHFFFAOYSA-N 0.000 claims description 2
FFAJTTRYZHEHKY-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[(1-chloroisoquinolin-7-yl)methyl]piperazin-2-one Chemical compound C1=CN=C(Cl)C2=CC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)Cl)=CC=C21 FFAJTTRYZHEHKY-UHFFFAOYSA-N 0.000 claims description 2
RYKYSAMFJVJJGW-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[(1-ethylpyrrolo[3,2-c]pyridin-2-yl)methyl]piperazin-2-one Chemical compound N1=CC=C2N(CC)C(CN3C(CN(CC3)S(=O)(=O)C=3SC4=CC(Cl)=CC=C4C=3)=O)=CC2=C1 RYKYSAMFJVJJGW-UHFFFAOYSA-N 0.000 claims description 2
ZTGGRTOLTZKBLG-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[(4-chloro-3-hydroxyphenyl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C(O)=CC(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=C1 ZTGGRTOLTZKBLG-UHFFFAOYSA-N 0.000 claims description 2
GAFDXQLFXQXSRS-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[(4-chlorophenyl)methyl]piperazin-2-one Chemical compound C1=CC(Cl)=CC=C1CN1C(=O)CN(S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)CC1 GAFDXQLFXQXSRS-UHFFFAOYSA-N 0.000 claims description 2
MBROHYWUDGAGES-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[2-(pyridin-4-ylamino)ethyl]piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CCNC1=CC=NC=C1 MBROHYWUDGAGES-UHFFFAOYSA-N 0.000 claims description 2
QENQTDWRYPQVKB-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[2-[(3-methylpyridin-4-yl)amino]ethyl]piperazin-2-one Chemical compound CC1=CN=CC=C1NCCN1C(=O)CN(S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)CC1 QENQTDWRYPQVKB-UHFFFAOYSA-N 0.000 claims description 2
UGLONZWDIHDYTK-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[2-[methyl(pyridin-4-yl)amino]ethyl]piperazin-2-one Chemical compound C1CN(S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)CC(=O)N1CCN(C)C1=CC=NC=C1 UGLONZWDIHDYTK-UHFFFAOYSA-N 0.000 claims description 2
NZNFLUOJACWZKX-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[[1-(2-hydroxyethyl)pyrrolo[3,2-c]pyridin-2-yl]methyl]piperazin-2-one Chemical compound N1=CC=C2N(CCO)C(CN3C(CN(CC3)S(=O)(=O)C=3SC4=CC(Cl)=CC=C4C=3)=O)=CC2=C1 NZNFLUOJACWZKX-UHFFFAOYSA-N 0.000 claims description 2
NSFXSTDNAOBFAH-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[[1-(2-methoxyethyl)pyrrolo[3,2-c]pyridin-2-yl]methyl]piperazin-2-one Chemical compound N1=CC=C2N(CCOC)C(CN3C(CN(CC3)S(=O)(=O)C=3SC4=CC(Cl)=CC=C4C=3)=O)=CC2=C1 NSFXSTDNAOBFAH-UHFFFAOYSA-N 0.000 claims description 2
QZZPBHWWPIIQAY-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-oxo-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazine-2-carboxylic acid Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CC(N(C(=O)C3)CC=3NC4=CC=NC=C4C=3)C(=O)O)=CC2=C1 QZZPBHWWPIIQAY-UHFFFAOYSA-N 0.000 claims description 2
YVRQNQPJAFGRQL-UHFFFAOYSA-N 4-[(6-chloro-1h-benzimidazol-2-yl)methyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC3=O)CC3=NC4=CC=C(C=C4N3)Cl)=CC2=C1 YVRQNQPJAFGRQL-UHFFFAOYSA-N 0.000 claims description 2
RBZUKXXTTQTBIU-UHFFFAOYSA-N 4-[(6-chloro-1h-benzimidazol-2-yl)methyl]-1-[(2,4-diaminoquinazolin-7-yl)methyl]piperidin-2-one Chemical compound C1=C(Cl)C=C2NC(CC3CCN(C(C3)=O)CC=3C=CC4=C(N)N=C(N=C4C=3)N)=NC2=C1 RBZUKXXTTQTBIU-UHFFFAOYSA-N 0.000 claims description 2
HHMWPVNSBJHBDE-UHFFFAOYSA-N 4-[(6-chloro-1h-benzimidazol-2-yl)sulfonyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC3=O)S(=O)(=O)C3=NC4=CC=C(C=C4N3)Cl)=CC2=C1 HHMWPVNSBJHBDE-UHFFFAOYSA-N 0.000 claims description 2
YMOHXXCSQMLKJX-UHFFFAOYSA-N 4-[(6-chloronaphthalen-2-yl)methyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC3=O)CC3=CC4=CC=C(C=C4C=C3)Cl)=CC2=C1 YMOHXXCSQMLKJX-UHFFFAOYSA-N 0.000 claims description 2
VOVOTMDETCHTIU-UHFFFAOYSA-N 4-[(6-fluoro-1-benzothiophen-2-yl)sulfonyl]-1-(furo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2OC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)F)=CC2=C1 VOVOTMDETCHTIU-UHFFFAOYSA-N 0.000 claims description 2
UJWDYGUWYIFRRY-UXBLZVDNSA-N 4-[(E)-2-(4-chlorophenyl)ethenyl]sulfonyl-1-(1H-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=CC(Cl)=CC=C1\C=C\S(=O)(=O)N1CC(=O)N(CC=2NC3=CC=NC=C3C=2)CC1 UJWDYGUWYIFRRY-UXBLZVDNSA-N 0.000 claims description 2
DNEWDHXGIQYTBG-DUXPYHPUSA-N 4-[(e)-3-(3,4-dichlorophenyl)prop-2-enoyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=C(Cl)C(Cl)=CC=C1\C=C\C(=O)N1CC(=O)N(CC=2NC3=CC=NC=C3C=2)CC1 DNEWDHXGIQYTBG-DUXPYHPUSA-N 0.000 claims description 2
ALTFPBOGERDBTD-ZZXKWVIFSA-N 4-[(e)-3-(3-amino-4-chlorophenyl)prop-2-enoyl]-1-[(4-aminoquinazolin-7-yl)methyl]piperazin-2-one Chemical compound C1=C(Cl)C(N)=CC(\C=C\C(=O)N2CC(=O)N(CC=3C=C4N=CN=C(N)C4=CC=3)CC2)=C1 ALTFPBOGERDBTD-ZZXKWVIFSA-N 0.000 claims description 2
UMEYOPZISKLVDS-ZZXKWVIFSA-N 4-[(e)-3-(4-chlorophenyl)prop-2-enoyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=CC(Cl)=CC=C1\C=C\C(=O)N1CC(=O)N(CC=2NC3=CC=NC=C3C=2)CC1 UMEYOPZISKLVDS-ZZXKWVIFSA-N 0.000 claims description 2
VADQCXJLTKNVMW-UHFFFAOYSA-N 4-[2-(1-benzothiophen-2-yl)ethenylsulfonyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=CC=C2SC(C=CS(=O)(=O)N3CC(N(CC3)CC=3NC4=CC=NC=C4C=3)=O)=CC2=C1 VADQCXJLTKNVMW-UHFFFAOYSA-N 0.000 claims description 2
ZBOMVVUHFWBCMQ-UHFFFAOYSA-N 4-[2-(4-chlorophenyl)-2-methylpropanoyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1CN(CC=2NC3=CC=NC=C3C=2)C(=O)CN1C(=O)C(C)(C)C1=CC=C(Cl)C=C1 ZBOMVVUHFWBCMQ-UHFFFAOYSA-N 0.000 claims description 2
XXDYGNPFEQTQPE-UHFFFAOYSA-N 4-[2-(4-chlorophenyl)acetyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=CC(Cl)=CC=C1CC(=O)N1CC(=O)N(CC=2NC3=CC=NC=C3C=2)CC1 XXDYGNPFEQTQPE-UHFFFAOYSA-N 0.000 claims description 2
SJIYXWACWHVDOA-UHFFFAOYSA-N 4-[2-(5-chloro-3-methyl-1-benzothiophen-2-yl)acetyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound S1C2=CC=C(Cl)C=C2C(C)=C1CC(=O)N1CC(=O)N(CC=2NC3=CC=NC=C3C=2)CC1 SJIYXWACWHVDOA-UHFFFAOYSA-N 0.000 claims description 2
LHLYPNUVSWTKQO-UHFFFAOYSA-N 4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]-1-[2-[(3-methylpyridin-4-yl)amino]ethyl]piperazin-2-one Chemical compound CC1=CN=CC=C1NCCN1C(=O)CN(S(=O)(=O)C=CC=2SC(Cl)=CC=2)CC1 LHLYPNUVSWTKQO-UHFFFAOYSA-N 0.000 claims description 2
ACKUTQKSELGEMB-UHFFFAOYSA-N 4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]-1-[2-[methyl(pyridin-4-yl)amino]ethyl]piperazin-2-one Chemical compound C=1C=NC=CC=1N(C)CCN(C(C1)=O)CCN1S(=O)(=O)C=CC1=CC=C(Cl)S1 ACKUTQKSELGEMB-UHFFFAOYSA-N 0.000 claims description 2
IULVBFFYXSEISI-UHFFFAOYSA-N 4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]-6-(hydroxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1C(=O)N(CC=2NC3=CC=NC=C3C=2)C(CO)CN1S(=O)(=O)C=CC1=CC=C(Cl)S1 IULVBFFYXSEISI-UHFFFAOYSA-N 0.000 claims description 2
TWYWQKVDFUCHGG-UHFFFAOYSA-N 4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]-6-oxo-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazine-2-carboxylic acid Chemical compound C1C(=O)N(CC=2NC3=CC=NC=C3C=2)C(C(=O)O)CN1S(=O)(=O)C=CC1=CC=C(Cl)S1 TWYWQKVDFUCHGG-UHFFFAOYSA-N 0.000 claims description 2
SDBJDGBRRRGJND-UHFFFAOYSA-N 4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound S1C(Cl)=CC=C1OCC(=O)N1CC(=O)N(CC=2NC3=CC=NC=C3C=2)CC1 SDBJDGBRRRGJND-UHFFFAOYSA-N 0.000 claims description 2
BATGWXDNQKGPMZ-UHFFFAOYSA-N 4-[3-(5-chlorothiophen-2-yl)prop-2-ynyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound S1C(Cl)=CC=C1C#CCN1CC(=O)N(CC=2NC3=CC=NC=C3C=2)CC1 BATGWXDNQKGPMZ-UHFFFAOYSA-N 0.000 claims description 2
KNDKGJXKIRVIMX-UHFFFAOYSA-N 4-[3-(5-chlorothiophen-2-yl)propanoyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound S1C(Cl)=CC=C1CCC(=O)N1CC(=O)N(CC=2NC3=CC=NC=C3C=2)CC1 KNDKGJXKIRVIMX-UHFFFAOYSA-N 0.000 claims description 2
FEKZVVYBNUDVKN-UHFFFAOYSA-N 4-[4-(6-methoxypyridin-3-yl)benzoyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=NC(OC)=CC=C1C1=CC=C(C(=O)N2CC(=O)N(CC=3NC4=CC=NC=C4C=3)CC2)C=C1 FEKZVVYBNUDVKN-UHFFFAOYSA-N 0.000 claims description 2
QIHAVYPUEXRAOP-LSDHHAIUSA-N 4-[[(3r,5s)-4-[(6-chloro-1-benzothiophen-2-yl)methyl]-3,5-dimethyl-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C([C@@H](N([C@H](C)C1=O)CC=2SC3=CC(Cl)=CC=C3C=2)C)N1CC1=CC=C(C(N)=N)C=C1 QIHAVYPUEXRAOP-LSDHHAIUSA-N 0.000 claims description 2
DTKIRRUFXIWGOP-UHFFFAOYSA-N 4-[[4-(1-benzothiophen-2-ylsulfonyl)-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1CN1C(=O)CN(S(=O)(=O)C=2SC3=CC=CC=C3C=2)CC1 DTKIRRUFXIWGOP-UHFFFAOYSA-N 0.000 claims description 2
MFMJJUAODHUZLJ-UHFFFAOYSA-N 4-[[4-(4-chlorothieno[3,2-c]pyridin-2-yl)sulfonyl-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1CN1C(=O)CN(S(=O)(=O)C=2SC3=CC=NC(Cl)=C3C=2)CC1 MFMJJUAODHUZLJ-UHFFFAOYSA-N 0.000 claims description 2
DNPBVWONJXADQD-UHFFFAOYSA-N 4-[[4-(4-methoxyphenyl)sulfonyl-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N1CC(=O)N(CC=2C=CC(=CC=2)C(N)=N)CC1 DNPBVWONJXADQD-UHFFFAOYSA-N 0.000 claims description 2
ZSKAHROGRNJTTR-UHFFFAOYSA-N 4-[[4-(7-chlorothieno[2,3-c]pyridin-2-yl)sulfonyl-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1CN1C(=O)CN(S(=O)(=O)C=2SC3=C(Cl)N=CC=C3C=2)CC1 ZSKAHROGRNJTTR-UHFFFAOYSA-N 0.000 claims description 2
FDHDMWOOKCMAGW-UHFFFAOYSA-N 4-[[4-(cyclohexylmethyl)-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1CN1C(=O)CN(CC2CCCCC2)CC1 FDHDMWOOKCMAGW-UHFFFAOYSA-N 0.000 claims description 2
GXOINXSOXBQARU-UHFFFAOYSA-N 4-[[4-[(6-chloro-1-benzothiophen-2-yl)methyl]-2,5-dioxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1CN1C(=O)CN(CC=2SC3=CC(Cl)=CC=C3C=2)C(=O)C1 GXOINXSOXBQARU-UHFFFAOYSA-N 0.000 claims description 2
IHUZNHAQGUWFMQ-UHFFFAOYSA-N 4-[[4-[(6-chloro-1-benzothiophen-2-yl)methyl]-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1CN1C(=O)CN(CC=2SC3=CC(Cl)=CC=C3C=2)CC1 IHUZNHAQGUWFMQ-UHFFFAOYSA-N 0.000 claims description 2
OHGPBYXTOZATGW-UHFFFAOYSA-N 4-[[4-[(6-chloro-1-benzothiophen-2-yl)methyl]-3-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1CN1CC(=O)N(CC=2SC3=CC(Cl)=CC=C3C=2)CC1 OHGPBYXTOZATGW-UHFFFAOYSA-N 0.000 claims description 2
MUARJTKMZRFTOB-UHFFFAOYSA-N 4-[[4-[(6-chloro-1h-benzimidazol-2-yl)methyl]-2-oxopiperidin-1-yl]methyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1CN1C(=O)CC(CC=2NC3=CC(Cl)=CC=C3N=2)CC1 MUARJTKMZRFTOB-UHFFFAOYSA-N 0.000 claims description 2
KHRQFFNPLVOGCU-SOFGYWHQSA-N 4-[[4-[(e)-3-(5-chlorothiophen-2-yl)prop-2-enoyl]-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1CN1C(=O)CN(C(=O)\C=C\C=2SC(Cl)=CC=2)CC1 KHRQFFNPLVOGCU-SOFGYWHQSA-N 0.000 claims description 2
YKXQIGTZVBKMFK-UHFFFAOYSA-N 4-[[4-[5-(5-chlorothiophen-2-yl)thiophen-2-yl]sulfonyl-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1CN1C(=O)CN(S(=O)(=O)C=2SC(=CC=2)C=2SC(Cl)=CC=2)CC1 YKXQIGTZVBKMFK-UHFFFAOYSA-N 0.000 claims description 2
TYMPJTQGIPWBAC-UHFFFAOYSA-N 4-[[6-(aminomethyl)-1-benzothiophen-2-yl]sulfonyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)CN)=CC2=C1 TYMPJTQGIPWBAC-UHFFFAOYSA-N 0.000 claims description 2
MQEFUFBEWBIBCD-UHFFFAOYSA-N 4-amino-3-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=C(N)C(CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=C1 MQEFUFBEWBIBCD-UHFFFAOYSA-N 0.000 claims description 2
HTAXOQIVKCKTJR-UHFFFAOYSA-N 4-bromothiophene Chemical compound BrC1=[C]SC=C1 HTAXOQIVKCKTJR-UHFFFAOYSA-N 0.000 claims description 2
RTELOJSBNKTGFC-UHFFFAOYSA-N 5-[[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazin-1-yl]methyl]-2-pyridin-2-yl-1h-pyrimidin-6-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC(C(=N1)O)=CN=C1C1=CC=CC=N1 RTELOJSBNKTGFC-UHFFFAOYSA-N 0.000 claims description 2
CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 claims description 2
KIRXVOCNFBUPAS-UHFFFAOYSA-N 6-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-1h-quinazolin-4-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC3=CC=C4N=CN=C(C4=C3)O)=CC2=C1 KIRXVOCNFBUPAS-UHFFFAOYSA-N 0.000 claims description 2
IWJYBELEGMFMIT-UHFFFAOYSA-N 6-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-2h-isoquinolin-1-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC=3C=C4C=CN=C(C4=CC=3)O)=CC2=C1 IWJYBELEGMFMIT-UHFFFAOYSA-N 0.000 claims description 2
JMHHQAJYCMWCOZ-UHFFFAOYSA-N 7-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-1h-quinazolin-4-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)O)=CC2=C1 JMHHQAJYCMWCOZ-UHFFFAOYSA-N 0.000 claims description 2
XDJNWLNXUVWPLD-UHFFFAOYSA-N 7-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-2h-isoquinolin-1-one Chemical compound C1=CNC(=O)C2=CC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)Cl)=CC=C21 XDJNWLNXUVWPLD-UHFFFAOYSA-N 0.000 claims description 2
PIOJSCVWTGEZLN-UHFFFAOYSA-N 7-chloroisoquinoline Chemical compound C1=CN=CC2=CC(Cl)=CC=C21 PIOJSCVWTGEZLN-UHFFFAOYSA-N 0.000 claims description 2
206010002388 Angina unstable Diseases 0.000 claims description 2
QMOMLGIPEDHUKJ-UHFFFAOYSA-N COC(=O)C1NCC(N(C1)CC1=CC=2C=NC=CC2N1C(=O)O)=O Chemical compound COC(=O)C1NCC(N(C1)CC1=CC=2C=NC=CC2N1C(=O)O)=O QMOMLGIPEDHUKJ-UHFFFAOYSA-N 0.000 claims description 2
UTBCJTIMRQGREY-UQKRIMTDSA-N COCC[C@@H](C(N(CC1=CC=C2C(N)=NC=NC2=C1)CC1)=O)N1C(O)=O.NC(C=C1)=CC=C1Cl Chemical compound COCC[C@@H](C(N(CC1=CC=C2C(N)=NC=NC2=C1)CC1)=O)N1C(O)=O.NC(C=C1)=CC=C1Cl UTBCJTIMRQGREY-UQKRIMTDSA-N 0.000 claims description 2
206010053567 Coagulopathies Diseases 0.000 claims description 2
YGJRDBHXGDEFDV-UQKRIMTDSA-N NC1=NC=NC2=CC(=CC=C12)CN1C([C@@H](N(CC1)C(=O)O)CCC)=O.ClC1=CC=CS1 Chemical compound NC1=NC=NC2=CC(=CC=C12)CN1C([C@@H](N(CC1)C(=O)O)CCC)=O.ClC1=CC=CS1 YGJRDBHXGDEFDV-UQKRIMTDSA-N 0.000 claims description 2
206010040070 Septic Shock Diseases 0.000 claims description 2
AVRWEULSKHQETA-UHFFFAOYSA-N Thiophene-2 Chemical compound S1C=2CCCCCC=2C(C(=O)OC)=C1NC(=O)C1=C(F)C(F)=C(F)C(F)=C1F AVRWEULSKHQETA-UHFFFAOYSA-N 0.000 claims description 2
208000007814 Unstable Angina Diseases 0.000 claims description 2
208000036142 Viral infection Diseases 0.000 claims description 2
230000003187 abdominal effect Effects 0.000 claims description 2
HMLDICSXYSRARQ-DJNXLDHESA-N benzyl (2s)-4-[(4-chloroquinolin-7-yl)methyl]-2,6-dimethyl-3-oxopiperazine-1-carboxylate Chemical compound N1([C@@H](C)C(=O)N(CC=2C=C3N=CC=C(Cl)C3=CC=2)CC1C)C(=O)OCC1=CC=CC=C1 HMLDICSXYSRARQ-DJNXLDHESA-N 0.000 claims description 2
LJQROSPWTQZVDZ-UHFFFAOYSA-N benzyl 3-oxo-4-(2-pyrrolo[3,2-c]pyridin-1-ylethyl)piperazine-1-carboxylate Chemical compound C1CN(CCN2C3=CC=NC=C3C=C2)C(=O)CN1C(=O)OCC1=CC=CC=C1 LJQROSPWTQZVDZ-UHFFFAOYSA-N 0.000 claims description 2
208000015294 blood coagulation disease Diseases 0.000 claims description 2
QYUPJBHXBTUGKX-UHFFFAOYSA-N ethyl 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-oxopiperazine-2-carboxylate Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CC(N(C(=O)C3)CC=3C=C4N=CN=C(N)C4=CC=3)C(=O)OCC)=CC2=C1 QYUPJBHXBTUGKX-UHFFFAOYSA-N 0.000 claims description 2
230000005764 inhibitory process Effects 0.000 claims description 2
201000004332 intermediate coronary syndrome Diseases 0.000 claims description 2
230000007774 longterm Effects 0.000 claims description 2
210000003141 lower extremity Anatomy 0.000 claims description 2
NMKXZWUXOYXPDL-UHFFFAOYSA-N methyl 1-(6-chloro-1-benzothiophene-2-carbonyl)-5-oxo-4-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazine-2-carboxylate Chemical compound C1=C(Cl)C=C2SC(C(=O)N3CC(=O)N(CC=4NC5=CC=NC=C5C=4)CC3C(=O)OC)=CC2=C1 NMKXZWUXOYXPDL-UHFFFAOYSA-N 0.000 claims description 2
VUPAEHUJGAMZIZ-UHFFFAOYSA-N n-(3-aminopropyl)-2-[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]acetamide Chemical compound C1C(=O)N(CC(=O)NCCCN)CCN1S(=O)(=O)C1=CC2=CC=C(Cl)C=C2S1 VUPAEHUJGAMZIZ-UHFFFAOYSA-N 0.000 claims description 2
STNHAUMLKDQTPH-UHFFFAOYSA-N n-[1-[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazin-1-yl]-3-(5-chlorothiophen-2-yl)-1-oxopropan-2-yl]benzamide Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)C(NC(=O)C=1C=CC=CC=1)CC1=CC=C(Cl)S1 STNHAUMLKDQTPH-UHFFFAOYSA-N 0.000 claims description 2
BVFARFRUJFHWIX-UHFFFAOYSA-N n-[3-[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazin-1-yl]-1-(5-chlorothiophen-2-yl)-3-oxoprop-1-en-2-yl]acetamide Chemical compound C1CN(CC=2C=C3N=CN=C(N)C3=CC=2)C(=O)CN1C(=O)C(NC(=O)C)=CC1=CC=C(Cl)S1 BVFARFRUJFHWIX-UHFFFAOYSA-N 0.000 claims description 2
FSRQBRDJUCRKPO-UHFFFAOYSA-N n-[3-[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazin-1-yl]-1-(5-chlorothiophen-2-yl)-3-oxoprop-1-en-2-yl]benzamide Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)C(=CC=1SC(Cl)=CC=1)NC(=O)C1=CC=CC=C1 FSRQBRDJUCRKPO-UHFFFAOYSA-N 0.000 claims description 2
125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims description 2
230000001575 pathological effect Effects 0.000 claims description 2
230000036303 septic shock Effects 0.000 claims description 2
WFJLQMCXRVHDAY-UHFFFAOYSA-N tert-butyl 2-[(2-oxopiperazin-1-yl)methyl]pyrrolo[3,2-c]pyridine-1-carboxylate Chemical compound C=1C2=CN=CC=C2N(C(=O)OC(C)(C)C)C=1CN1CCNCC1=O WFJLQMCXRVHDAY-UHFFFAOYSA-N 0.000 claims description 2
DRZYCRFOGWMEES-UHFFFAOYSA-N tert-butyl n-pyridin-4-ylcarbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=NC=C1 DRZYCRFOGWMEES-UHFFFAOYSA-N 0.000 claims description 2
230000009385 viral infection Effects 0.000 claims description 2
230000004962 physiological condition Effects 0.000 claims 5
DBLWWGLWGKKJQH-KGLIPLIRSA-N (3s,5r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]-3,5-dimethylpiperazin-2-one Chemical compound N1([C@@H](C)C(=O)N(CC=2C=C3N=CN=C(N)C3=CC=2)C[C@H]1C)S(=O)(=O)C=CC1=CC=C(Cl)S1 DBLWWGLWGKKJQH-KGLIPLIRSA-N 0.000 claims 2
WNQPWDUXZIBVAW-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-(6-chlorothieno[2,3-b]pyridin-2-yl)sulfonylpiperazin-2-one Chemical compound C1=C(Cl)N=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 WNQPWDUXZIBVAW-UHFFFAOYSA-N 0.000 claims 2
VXONTEUOQXFJJS-UHFFFAOYSA-N 4-({4-[(6-chloro-1-benzothien-2-yl)sulfonyl]-2-oxopiperazin-1-yl}methyl)benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1CN1C(=O)CN(S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)CC1 VXONTEUOQXFJJS-UHFFFAOYSA-N 0.000 claims 2
JBKAVYVUVXLHPJ-UHFFFAOYSA-N 5-chlorothiophen-3-amine Chemical compound NC1=CSC(Cl)=C1 JBKAVYVUVXLHPJ-UHFFFAOYSA-N 0.000 claims 2
206010053648 Vascular occlusion Diseases 0.000 claims 2
238000002583 angiography Methods 0.000 claims 2
QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 claims 2
230000002526 effect on cardiovascular system Effects 0.000 claims 2
210000001624 hip Anatomy 0.000 claims 2
238000001356 surgical procedure Methods 0.000 claims 2
208000021331 vascular occlusion disease Diseases 0.000 claims 2
SXJRFJQQWDUBFI-QGZVFWFLSA-N (2R)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-oxopiperazine-2-carboxylic acid Chemical compound NC1=NC=NC2=CC(CN3[C@H](CN(CC3=O)S(=O)(=O)C3=CC4=CC=C(Cl)C=C4S3)C(O)=O)=CC=C12 SXJRFJQQWDUBFI-QGZVFWFLSA-N 0.000 claims 1
HFVVFEJIPTUERY-ZDUSSCGKSA-N (2s)-4-[(4-aminoquinazolin-7-yl)methyl]-2-(methoxymethyl)-3-oxopiperazine-1-carboxylic acid Chemical compound O=C1[C@H](COC)N(C(O)=O)CCN1CC1=CC=C(C(N)=NC=N2)C2=C1 HFVVFEJIPTUERY-ZDUSSCGKSA-N 0.000 claims 1
RVUHBXCXLSZLCO-AXDSSHIGSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-3,5-dimethylpiperazin-2-one Chemical compound O=C1[C@H](C)NC(C)CN1CC1=CC=C(C(N)=NC=N2)C2=C1 RVUHBXCXLSZLCO-AXDSSHIGSA-N 0.000 claims 1
OGSMMTQXQFMXBW-AWEZNQCLSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1-benzothiophen-2-yl)methyl]-3-methylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4SC5=CC=C(Cl)C=C5C=4)[C@H](C3=O)C)=CC=C21 OGSMMTQXQFMXBW-AWEZNQCLSA-N 0.000 claims 1
HVZUBRSERCSJCA-QFIPXVFZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(3-chloro-5-methoxyphenoxy)acetyl]-3-propylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCC)C(=O)COC1=CC(Cl)=CC(OC)=C1 HVZUBRSERCSJCA-QFIPXVFZSA-N 0.000 claims 1
QMTZEUJZASBPEE-NRFANRHFSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(3-chlorophenoxy)acetyl]-3-propylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCC)C(=O)COC1=CC=CC(Cl)=C1 QMTZEUJZASBPEE-NRFANRHFSA-N 0.000 claims 1
IYGKCNVPPPZLQE-KRWDZBQOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC1=CC(Cl)=CS1 IYGKCNVPPPZLQE-KRWDZBQOSA-N 0.000 claims 1
WVPQMKWNVAPBCA-LBPRGKRZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-3-yl)oxyacetyl]-3-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)C)C(=O)COC1=CSC(Cl)=C1 WVPQMKWNVAPBCA-LBPRGKRZSA-N 0.000 claims 1
LKOMQQCIRWZDMF-SFHVURJKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-[(6-chloropyridin-3-yl)amino]acetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)CNC1=CC=C(Cl)N=C1 LKOMQQCIRWZDMF-SFHVURJKSA-N 0.000 claims 1
UCMROFXIOMAPTC-SFHVURJKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(1h-imidazol-5-yl)prop-2-enoyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)C=CC1=CN=CN1 UCMROFXIOMAPTC-SFHVURJKSA-N 0.000 claims 1
AXXIWXDROTYGFT-NRFANRHFSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(3-chlorophenyl)prop-2-enoyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)C=CC1=CC=CC(Cl)=C1 AXXIWXDROTYGFT-NRFANRHFSA-N 0.000 claims 1
TVJGEUWLKHSCRW-SFHVURJKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]-3-ethylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CC)C(=O)C=CC1=CC=C(Cl)S1 TVJGEUWLKHSCRW-SFHVURJKSA-N 0.000 claims 1
MAZLTBVYVVBNMB-PKDNWHCCSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)propanoyl]-3-ethyl-6-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)C(C)C1)=O)CC)C(=O)CCC1=CC=C(Cl)S1 MAZLTBVYVVBNMB-PKDNWHCCSA-N 0.000 claims 1
DEEUVNUHXFDEBU-AWEZNQCLSA-N (3s)-1-[(4-aminoquinolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-3-methylpiperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3[C@H](C(N(CC=4C=C5N=CC=C(N)C5=CC=4)CC3)=O)C)=CC2=C1 DEEUVNUHXFDEBU-AWEZNQCLSA-N 0.000 claims 1
RYRDQANCZPRWQE-QUGAMOGWSA-N (3s)-1-[(4-aminoquinolin-7-yl)methyl]-4-[(7-chloroisoquinolin-3-yl)methyl]-3-[(1r)-1-methoxyethyl]piperazin-2-one Chemical compound NC1=CC=NC2=CC(CN3CCN(CC=4N=CC5=CC(Cl)=CC=C5C=4)[C@H](C3=O)[C@@H](C)OC)=CC=C21 RYRDQANCZPRWQE-QUGAMOGWSA-N 0.000 claims 1
FXTXFJBVDHNYSY-KRWDZBQOSA-N (3s)-4-[(5-chloro-1h-indol-2-yl)methyl]-1-[[4-(ethylamino)quinolin-7-yl]methyl]-3-methylpiperazin-2-one Chemical compound ClC1=CC=C2NC(CN3CCN(C([C@@H]3C)=O)CC=3C=C4N=CC=C(C4=CC=3)NCC)=CC2=C1 FXTXFJBVDHNYSY-KRWDZBQOSA-N 0.000 claims 1
VNMXBPKNADPIMN-IBGZPJMESA-N (3s)-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-3-(methoxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3[C@H](C(N(CC=4NC5=CC=NC=C5C=4)CC3)=O)COC)=CC2=C1 VNMXBPKNADPIMN-IBGZPJMESA-N 0.000 claims 1
LCOKXLTVWPWSLI-SFHVURJKSA-N (3s)-4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]-3-(methoxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2NC3=CC=NC=C3C=2)CC1)=O)COC)S(=O)(=O)C=CC1=CC=C(Cl)S1 LCOKXLTVWPWSLI-SFHVURJKSA-N 0.000 claims 1
XKCHZJNSXDWCBD-PBHICJAKSA-N (3s,6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-6-(hydroxymethyl)-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)[C@@H](CO)C1)=O)COC)C(=O)COC1=CC=C(Cl)S1 XKCHZJNSXDWCBD-PBHICJAKSA-N 0.000 claims 1
IKAPTTKIZZCVRD-QGZVFWFLSA-N (6r)-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-6-(hydroxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3C[C@@H](N(C(=O)C3)CC=3NC4=CC=NC=C4C=3)CO)=CC2=C1 IKAPTTKIZZCVRD-QGZVFWFLSA-N 0.000 claims 1
WBTXGVXORHZLMN-UHFFFAOYSA-N 1-(1H-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazine-2-carboxylic acid Chemical compound N1C(=CC=2C=NC=CC=21)CN1C(CNCC1)C(=O)O WBTXGVXORHZLMN-UHFFFAOYSA-N 0.000 claims 1
OJUCVMIOVOIAAR-UHFFFAOYSA-N 1-(methoxymethyl)-6-methylpiperazin-2-one Chemical compound COCN1C(C)CNCC1=O OJUCVMIOVOIAAR-UHFFFAOYSA-N 0.000 claims 1
YEUZWNMZCJAJLS-UHFFFAOYSA-N 1-[(2-aminoquinolin-6-yl)methyl]-4-(6-chlorothieno[2,3-b]pyridin-2-yl)sulfonylpiperazin-2-one Chemical compound C1=C(Cl)N=C2SC(S(=O)(=O)N3CCN(C(C3)=O)CC3=CC4=CC=C(N=C4C=C3)N)=CC2=C1 YEUZWNMZCJAJLS-UHFFFAOYSA-N 0.000 claims 1
MAGSYHOGBCMFIO-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-methyl-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC3=O)CC3=CC4=CC=C(C=C4S3)C)=CC=C21 MAGSYHOGBCMFIO-UHFFFAOYSA-N 0.000 claims 1
VETFOERZUYQSAV-GQCTYLIASA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(e)-3-(6-chloro-1-benzothiophen-2-yl)prop-2-enoyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(/C=C/C(=O)N3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 VETFOERZUYQSAV-GQCTYLIASA-N 0.000 claims 1
PXYXJYOSGQPXQY-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(6-chloro-1-benzothiophen-2-yl)acetyl]piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(CC(=O)N3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 PXYXJYOSGQPXQY-UHFFFAOYSA-N 0.000 claims 1
RVRVFCFMHAOXIO-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[6-(trifluoromethyl)-1h-benzimidazol-2-yl]methyl]piperazin-2-one Chemical compound C1=C(C(F)(F)F)C=C2NC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=NC2=C1 RVRVFCFMHAOXIO-UHFFFAOYSA-N 0.000 claims 1
RMIKRWSQRKNMCM-UHFFFAOYSA-N 1-[(4-aminothieno[2,3-d]pyrimidin-6-yl)methyl]piperazin-2-one Chemical compound C=1C=2C(N)=NC=NC=2SC=1CN1CCNCC1=O RMIKRWSQRKNMCM-UHFFFAOYSA-N 0.000 claims 1
BXGFHARRYNXCDZ-UHFFFAOYSA-N 1-[(4-chloroquinolin-7-yl)methyl]piperazin-2-one Chemical compound C=1C=C2C(Cl)=CC=NC2=CC=1CN1CCNCC1=O BXGFHARRYNXCDZ-UHFFFAOYSA-N 0.000 claims 1
VCKBIHFIJZFNKN-UHFFFAOYSA-N 1-prop-2-ynylpiperazin-2-one Chemical compound O=C1CNCCN1CC#C VCKBIHFIJZFNKN-UHFFFAOYSA-N 0.000 claims 1
125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims 1
125000000301 2-(3-chlorophenyl)ethyl group Chemical group [H]C1=C([H])C(=C([H])C(Cl)=C1[H])C([H])([H])C([H])([H])* 0.000 claims 1
MEJOLOKJUSMXPM-UHFFFAOYSA-N 2-[3-oxo-4-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-1-yl]sulfonyl-1-benzothiophene-6-carbonitrile Chemical compound C1=C(C#N)C=C2SC(S(=O)(=O)N3CC(N(CC3)CC=3NC4=CC=NC=C4C=3)=O)=CC2=C1 MEJOLOKJUSMXPM-UHFFFAOYSA-N 0.000 claims 1
XHQSKSFGZYAQNO-UHFFFAOYSA-N 2-[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]-n-[2-(1,3-thiazol-4-yl)ethyl]acetamide Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(=O)NCCC1=CSC=N1 XHQSKSFGZYAQNO-UHFFFAOYSA-N 0.000 claims 1
WLPATYNQCGVFFH-UHFFFAOYSA-N 2-phenylbenzonitrile Chemical compound N#CC1=CC=CC=C1C1=CC=CC=C1 WLPATYNQCGVFFH-UHFFFAOYSA-N 0.000 claims 1
IBOKUVQAAKXRRX-UHFFFAOYSA-N 4-(6-chloro-1-benzothiophene-2-carbonyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC3=O)C(=O)C3=CC4=CC=C(C=C4S3)Cl)=CC2=C1 IBOKUVQAAKXRRX-UHFFFAOYSA-N 0.000 claims 1
VJJIIGXVNNUUIY-UHFFFAOYSA-N 4-[(2-oxo-4-thieno[2,3-c]pyridin-2-ylsulfonylpiperazin-1-yl)methyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1CN1C(=O)CN(S(=O)(=O)C=2SC3=CN=CC=C3C=2)CC1 VJJIIGXVNNUUIY-UHFFFAOYSA-N 0.000 claims 1
GCQKWAIOYGOPBY-UHFFFAOYSA-N 4-[(3-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC3=O)S(=O)(=O)C3=C(C4=CC=CC=C4S3)Cl)=CC2=C1 GCQKWAIOYGOPBY-UHFFFAOYSA-N 0.000 claims 1
VWXDBAUVLWCHEA-UHFFFAOYSA-N 4-[(4-aminoquinazolin-7-yl)methyl]-n-(4-chlorothiophen-2-yl)-3-oxopiperazine-1-carboxamide Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)NC1=CC(Cl)=CS1 VWXDBAUVLWCHEA-UHFFFAOYSA-N 0.000 claims 1
BBBJYUVZSFKEBR-UHFFFAOYSA-N 4-[(4-aminoquinazolin-7-yl)methyl]-n-(4-methoxyphenyl)-3-oxopiperazine-1-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)N1CC(=O)N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1 BBBJYUVZSFKEBR-UHFFFAOYSA-N 0.000 claims 1
CTFPGRYHAAMXHC-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-(furo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2OC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)Cl)=CC2=C1 CTFPGRYHAAMXHC-UHFFFAOYSA-N 0.000 claims 1
WEJRWYKOINFKCI-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[3-(1h-imidazol-5-yl)propyl]piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CCCC1=CN=CN1 WEJRWYKOINFKCI-UHFFFAOYSA-N 0.000 claims 1
ADTFLQVGDFRGOM-OWOJBTEDSA-N 4-[(e)-3-(4-bromothiophen-2-yl)prop-2-enoyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound BrC1=CSC(\C=C\C(=O)N2CC(=O)N(CC=3NC4=CC=NC=C4C=3)CC2)=C1 ADTFLQVGDFRGOM-OWOJBTEDSA-N 0.000 claims 1
ADIHWLXKNSDPMC-ONEGZZNKSA-N 4-[(e)-3-(6-chloro-1-benzothiophen-2-yl)prop-2-enoyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC3=O)C(=O)/C=C/C3=CC4=CC=C(C=C4S3)Cl)=CC2=C1 ADIHWLXKNSDPMC-ONEGZZNKSA-N 0.000 claims 1
RWFNDWRMVQXYAW-UHFFFAOYSA-N 4-[1-(3,5-dichlorophenyl)-2,5-dimethylpyrrole-3-carbonyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound CC1=CC(C(=O)N2CC(=O)N(CC=3NC4=CC=NC=C4C=3)CC2)=C(C)N1C1=CC(Cl)=CC(Cl)=C1 RWFNDWRMVQXYAW-UHFFFAOYSA-N 0.000 claims 1
GQUHVKGRJHOIQQ-UHFFFAOYSA-N 4-[[4-(5-chlorothieno[3,2-b]pyridin-2-yl)sulfonyl-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1CN1C(=O)CN(S(=O)(=O)C=2SC3=CC=C(Cl)N=C3C=2)CC1 GQUHVKGRJHOIQQ-UHFFFAOYSA-N 0.000 claims 1
WPAMMUBHROJMEE-UHFFFAOYSA-N 4-[[5-(aminomethyl)-1-benzothiophen-2-yl]sulfonyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC3=O)S(=O)(=O)C=3SC4=CC=C(C=C4C=3)CN)=CC2=C1 WPAMMUBHROJMEE-UHFFFAOYSA-N 0.000 claims 1
WDFQBORIUYODSI-UHFFFAOYSA-N 4-bromoaniline Chemical compound NC1=CC=C(Br)C=C1 WDFQBORIUYODSI-UHFFFAOYSA-N 0.000 claims 1
KRZCOLNOCZKSDF-UHFFFAOYSA-N 4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1 KRZCOLNOCZKSDF-UHFFFAOYSA-N 0.000 claims 1
LLADQKTVQKKMJR-UHFFFAOYSA-N 4-prop-2-ynylpiperazin-2-one Chemical compound O=C1CN(CC#C)CCN1 LLADQKTVQKKMJR-UHFFFAOYSA-N 0.000 claims 1
PCHBMNCFKJKQPA-UHFFFAOYSA-N 5-chlorothiophen-2-amine Chemical compound NC1=CC=C(Cl)S1 PCHBMNCFKJKQPA-UHFFFAOYSA-N 0.000 claims 1
BSTKHZGENGWUPV-UHFFFAOYSA-N 6-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-1h-quinolin-2-one Chemical compound N1C(=O)C=CC2=CC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)Cl)=CC=C21 BSTKHZGENGWUPV-UHFFFAOYSA-N 0.000 claims 1
206010002383 Angina Pectoris Diseases 0.000 claims 1
ZXUSHLXSQZZQEB-UHFFFAOYSA-N C1CN(C(=O)CN1C(=O)N)CC2=CC3=C(C=C2)C(=NC=N3)N Chemical compound C1CN(C(=O)CN1C(=O)N)CC2=CC3=C(C=C2)C(=NC=N3)N ZXUSHLXSQZZQEB-UHFFFAOYSA-N 0.000 claims 1
HDJLRSJLGKSOBU-UHFFFAOYSA-N C1CN(C(=O)CN1CCS(=O)(=O)C2=CC(=CC=C2)Cl)CC3=CC4=C(C=C3)C(=NC=N4)N Chemical compound C1CN(C(=O)CN1CCS(=O)(=O)C2=CC(=CC=C2)Cl)CC3=CC4=C(C=C3)C(=NC=N4)N HDJLRSJLGKSOBU-UHFFFAOYSA-N 0.000 claims 1
SMISHCMUSWSIIX-LURJTMIESA-N CCC[C@H]1C(=O)NCCN1C(=O)O Chemical compound CCC[C@H]1C(=O)NCCN1C(=O)O SMISHCMUSWSIIX-LURJTMIESA-N 0.000 claims 1
206010010904 Convulsion Diseases 0.000 claims 1
206010056489 Coronary artery restenosis Diseases 0.000 claims 1
210000001015 abdomen Anatomy 0.000 claims 1
ATMLPEJAVWINOF-UHFFFAOYSA-N acrylic acid acrylic acid Chemical compound OC(=O)C=C.OC(=O)C=C ATMLPEJAVWINOF-UHFFFAOYSA-N 0.000 claims 1
238000002399 angioplasty Methods 0.000 claims 1
125000005605 benzo group Chemical group 0.000 claims 1
HMLDICSXYSRARQ-SJORKVTESA-N benzyl (2s,6r)-4-[(4-chloroquinolin-7-yl)methyl]-2,6-dimethyl-3-oxopiperazine-1-carboxylate Chemical compound N1([C@@H](C)C(=O)N(CC=2C=C3N=CC=C(Cl)C3=CC=2)C[C@H]1C)C(=O)OCC1=CC=CC=C1 HMLDICSXYSRARQ-SJORKVTESA-N 0.000 claims 1
125000004050 enoyl group Chemical group 0.000 claims 1
125000004475 heteroaralkyl group Chemical group 0.000 claims 1
208000015181 infectious disease Diseases 0.000 claims 1
238000007917 intracranial administration Methods 0.000 claims 1
230000000302 ischemic effect Effects 0.000 claims 1
ODQZNBWVRPKMKN-UHFFFAOYSA-N methyl piperazine-2-carboxylate Chemical compound COC(=O)C1CNCCN1 ODQZNBWVRPKMKN-UHFFFAOYSA-N 0.000 claims 1
230000002035 prolonged effect Effects 0.000 claims 1
230000002685 pulmonary effect Effects 0.000 claims 1
125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
ZUCLSHNCCUDVQA-UHFFFAOYSA-N tert-butyl 4-[3-(2-oxopiperazin-1-yl)propyl]piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1CCCN1C(=O)CNCC1 ZUCLSHNCCUDVQA-UHFFFAOYSA-N 0.000 claims 1
CUPOOAWTRIURFT-UHFFFAOYSA-N thiophene-2-carbonitrile Chemical compound N#CC1=CC=CS1 CUPOOAWTRIURFT-UHFFFAOYSA-N 0.000 claims 1
238000007631 vascular surgery Methods 0.000 claims 1
210000005166 vasculature Anatomy 0.000 claims 1
230000003612 virological effect Effects 0.000 claims 1
239000000543 intermediate Substances 0.000 abstract description 19
239000000243 solution Substances 0.000 description 300
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 221
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 213
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 204
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 109
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 105
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 95
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 90
238000005481 NMR spectroscopy Methods 0.000 description 77
239000007787 solid Substances 0.000 description 70
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 60
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 57
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 55
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 54
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 53
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 52
239000012044 organic layer Substances 0.000 description 48
125000000217 alkyl group Chemical group 0.000 description 47
238000001819 mass spectrum Methods 0.000 description 46
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 45
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 44
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 44
239000000741 silica gel Substances 0.000 description 41
229910002027 silica gel Inorganic materials 0.000 description 41
125000003118 aryl group Chemical group 0.000 description 39
238000005160 1H NMR spectroscopy Methods 0.000 description 32
239000010410 layer Substances 0.000 description 31
239000011541 reaction mixture Substances 0.000 description 30
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 27
239000002585 base Substances 0.000 description 27
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 26
239000003921 oil Substances 0.000 description 26
235000019198 oils Nutrition 0.000 description 26
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 25
238000004587 chromatography analysis Methods 0.000 description 25
238000002360 preparation method Methods 0.000 description 25
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 24
239000001301 oxygen Substances 0.000 description 24
239000002904 solvent Substances 0.000 description 24
238000000746 purification Methods 0.000 description 22
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 21
125000006413 ring segment Chemical group 0.000 description 21
125000001424 substituent group Chemical group 0.000 description 21
PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 20
239000012043 crude product Substances 0.000 description 20
229910052943 magnesium sulfate Inorganic materials 0.000 description 20
235000019341 magnesium sulphate Nutrition 0.000 description 20
125000004043 oxo group Chemical group O=* 0.000 description 20
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 18
VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 18
125000002252 acyl group Chemical group 0.000 description 17
125000003435 aroyl group Chemical group 0.000 description 16
238000009835 boiling Methods 0.000 description 16
239000000460 chlorine Substances 0.000 description 16
239000000047 product Substances 0.000 description 16
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 15
125000004414 alkyl thio group Chemical group 0.000 description 15
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 15
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 15
239000012074 organic phase Substances 0.000 description 15
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
125000004442 acylamino group Chemical group 0.000 description 14
125000004390 alkyl sulfonyl group Chemical group 0.000 description 13
125000000753 cycloalkyl group Chemical group 0.000 description 13
125000004434 sulfur atom Chemical group 0.000 description 13
WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 12
238000006243 chemical reaction Methods 0.000 description 12
238000001914 filtration Methods 0.000 description 12
KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 12
MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 11
229960000583 acetic acid Drugs 0.000 description 11
125000003342 alkenyl group Chemical group 0.000 description 11
125000003282 alkyl amino group Chemical group 0.000 description 11
125000004093 cyano group Chemical group *C#N 0.000 description 11
125000004122 cyclic group Chemical group 0.000 description 11
229910052736 halogen Inorganic materials 0.000 description 11
150000002367 halogens Chemical class 0.000 description 11
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 11
PHPBFBHVSTXJOL-UHFFFAOYSA-N 6-chloro-1-benzothiophene-2-sulfonyl chloride Chemical compound ClC1=CC=C2C=C(S(Cl)(=O)=O)SC2=C1 PHPBFBHVSTXJOL-UHFFFAOYSA-N 0.000 description 10
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 10
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 10
235000011054 acetic acid Nutrition 0.000 description 10
239000003153 chemical reaction reagent Substances 0.000 description 10
150000002148 esters Chemical class 0.000 description 10
239000000706 filtrate Substances 0.000 description 10
150000002500 ions Chemical class 0.000 description 10
239000012312 sodium hydride Substances 0.000 description 10
229910000104 sodium hydride Inorganic materials 0.000 description 10
229910052938 sodium sulfate Inorganic materials 0.000 description 10
235000011152 sodium sulphate Nutrition 0.000 description 10
239000007921 spray Substances 0.000 description 10
239000011593 sulfur Substances 0.000 description 10
WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 9
241000534944 Thia Species 0.000 description 9
125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 description 9
IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 8
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 8
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
150000001299 aldehydes Chemical class 0.000 description 8
150000001412 amines Chemical class 0.000 description 8
229940024606 amino acid Drugs 0.000 description 8
125000003277 amino group Chemical group 0.000 description 8
MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 8
239000012442 inert solvent Substances 0.000 description 8
XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 8
XCYNZJTVHSBOSN-UHFFFAOYSA-N 2-(5-chlorothiophen-2-yl)ethenesulfonyl chloride Chemical compound ClC1=CC=C(C=CS(Cl)(=O)=O)S1 XCYNZJTVHSBOSN-UHFFFAOYSA-N 0.000 description 7
NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 7
239000004342 Benzoyl peroxide Substances 0.000 description 7
OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 7
150000001413 amino acids Chemical class 0.000 description 7
125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 7
QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 7
239000007864 aqueous solution Substances 0.000 description 7
235000019400 benzoyl peroxide Nutrition 0.000 description 7
229960003328 benzoyl peroxide Drugs 0.000 description 7
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 7
125000001309 chloro group Chemical group Cl* 0.000 description 7
125000002768 hydroxyalkyl group Chemical group 0.000 description 7
PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 7
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
238000003786 synthesis reaction Methods 0.000 description 7
OCHWJELTXIZAIN-UHFFFAOYSA-N 4-chloro-7-methylquinazoline Chemical compound ClC1=NC=NC2=CC(C)=CC=C21 OCHWJELTXIZAIN-UHFFFAOYSA-N 0.000 description 6
NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 6
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 6
VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 6
125000005239 aroylamino group Chemical group 0.000 description 6
125000005098 aryl alkoxy carbonyl group Chemical group 0.000 description 6
125000002102 aryl alkyloxo group Chemical group 0.000 description 6
125000005161 aryl oxy carbonyl group Chemical group 0.000 description 6
238000009833 condensation Methods 0.000 description 6
230000005494 condensation Effects 0.000 description 6
USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 6
125000005843 halogen group Chemical group 0.000 description 6
150000002430 hydrocarbons Chemical group 0.000 description 6
RCCPEORTSYDPMB-UHFFFAOYSA-N hydroxy benzenecarboximidothioate Chemical compound OSC(=N)C1=CC=CC=C1 RCCPEORTSYDPMB-UHFFFAOYSA-N 0.000 description 6
ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 6
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
239000002244 precipitate Substances 0.000 description 6
238000010898 silica gel chromatography Methods 0.000 description 6
SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 6
HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
239000000725 suspension Substances 0.000 description 6
238000011282 treatment Methods 0.000 description 6
RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 6
ZMIAGLFTJCNFIR-UHFFFAOYSA-N 7-(bromomethyl)-4-chloroquinoline Chemical compound BrCC1=CC=C2C(Cl)=CC=NC2=C1 ZMIAGLFTJCNFIR-UHFFFAOYSA-N 0.000 description 5
IAZDPXIOMUYVGZ-UHFFFAOYSA-N DMSO Substances CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 5
239000012317 TBTU Substances 0.000 description 5
CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 5
150000007513 acids Chemical class 0.000 description 5
150000001298 alcohols Chemical class 0.000 description 5
125000004659 aryl alkyl thio group Chemical group 0.000 description 5
125000004104 aryloxy group Chemical group 0.000 description 5
125000004429 atom Chemical group 0.000 description 5
239000011203 carbon fibre reinforced carbon Substances 0.000 description 5
229910052801 chlorine Inorganic materials 0.000 description 5
239000012230 colorless oil Substances 0.000 description 5
238000001816 cooling Methods 0.000 description 5
239000012458 free base Substances 0.000 description 5
238000010438 heat treatment Methods 0.000 description 5
DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 5
GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium;hydroxide;hydrate Chemical compound [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 5
230000002829 reductive effect Effects 0.000 description 5
238000010992 reflux Methods 0.000 description 5
150000003335 secondary amines Chemical class 0.000 description 5
239000007858 starting material Substances 0.000 description 5
YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 5
SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 4
AVRPFRMDMNDIDH-UHFFFAOYSA-N 1h-quinazolin-2-one Chemical compound C1=CC=CC2=NC(O)=NC=C21 AVRPFRMDMNDIDH-UHFFFAOYSA-N 0.000 description 4
WMPTYRGXBUYONY-UHFFFAOYSA-N 2-chloroquinazoline Chemical compound C1=CC=CC2=NC(Cl)=NC=C21 WMPTYRGXBUYONY-UHFFFAOYSA-N 0.000 description 4
QKRVOGZPQVCVPZ-UHFFFAOYSA-N 2-chlorothieno[3,2-d]pyrimidine Chemical compound ClC1=NC=C2SC=CC2=N1 QKRVOGZPQVCVPZ-UHFFFAOYSA-N 0.000 description 4
FQBABLFSLXFYOQ-UHFFFAOYSA-N 3-(bromomethyl)-7-chloroisoquinoline Chemical compound C1=C(CBr)N=CC2=CC(Cl)=CC=C21 FQBABLFSLXFYOQ-UHFFFAOYSA-N 0.000 description 4
VWYFITBWBRVBSW-UHFFFAOYSA-N 5-chlorothiophene-2-carbaldehyde Chemical compound ClC1=CC=C(C=O)S1 VWYFITBWBRVBSW-UHFFFAOYSA-N 0.000 description 4
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 4
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 4
PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
239000005909 Kieselgur Substances 0.000 description 4
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 4
RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 4
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
125000005078 alkoxycarbonylalkyl group Chemical group 0.000 description 4
150000001450 anions Chemical class 0.000 description 4
125000005110 aryl thio group Chemical group 0.000 description 4
229910052799 carbon Inorganic materials 0.000 description 4
239000003054 catalyst Substances 0.000 description 4
125000004447 heteroarylalkenyl group Chemical group 0.000 description 4
125000005367 heteroarylalkylthio group Chemical group 0.000 description 4
125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 4
125000002249 indol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([*])=C([H])C2=C1[H] 0.000 description 4
229910052740 iodine Inorganic materials 0.000 description 4
239000012948 isocyanate Substances 0.000 description 4
150000002513 isocyanates Chemical class 0.000 description 4
150000002576 ketones Chemical class 0.000 description 4
239000000463 material Substances 0.000 description 4
239000003960 organic solvent Substances 0.000 description 4
CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
125000004430 oxygen atom Chemical group O* 0.000 description 4
125000006239 protecting group Chemical group 0.000 description 4
MZPWKJZDOCIALD-UHFFFAOYSA-N pyrocatechol sulfate Chemical compound OC1=CC=CC=C1OS(O)(=O)=O MZPWKJZDOCIALD-UHFFFAOYSA-N 0.000 description 4
239000012279 sodium borohydride Substances 0.000 description 4
229910000033 sodium borohydride Inorganic materials 0.000 description 4
LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 4
IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 4
URZBIOXYNMRLJS-AKGZTFGVSA-N (3s)-3,5-dimethylpiperazin-2-one Chemical compound CC1CNC(=O)[C@H](C)N1 URZBIOXYNMRLJS-AKGZTFGVSA-N 0.000 description 3
FRONIFQNPCAWAG-UHFFFAOYSA-N (4-chloroquinolin-7-yl)methanol Chemical compound ClC1=CC=NC2=CC(CO)=CC=C21 FRONIFQNPCAWAG-UHFFFAOYSA-N 0.000 description 3
RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 3
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
OGHAEMCBPGWRAP-UHFFFAOYSA-N 1,7-dichloro-3-methylisoquinoline Chemical compound C1=C(Cl)C=C2C(Cl)=NC(C)=CC2=C1 OGHAEMCBPGWRAP-UHFFFAOYSA-N 0.000 description 3
SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 3
PNIFAQRCVWPHAL-UHFFFAOYSA-N 2-(5-chlorothiophen-2-yl)oxyacetic acid Chemical compound OC(=O)COC1=CC=C(Cl)S1 PNIFAQRCVWPHAL-UHFFFAOYSA-N 0.000 description 3
YDDKTDCJSIMZQH-UHFFFAOYSA-N 2-(benzhydrylideneamino)-4-(bromomethyl)benzonitrile Chemical compound BrCC1=CC=C(C#N)C(N=C(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 YDDKTDCJSIMZQH-UHFFFAOYSA-N 0.000 description 3
FHKVYSWHLRBZFO-OWOJBTEDSA-N 2-[(e)-3-bromoprop-1-enyl]-5-chlorothiophene Chemical compound ClC1=CC=C(\C=C\CBr)S1 FHKVYSWHLRBZFO-OWOJBTEDSA-N 0.000 description 3
IYVWVKHCAAANOH-UHFFFAOYSA-N 2-acetamido-3-(5-chlorothiophen-2-yl)prop-2-enoic acid Chemical compound CC(=O)NC(C(O)=O)=CC1=CC=C(Cl)S1 IYVWVKHCAAANOH-UHFFFAOYSA-N 0.000 description 3
NDFNSZGGWUAZJA-UHFFFAOYSA-N 4-chloro-1-benzothiophene-2-sulfonyl chloride Chemical compound ClC1=CC=CC2=C1C=C(S(Cl)(=O)=O)S2 NDFNSZGGWUAZJA-UHFFFAOYSA-N 0.000 description 3
BTFSHHNPEBUFHH-UHFFFAOYSA-N 5-iodo-2-methoxy-3-methylpyridine Chemical compound COC1=NC=C(I)C=C1C BTFSHHNPEBUFHH-UHFFFAOYSA-N 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 3
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 3
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
206010051055 Deep vein thrombosis Diseases 0.000 description 3
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical class [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
239000000654 additive Substances 0.000 description 3
230000000996 additive effect Effects 0.000 description 3
125000001931 aliphatic group Chemical group 0.000 description 3
230000029936 alkylation Effects 0.000 description 3
238000005804 alkylation reaction Methods 0.000 description 3
150000001414 amino alcohols Chemical class 0.000 description 3
229910021529 ammonia Inorganic materials 0.000 description 3
150000008064 anhydrides Chemical class 0.000 description 3
229940127219 anticoagulant drug Drugs 0.000 description 3
125000005018 aryl alkenyl group Chemical group 0.000 description 3
125000004391 aryl sulfonyl group Chemical group 0.000 description 3
230000009286 beneficial effect Effects 0.000 description 3
HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 3
SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 3
125000004181 carboxyalkyl group Chemical group 0.000 description 3
230000003197 catalytic effect Effects 0.000 description 3
210000004027 cell Anatomy 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
AQEFLFZSWDEAIP-UHFFFAOYSA-N di-tert-butyl ether Chemical compound CC(C)(C)OC(C)(C)C AQEFLFZSWDEAIP-UHFFFAOYSA-N 0.000 description 3
PQJJJMRNHATNKG-UHFFFAOYSA-N ethyl bromoacetate Chemical compound CCOC(=O)CBr PQJJJMRNHATNKG-UHFFFAOYSA-N 0.000 description 3
PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 3
229910052731 fluorine Inorganic materials 0.000 description 3
125000001153 fluoro group Chemical group F* 0.000 description 3
125000005143 heteroarylsulfonyl group Chemical group 0.000 description 3
125000005368 heteroarylthio group Chemical group 0.000 description 3
238000005984 hydrogenation reaction Methods 0.000 description 3
230000007062 hydrolysis Effects 0.000 description 3
238000006460 hydrolysis reaction Methods 0.000 description 3
239000005457 ice water Substances 0.000 description 3
RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
239000011630 iodine Substances 0.000 description 3
229910052744 lithium Inorganic materials 0.000 description 3
239000012280 lithium aluminium hydride Substances 0.000 description 3
229940040692 lithium hydroxide monohydrate Drugs 0.000 description 3
CMOWWXDFLCKZRC-HWKANZROSA-N methyl (e)-3-(5-chlorothiophen-2-yl)prop-2-enoate Chemical compound COC(=O)\C=C\C1=CC=C(Cl)S1 CMOWWXDFLCKZRC-HWKANZROSA-N 0.000 description 3
125000002950 monocyclic group Chemical group 0.000 description 3
150000002825 nitriles Chemical class 0.000 description 3
BXRNXXXXHLBUKK-UHFFFAOYSA-N piperazine-2,5-dione Chemical class O=C1CNC(=O)CN1 BXRNXXXXHLBUKK-UHFFFAOYSA-N 0.000 description 3
XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical compound O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 description 3
239000002798 polar solvent Substances 0.000 description 3
229910000027 potassium carbonate Inorganic materials 0.000 description 3
YORCIIVHUBAYBQ-UHFFFAOYSA-N propargyl bromide Chemical compound BrCC#C YORCIIVHUBAYBQ-UHFFFAOYSA-N 0.000 description 3
150000005255 pyrrolopyridines Chemical class 0.000 description 3
230000009467 reduction Effects 0.000 description 3
238000006722 reduction reaction Methods 0.000 description 3
229910001961 silver nitrate Inorganic materials 0.000 description 3
235000017557 sodium bicarbonate Nutrition 0.000 description 3
229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
238000003756 stirring Methods 0.000 description 3
QBYGMGDPOWAXSC-MQWKRIRWSA-N tert-butyl n-[(2s)-1-(2-hydroxypropylamino)-1-oxopropan-2-yl]carbamate Chemical compound CC(O)CNC(=O)[C@H](C)NC(=O)OC(C)(C)C QBYGMGDPOWAXSC-MQWKRIRWSA-N 0.000 description 3
DEWBJXPANXZOND-QMMMGPOBSA-N tert-butyl n-[(2s)-1-oxo-1-(2-oxopropylamino)propan-2-yl]carbamate Chemical compound CC(C)(C)OC(=O)N[C@@H](C)C(=O)NCC(C)=O DEWBJXPANXZOND-QMMMGPOBSA-N 0.000 description 3
GFZLEUSLQORNJJ-UHFFFAOYSA-N thieno[3,2-d]pyrimidine 5-oxide Chemical compound C1=NC=C2S(=O)C=CC2=N1 GFZLEUSLQORNJJ-UHFFFAOYSA-N 0.000 description 3
UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 3
GCTFTMWXZFLTRR-GFCCVEGCSA-N (2r)-2-amino-n-[3-(difluoromethoxy)-4-(1,3-oxazol-5-yl)phenyl]-4-methylpentanamide Chemical compound FC(F)OC1=CC(NC(=O)[C@H](N)CC(C)C)=CC=C1C1=CN=CO1 GCTFTMWXZFLTRR-GFCCVEGCSA-N 0.000 description 2
GNKAEOBAWYIYDV-VWLOTQADSA-N (3s)-4-[(5-chloro-1h-indol-2-yl)methyl]-3-(methoxymethyl)-1-[[4-(methylamino)quinolin-7-yl]methyl]piperazin-2-one Chemical compound ClC1=CC=C2NC(CN3CCN(C([C@@H]3COC)=O)CC=3C=C4N=CC=C(C4=CC=3)NC)=CC2=C1 GNKAEOBAWYIYDV-VWLOTQADSA-N 0.000 description 2
VGQQRAFINZGCNU-UHFFFAOYSA-N (6-chloro-1-benzothiophen-2-yl)methanol Chemical compound C1=C(Cl)C=C2SC(CO)=CC2=C1 VGQQRAFINZGCNU-UHFFFAOYSA-N 0.000 description 2
YEVDJWVEYDOQQC-OWOJBTEDSA-N (e)-3-(4-chlorothiophen-2-yl)prop-2-enoic acid Chemical compound OC(=O)\C=C\C1=CC(Cl)=CS1 YEVDJWVEYDOQQC-OWOJBTEDSA-N 0.000 description 2
JAFVPRMULXJDEN-DUXPYHPUSA-N (e)-3-(5-chlorothiophen-2-yl)prop-2-enoic acid Chemical compound OC(=O)\C=C\C1=CC=C(Cl)S1 JAFVPRMULXJDEN-DUXPYHPUSA-N 0.000 description 2
DJMOXMNDXFFONV-UHFFFAOYSA-N 1,3-dimethyl-7-[2-(n-methylanilino)ethyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCN(C)C1=CC=CC=C1 DJMOXMNDXFFONV-UHFFFAOYSA-N 0.000 description 2
BDSDVMMCXGKRJO-UHFFFAOYSA-N 1-(2-amino-4-methylphenyl)ethanone Chemical compound CC(=O)C1=CC=C(C)C=C1N BDSDVMMCXGKRJO-UHFFFAOYSA-N 0.000 description 2
UPVDTZDVDGTUEP-UHFFFAOYSA-N 1-(4-methyl-2-nitrophenyl)ethanone Chemical compound CC(=O)C1=CC=C(C)C=C1[N+]([O-])=O UPVDTZDVDGTUEP-UHFFFAOYSA-N 0.000 description 2
HZRHZMKQRJWMKE-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 HZRHZMKQRJWMKE-UHFFFAOYSA-N 0.000 description 2
DNDGZAZZJFILHI-UHFFFAOYSA-N 1-chloro-3-(2,2-dimethoxyethylsulfanyl)benzene Chemical compound COC(OC)CSC1=CC=CC(Cl)=C1 DNDGZAZZJFILHI-UHFFFAOYSA-N 0.000 description 2
QKWWDTYDYOFRJL-UHFFFAOYSA-N 2,2-dimethoxyethanamine Chemical compound COC(CN)OC QKWWDTYDYOFRJL-UHFFFAOYSA-N 0.000 description 2
GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 2
OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 2
LWRSYTXEQUUTKW-UHFFFAOYSA-N 2,4-dimethoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C(OC)=C1 LWRSYTXEQUUTKW-UHFFFAOYSA-N 0.000 description 2
INNHCRALJNUFMZ-UHFFFAOYSA-N 2-(3-bromoprop-1-ynyl)-5-chlorothiophene Chemical compound ClC1=CC=C(C#CCBr)S1 INNHCRALJNUFMZ-UHFFFAOYSA-N 0.000 description 2
DMYZZZCPJOWSNT-UHFFFAOYSA-N 2-(3-fluorophenoxy)acetic acid Chemical compound OC(=O)COC1=CC=CC(F)=C1 DMYZZZCPJOWSNT-UHFFFAOYSA-N 0.000 description 2
UFOOOWRMXIBKHA-UHFFFAOYSA-N 2-(5-chlorothiophen-2-yl)-1-diethoxyphosphoryl-n,n-dimethylethenamine Chemical compound CCOP(=O)(OCC)C(N(C)C)=CC1=CC=C(Cl)S1 UFOOOWRMXIBKHA-UHFFFAOYSA-N 0.000 description 2
QAHATWMAZYFBSC-UHFFFAOYSA-N 2-(5-chlorothiophen-2-yl)acetic acid Chemical compound OC(=O)CC1=CC=C(Cl)S1 QAHATWMAZYFBSC-UHFFFAOYSA-N 0.000 description 2
DZHZKISBQULZJO-UHFFFAOYSA-N 2-(5-chlorothiophen-2-yl)sulfanylacetic acid Chemical compound OC(=O)CSC1=CC=C(Cl)S1 DZHZKISBQULZJO-UHFFFAOYSA-N 0.000 description 2
DKKWTXSMSSSCDL-UHFFFAOYSA-N 2-(benzhydrylideneamino)-4-methylbenzonitrile Chemical compound CC1=CC=C(C#N)C(N=C(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 DKKWTXSMSSSCDL-UHFFFAOYSA-N 0.000 description 2
GLPPKHRDYWCIDA-UHFFFAOYSA-N 2-(bromomethyl)-5-(5-chlorothiophen-2-yl)thiophene Chemical group S1C(Cl)=CC=C1C1=CC=C(CBr)S1 GLPPKHRDYWCIDA-UHFFFAOYSA-N 0.000 description 2
BBTKFFLJVORJDU-UHFFFAOYSA-N 2-(bromomethyl)-6-chloro-1-benzothiophene Chemical compound ClC1=CC=C2C=C(CBr)SC2=C1 BBTKFFLJVORJDU-UHFFFAOYSA-N 0.000 description 2
AIZQCJHGMMVDAN-UHFFFAOYSA-N 2-(bromomethyl)-6-chloronaphthalene Chemical compound C1=C(CBr)C=CC2=CC(Cl)=CC=C21 AIZQCJHGMMVDAN-UHFFFAOYSA-N 0.000 description 2
NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
ZFAJPWYXLYGUJU-UHFFFAOYSA-N 2-bromo-5-chlorothiophene Chemical compound ClC1=CC=C(Br)S1 ZFAJPWYXLYGUJU-UHFFFAOYSA-N 0.000 description 2
WBIAGGDFPTWSBH-UHFFFAOYSA-N 2-chloro-6-methylnaphthalene Chemical compound C1=C(Cl)C=CC2=CC(C)=CC=C21 WBIAGGDFPTWSBH-UHFFFAOYSA-N 0.000 description 2
FHHZTIXPIXHMLC-UHFFFAOYSA-N 2-chloro-6-methylquinoline Chemical compound N1=C(Cl)C=CC2=CC(C)=CC=C21 FHHZTIXPIXHMLC-UHFFFAOYSA-N 0.000 description 2
RNPYPDNQXNVCHI-UHFFFAOYSA-N 3-(4-chlorophenyl)-2-methylprop-2-enoyl azide Chemical compound [N-]=[N+]=NC(=O)C(C)=CC1=CC=C(Cl)C=C1 RNPYPDNQXNVCHI-UHFFFAOYSA-N 0.000 description 2
MPGLTYSJSMJBJT-UHFFFAOYSA-N 3-(5-chlorothiophen-2-yl)prop-2-yn-1-ol Chemical compound OCC#CC1=CC=C(Cl)S1 MPGLTYSJSMJBJT-UHFFFAOYSA-N 0.000 description 2
SZYXCSAGLXGJQW-UHFFFAOYSA-N 3-(5-chlorothiophen-2-yl)propanal Chemical compound ClC1=CC=C(CCC=O)S1 SZYXCSAGLXGJQW-UHFFFAOYSA-N 0.000 description 2
NAGMMCFONJGKBZ-UHFFFAOYSA-N 3-(5-chlorothiophen-2-yl)propanoic acid Chemical compound OC(=O)CCC1=CC=C(Cl)S1 NAGMMCFONJGKBZ-UHFFFAOYSA-N 0.000 description 2
LBEPNLIADKHBQQ-UHFFFAOYSA-N 3-(6-acetamidopyridin-3-yl)prop-2-enoic acid Chemical compound CC(=O)NC1=CC=C(C=CC(O)=O)C=N1 LBEPNLIADKHBQQ-UHFFFAOYSA-N 0.000 description 2
RKTFOZFRTWRSLT-UHFFFAOYSA-N 3-(6-aminopyridin-3-yl)prop-2-enoic acid Chemical compound NC1=CC=C(C=CC(O)=O)C=N1 RKTFOZFRTWRSLT-UHFFFAOYSA-N 0.000 description 2
HUCPLTHAOVOFFD-UHFFFAOYSA-N 3-(bromomethyl)-5-iodo-2-methoxypyridine Chemical compound COC1=NC=C(I)C=C1CBr HUCPLTHAOVOFFD-UHFFFAOYSA-N 0.000 description 2
WEHOBOMKSMVHCX-UHFFFAOYSA-N 3-[tert-butyl(dimethyl)silyl]oxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)NC(C(O)=O)CO[Si](C)(C)C(C)(C)C WEHOBOMKSMVHCX-UHFFFAOYSA-N 0.000 description 2
BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
SOFYDCANIQBROH-UHFFFAOYSA-N 4-[(5-chlorothiophen-2-yl)methylidene]-2-methyl-1,3-oxazol-5-one Chemical compound O=C1OC(C)=NC1=CC1=CC=C(Cl)S1 SOFYDCANIQBROH-UHFFFAOYSA-N 0.000 description 2
YGYUMNQONHLLNC-UHFFFAOYSA-N 4-chloro-1-benzothiophene Chemical compound ClC1=CC=CC2=C1C=CS2 YGYUMNQONHLLNC-UHFFFAOYSA-N 0.000 description 2
LLRQVSZVVAKRJA-UHFFFAOYSA-N 4-chloro-7-(trifluoromethyl)quinoline Chemical compound ClC1=CC=NC2=CC(C(F)(F)F)=CC=C21 LLRQVSZVVAKRJA-UHFFFAOYSA-N 0.000 description 2
VMGVGPMZWPOPJP-UHFFFAOYSA-N 4-chloroquinoline-7-carboxylic acid Chemical compound ClC1=CC=NC2=CC(C(=O)O)=CC=C21 VMGVGPMZWPOPJP-UHFFFAOYSA-N 0.000 description 2
NDRFSRJILIUQLH-UHFFFAOYSA-N 4-chlorothiophen-2-amine Chemical compound NC1=CC(Cl)=CS1 NDRFSRJILIUQLH-UHFFFAOYSA-N 0.000 description 2
YYEIZVYJDLYMIH-UHFFFAOYSA-N 4-chlorothiophene-2-carbaldehyde Chemical compound ClC1=CSC(C=O)=C1 YYEIZVYJDLYMIH-UHFFFAOYSA-N 0.000 description 2
YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
YVDLIYGQTYRGIO-UHFFFAOYSA-N 5-(5-chlorothiophen-2-yl)thiophene-2-carbaldehyde Chemical compound S1C(Cl)=CC=C1C1=CC=C(C=O)S1 YVDLIYGQTYRGIO-UHFFFAOYSA-N 0.000 description 2
OHEOLKHLDJYUCZ-UHFFFAOYSA-N 5-(5-chlorothiophen-2-yl)thiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=C(Cl)S1 OHEOLKHLDJYUCZ-UHFFFAOYSA-N 0.000 description 2
UNWUBRQQNRTTRI-UHFFFAOYSA-N 5-(5-chlorothiophen-2-yl)thiophene-2-sulfonyl chloride Chemical compound S1C(Cl)=CC=C1C1=CC=C(S(Cl)(=O)=O)S1 UNWUBRQQNRTTRI-UHFFFAOYSA-N 0.000 description 2
XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 description 2
VUHAQQKHOFFPEF-UHFFFAOYSA-N 6-(bromomethyl)-2-chloroquinoline Chemical compound C1=C(CBr)C=CC2=NC(Cl)=CC=C21 VUHAQQKHOFFPEF-UHFFFAOYSA-N 0.000 description 2
YLOJXKIILDOPQZ-UHFFFAOYSA-N 6-(bromomethyl)-3-chloro-1-(4-methylphenyl)sulfonylindole Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1C2=CC(CBr)=CC=C2C(Cl)=C1 YLOJXKIILDOPQZ-UHFFFAOYSA-N 0.000 description 2
RTDMINFRPDGVIG-UHFFFAOYSA-N 6-chloro-1-benzothiophene-2-carbaldehyde Chemical compound ClC1=CC=C2C=C(C=O)SC2=C1 RTDMINFRPDGVIG-UHFFFAOYSA-N 0.000 description 2
FPACZKFPALWXQS-UHFFFAOYSA-N 6-chloro-2-methyl-3,4-dihydro-1h-naphthalen-2-ol Chemical compound ClC1=CC=C2CC(C)(O)CCC2=C1 FPACZKFPALWXQS-UHFFFAOYSA-N 0.000 description 2
QQSYTUUAEZUAKL-UHFFFAOYSA-N 6-chloro-3,4-dihydro-1h-naphthalen-2-one Chemical compound C1C(=O)CCC2=CC(Cl)=CC=C21 QQSYTUUAEZUAKL-UHFFFAOYSA-N 0.000 description 2
YXMZSPUJMICFKD-UHFFFAOYSA-N 7-(bromomethyl)-4-chloroquinazoline Chemical compound BrCC1=CC=C2C(Cl)=NC=NC2=C1 YXMZSPUJMICFKD-UHFFFAOYSA-N 0.000 description 2
VVPVHOYWNBPQJY-UHFFFAOYSA-N 7-chloro-3-methyl-1h-quinolin-2-one Chemical compound C1=C(Cl)C=C2NC(=O)C(C)=CC2=C1 VVPVHOYWNBPQJY-UHFFFAOYSA-N 0.000 description 2
CHXAYUSRURSBER-UHFFFAOYSA-N 7-chloro-3-methyl-2h-isoquinolin-1-one Chemical compound C1=C(Cl)C=C2C(=O)NC(C)=CC2=C1 CHXAYUSRURSBER-UHFFFAOYSA-N 0.000 description 2
BTPQWFASIRXALW-UHFFFAOYSA-N 7-chloro-3-methylisoquinoline Chemical compound C1=C(Cl)C=C2C=NC(C)=CC2=C1 BTPQWFASIRXALW-UHFFFAOYSA-N 0.000 description 2
ODTKNTKALDWUKJ-UHFFFAOYSA-N 7-chloroisoquinoline-3-carbaldehyde Chemical compound C1=C(C=O)N=CC2=CC(Cl)=CC=C21 ODTKNTKALDWUKJ-UHFFFAOYSA-N 0.000 description 2
HIXONRGTPXMCCP-UHFFFAOYSA-N 7-chloroisoquinoline-3-carboxylic acid Chemical compound C1=C(Cl)C=C2C=NC(C(=O)O)=CC2=C1 HIXONRGTPXMCCP-UHFFFAOYSA-N 0.000 description 2
APPHSAIPZPYEGB-UHFFFAOYSA-N 7-methyl-1h-quinazolin-4-one Chemical compound N1C=NC(=O)C=2C1=CC(C)=CC=2 APPHSAIPZPYEGB-UHFFFAOYSA-N 0.000 description 2
UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 2
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 2
PNKUSGQVOMIXLU-UHFFFAOYSA-N Formamidine Chemical compound NC=N PNKUSGQVOMIXLU-UHFFFAOYSA-N 0.000 description 2
101000869693 Homo sapiens Protein S100-A9 Proteins 0.000 description 2
238000006546 Horner-Wadsworth-Emmons reaction Methods 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
OKJIRPAQVSHGFK-UHFFFAOYSA-N N-acetylglycine Chemical compound CC(=O)NCC(O)=O OKJIRPAQVSHGFK-UHFFFAOYSA-N 0.000 description 2
PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 2
OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
102100032420 Protein S100-A9 Human genes 0.000 description 2
SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
208000006011 Stroke Diseases 0.000 description 2
YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
KOXYDVGGTQILRZ-UHFFFAOYSA-N [3-chloro-1-(1-methylcyclohexa-2,4-dien-1-yl)sulfonylindol-6-yl]methanol Chemical compound C1=C(Cl)C2=CC=C(CO)C=C2N1S(=O)(=O)C1(C)CC=CC=C1 KOXYDVGGTQILRZ-UHFFFAOYSA-N 0.000 description 2
DISOUWLSIYQPLV-UHFFFAOYSA-N [5-(5-chlorothiophen-2-yl)thiophen-2-yl]methanol Chemical compound S1C(CO)=CC=C1C1=CC=C(Cl)S1 DISOUWLSIYQPLV-UHFFFAOYSA-N 0.000 description 2
125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
150000003855 acyl compounds Chemical class 0.000 description 2
125000004423 acyloxy group Chemical group 0.000 description 2
230000001476 alcoholic effect Effects 0.000 description 2
125000004466 alkoxycarbonylamino group Chemical group 0.000 description 2
150000003973 alkyl amines Chemical class 0.000 description 2
125000004644 alkyl sulfinyl group Chemical group 0.000 description 2
XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
239000003125 aqueous solvent Substances 0.000 description 2
239000012298 atmosphere Substances 0.000 description 2
125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 2
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
NVVOSONODVYVRG-DTIOYNMSSA-N benzyl (2s)-2,6-dimethyl-3-oxopiperazine-1-carboxylate Chemical compound CC1CNC(=O)[C@H](C)N1C(=O)OCC1=CC=CC=C1 NVVOSONODVYVRG-DTIOYNMSSA-N 0.000 description 2
NVVOSONODVYVRG-QWRGUYRKSA-N benzyl (2s,6s)-2,6-dimethyl-3-oxopiperazine-1-carboxylate Chemical compound C[C@H]1CNC(=O)[C@H](C)N1C(=O)OCC1=CC=CC=C1 NVVOSONODVYVRG-QWRGUYRKSA-N 0.000 description 2
VCFOIBWFHCUOTD-UHFFFAOYSA-N benzyl 2,2-dimethyl-3-oxopiperazine-1-carboxylate Chemical compound C1CNC(=O)C(C)(C)N1C(=O)OCC1=CC=CC=C1 VCFOIBWFHCUOTD-UHFFFAOYSA-N 0.000 description 2
IJDDHRUZALXTGG-UHFFFAOYSA-N benzyl 2-(1-methoxyethyl)-3-oxopiperazine-1-carboxylate Chemical compound C1CNC(=O)C(C(C)OC)N1C(=O)OCC1=CC=CC=C1 IJDDHRUZALXTGG-UHFFFAOYSA-N 0.000 description 2
OQGGCSABDDZJTE-UHFFFAOYSA-N benzyl 2-(2-methylpropyl)-3-oxopiperazine-1-carboxylate Chemical compound C1CNC(=O)C(CC(C)C)N1C(=O)OCC1=CC=CC=C1 OQGGCSABDDZJTE-UHFFFAOYSA-N 0.000 description 2
VUYLDVZOLYHPLL-UHFFFAOYSA-N benzyl 2-(methoxymethyl)-3-oxopiperazine-1-carboxylate Chemical compound C1CNC(=O)C(COC)N1C(=O)OCC1=CC=CC=C1 VUYLDVZOLYHPLL-UHFFFAOYSA-N 0.000 description 2
PENNVGXWADJIBS-UHFFFAOYSA-N benzyl 2-(methoxymethyl)-5-methyl-3-oxopiperazine-1-carboxylate Chemical compound C1C(C)NC(=O)C(COC)N1C(=O)OCC1=CC=CC=C1 PENNVGXWADJIBS-UHFFFAOYSA-N 0.000 description 2
MWCGAQKLERGQBQ-UHFFFAOYSA-N benzyl 2-benzyl-3-oxopiperazine-1-carboxylate Chemical compound C1CNC(=O)C(CC=2C=CC=CC=2)N1C(=O)OCC1=CC=CC=C1 MWCGAQKLERGQBQ-UHFFFAOYSA-N 0.000 description 2
XBZMLPWZBVEFNL-UHFFFAOYSA-N benzyl 2-ethyl-3-oxopiperazine-1-carboxylate Chemical compound C1CNC(=O)C(CC)N1C(=O)OCC1=CC=CC=C1 XBZMLPWZBVEFNL-UHFFFAOYSA-N 0.000 description 2
QGOPZRYPDFSHOY-UHFFFAOYSA-N benzyl 2-methyl-3-oxopiperazine-1-carboxylate Chemical compound C1CNC(=O)C(C)N1C(=O)OCC1=CC=CC=C1 QGOPZRYPDFSHOY-UHFFFAOYSA-N 0.000 description 2
OLTBNLURCAXBTG-UHFFFAOYSA-N benzyl 3-oxo-2-propan-2-ylpiperazine-1-carboxylate Chemical compound C1CNC(=O)C(C(C)C)N1C(=O)OCC1=CC=CC=C1 OLTBNLURCAXBTG-UHFFFAOYSA-N 0.000 description 2
ZKETUCKAECRXHE-UHFFFAOYSA-N benzyl 3-oxo-2-propylpiperazine-1-carboxylate Chemical compound C1CNC(=O)C(CCC)N1C(=O)OCC1=CC=CC=C1 ZKETUCKAECRXHE-UHFFFAOYSA-N 0.000 description 2
WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
230000023555 blood coagulation Effects 0.000 description 2
230000031709 bromination Effects 0.000 description 2
238000005893 bromination reaction Methods 0.000 description 2
239000004202 carbamide Substances 0.000 description 2
150000001721 carbon Chemical group 0.000 description 2
229910002091 carbon monoxide Inorganic materials 0.000 description 2
PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
150000001768 cations Chemical class 0.000 description 2
239000003638 chemical reducing agent Substances 0.000 description 2
239000012320 chlorinating reagent Substances 0.000 description 2
FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 description 2
AHZOHFYNIDGBKN-UHFFFAOYSA-N chloro(ethoxy)phosphinic acid Chemical compound CCOP(O)(Cl)=O AHZOHFYNIDGBKN-UHFFFAOYSA-N 0.000 description 2
230000001684 chronic effect Effects 0.000 description 2
229940125900 compound 59 Drugs 0.000 description 2
239000012141 concentrate Substances 0.000 description 2
235000008504 concentrate Nutrition 0.000 description 2
239000013078 crystal Substances 0.000 description 2
238000010511 deprotection reaction Methods 0.000 description 2
OKKJLVBELUTLKV-MICDWDOJSA-N deuteriomethanol Chemical compound [2H]CO OKKJLVBELUTLKV-MICDWDOJSA-N 0.000 description 2
239000006185 dispersion Substances 0.000 description 2
CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 2
GJFVSUVYKNIUGK-UHFFFAOYSA-N ethyl 2-(5-chlorothiophen-2-yl)ethenesulfonate Chemical compound CCOS(=O)(=O)C=CC1=CC=C(Cl)S1 GJFVSUVYKNIUGK-UHFFFAOYSA-N 0.000 description 2
KRMIVGBMPKDNCS-UHFFFAOYSA-N ethyl 2-(5-chlorothiophen-2-yl)oxyacetate Chemical compound CCOC(=O)COC1=CC=C(Cl)S1 KRMIVGBMPKDNCS-UHFFFAOYSA-N 0.000 description 2
RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 2
125000005150 heteroarylsulfinyl group Chemical group 0.000 description 2
238000011905 homologation Methods 0.000 description 2
150000004678 hydrides Chemical class 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
150000002466 imines Chemical class 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
239000002184 metal Substances 0.000 description 2
VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 2
PEILIKNAQRIDJS-NSCUHMNNSA-N methyl (e)-3-(4-chlorothiophen-2-yl)prop-2-enoate Chemical compound COC(=O)\C=C\C1=CC(Cl)=CS1 PEILIKNAQRIDJS-NSCUHMNNSA-N 0.000 description 2
SVBPOUYXRNTUMN-UHFFFAOYSA-N methyl 2-[[3-[tert-butyl(dimethyl)silyl]oxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]propyl]-phenylmethoxycarbonylamino]acetate Chemical compound CC(C)(C)[Si](C)(C)OCC(NC(=O)OC(C)(C)C)CN(CC(=O)OC)C(=O)OCC1=CC=CC=C1 SVBPOUYXRNTUMN-UHFFFAOYSA-N 0.000 description 2
JNCDQCOYUDDOLU-UHFFFAOYSA-N methyl 3-chloro-1h-indole-6-carboxylate Chemical compound COC(=O)C1=CC=C2C(Cl)=CNC2=C1 JNCDQCOYUDDOLU-UHFFFAOYSA-N 0.000 description 2
QUCTXYQKZCLAPW-UHFFFAOYSA-N methyl 4-chloroquinoline-7-carboxylate Chemical compound ClC1=CC=NC2=CC(C(=O)OC)=CC=C21 QUCTXYQKZCLAPW-UHFFFAOYSA-N 0.000 description 2
DEXOQMPZKDOYBE-UHFFFAOYSA-N methyl 5-(bromomethyl)-6-methoxypyridine-3-carboxylate Chemical compound COC(=O)C1=CN=C(OC)C(CBr)=C1 DEXOQMPZKDOYBE-UHFFFAOYSA-N 0.000 description 2
RYHJIMBSUHCONW-UHFFFAOYSA-N methyl 6-methoxy-5-methylpyridine-3-carboxylate Chemical compound COC(=O)C1=CN=C(OC)C(C)=C1 RYHJIMBSUHCONW-UHFFFAOYSA-N 0.000 description 2
239000002480 mineral oil Substances 0.000 description 2
235000010446 mineral oil Nutrition 0.000 description 2
PEAZSVAAOGKKJD-UHFFFAOYSA-N n-(3-chlorophenyl)-2-methyl-3-phenylprop-2-enamide Chemical compound C=1C=CC(Cl)=CC=1NC(=O)C(C)=CC1=CC=CC=C1 PEAZSVAAOGKKJD-UHFFFAOYSA-N 0.000 description 2
MJFCOXATGBYERZ-UHFFFAOYSA-N n-(5-bromopyridin-2-yl)acetamide Chemical compound CC(=O)NC1=CC=C(Br)C=N1 MJFCOXATGBYERZ-UHFFFAOYSA-N 0.000 description 2
125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
230000000269 nucleophilic effect Effects 0.000 description 2
KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
RZXMPPFPUUCRFN-UHFFFAOYSA-N p-toluidine Chemical compound CC1=CC=C(N)C=C1 RZXMPPFPUUCRFN-UHFFFAOYSA-N 0.000 description 2
NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
238000005897 peptide coupling reaction Methods 0.000 description 2
230000002093 peripheral effect Effects 0.000 description 2
UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 2
CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 2
230000002265 prevention Effects 0.000 description 2
CAEWJEXPFKNBQL-UHFFFAOYSA-N prop-2-enyl carbonochloridate Chemical compound ClC(=O)OCC=C CAEWJEXPFKNBQL-UHFFFAOYSA-N 0.000 description 2
CZAAKPFIWJXPQT-UHFFFAOYSA-N quinazolin-2-amine Chemical compound C1=CC=CC2=NC(N)=NC=C21 CZAAKPFIWJXPQT-UHFFFAOYSA-N 0.000 description 2
150000003254 radicals Chemical class 0.000 description 2
238000001953 recrystallisation Methods 0.000 description 2
238000006268 reductive amination reaction Methods 0.000 description 2
208000037803 restenosis Diseases 0.000 description 2
238000007363 ring formation reaction Methods 0.000 description 2
239000011734 sodium Substances 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical class [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 2
239000001632 sodium acetate Substances 0.000 description 2
235000017281 sodium acetate Nutrition 0.000 description 2
LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
235000019345 sodium thiosulphate Nutrition 0.000 description 2
238000001228 spectrum Methods 0.000 description 2
239000000126 substance Substances 0.000 description 2
KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
OJXASOYYODXRPT-UHFFFAOYSA-N sulfamoylurea Chemical compound NC(=O)NS(N)(=O)=O OJXASOYYODXRPT-UHFFFAOYSA-N 0.000 description 2
125000000446 sulfanediyl group Chemical group *S* 0.000 description 2
229940124530 sulfonamide Drugs 0.000 description 2
150000003456 sulfonamides Chemical class 0.000 description 2
DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
BADVOCKFMHIXQE-UHFFFAOYSA-N tert-butyl 2-(bromomethyl)-5-chloroindole-1-carboxylate Chemical compound ClC1=CC=C2N(C(=O)OC(C)(C)C)C(CBr)=CC2=C1 BADVOCKFMHIXQE-UHFFFAOYSA-N 0.000 description 2
FCMLWBBLOASUSO-UHFFFAOYSA-N tert-butyl 3-oxopiperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNC(=O)C1 FCMLWBBLOASUSO-UHFFFAOYSA-N 0.000 description 2
LWZKTBHUZXZMAA-UHFFFAOYSA-N tert-butyl 5-chloro-2-methylindole-1-carboxylate Chemical compound ClC1=CC=C2N(C(=O)OC(C)(C)C)C(C)=CC2=C1 LWZKTBHUZXZMAA-UHFFFAOYSA-N 0.000 description 2
OJNLGZNUONPASC-UHFFFAOYSA-N tert-butyl n-[1-[tert-butyl(dimethyl)silyl]oxy-3-oxopropan-2-yl]carbamate Chemical compound CC(C)(C)OC(=O)NC(C=O)CO[Si](C)(C)C(C)(C)C OJNLGZNUONPASC-UHFFFAOYSA-N 0.000 description 2
HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 2
125000004632 tetrahydrothiopyranyl group Chemical group S1C(CCCC1)* 0.000 description 2
125000001113 thiadiazolyl group Chemical group 0.000 description 2
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
WZMPOCLULGAHJR-UHFFFAOYSA-N thiophen-2-ol Chemical compound OC1=CC=CS1 WZMPOCLULGAHJR-UHFFFAOYSA-N 0.000 description 2
230000001732 thrombotic effect Effects 0.000 description 2
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
125000005270 trialkylamine group Chemical group 0.000 description 2
GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 description 2
238000010626 work up procedure Methods 0.000 description 2
ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 1
LXNAFUAECWLHTH-YFKPBYRVSA-N (2s)-2-(methoxymethyl)-3-oxopiperazine-1-carboxylic acid Chemical compound COC[C@@H]1N(C(O)=O)CCNC1=O LXNAFUAECWLHTH-YFKPBYRVSA-N 0.000 description 1
HILANAOEGRRUEB-ZDUSSCGKSA-N (2s)-2-(n-phenylmethoxycarbonylanilino)propanoic acid Chemical compound C=1C=CC=CC=1N([C@@H](C)C(O)=O)C(=O)OCC1=CC=CC=C1 HILANAOEGRRUEB-ZDUSSCGKSA-N 0.000 description 1
QVHJQCGUWFKTSE-YFKPBYRVSA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)OC(C)(C)C QVHJQCGUWFKTSE-YFKPBYRVSA-N 0.000 description 1
FHOAKXBXYSJBGX-YFKPBYRVSA-N (2s)-3-hydroxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)N[C@@H](CO)C(O)=O FHOAKXBXYSJBGX-YFKPBYRVSA-N 0.000 description 1
LQHGCFKPNOTYIQ-JTQLQIEISA-N (2s)-3-methoxy-2-(phenylmethoxycarbonylamino)propanoic acid Chemical compound COC[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 LQHGCFKPNOTYIQ-JTQLQIEISA-N 0.000 description 1
CANZBRDGRHNSGZ-NSHDSACASA-N (2s)-3-methyl-2-(phenylmethoxycarbonylamino)butanoic acid Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 CANZBRDGRHNSGZ-NSHDSACASA-N 0.000 description 1
XIOZGRLOQXBUPS-VIFPVBQESA-N (2s)-4-[(4-aminoquinazolin-7-yl)methyl]-2-methyl-3-oxopiperazine-1-carboxylic acid Chemical compound O=C1[C@H](C)N(C(O)=O)CCN1CC1=CC=C(C(N)=NC=N2)C2=C1 XIOZGRLOQXBUPS-VIFPVBQESA-N 0.000 description 1
SGOFMRWFLJVKBE-FQEVSTJZSA-N (2s)-4-[(4-aminoquinazolin-7-yl)methyl]-n-(5-chloro-2-methoxyphenyl)-3-oxo-2-propylpiperazine-1-carboxamide Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCC)C(=O)NC1=CC(Cl)=CC=C1OC SGOFMRWFLJVKBE-FQEVSTJZSA-N 0.000 description 1
BJFPYGGTDAYECS-UHFFFAOYSA-N (3-chlorophenyl)methanamine Chemical compound NCC1=CC=CC(Cl)=C1 BJFPYGGTDAYECS-UHFFFAOYSA-N 0.000 description 1
JJGULMOZRJTGBE-VKHMYHEASA-N (3S)-5-oxopiperazine-1,3-dicarboxylic acid Chemical compound OC(=O)[C@@H]1CN(C(O)=O)CC(=O)N1 JJGULMOZRJTGBE-VKHMYHEASA-N 0.000 description 1
HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 1
AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
PSRRQJHTNPLUEC-DEOSSOPVSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-3-benzyl-4-(6-chloro-1-benzothiophene-2-carbonyl)piperazin-2-one Chemical compound C([C@@H]1N(CCN(C1=O)CC=1C=C2N=CN=C(C2=CC=1)N)C(=O)C=1SC2=CC(Cl)=CC=C2C=1)C1=CC=CC=C1 PSRRQJHTNPLUEC-DEOSSOPVSA-N 0.000 description 1
WBAUIDITRKLCSW-SANMLTNESA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-3-benzyl-4-[(6-chloro-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound C([C@@H]1N(CC=2SC3=CC(Cl)=CC=C3C=2)CCN(C1=O)CC=1C=C2N=CN=C(C2=CC=1)N)C1=CC=CC=C1 WBAUIDITRKLCSW-SANMLTNESA-N 0.000 description 1
NXYOYUWOHAQXTE-SFHVURJKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-(2,3-dichloro-1-benzothiophene-6-carbonyl)-3-ethylpiperazin-2-one Chemical compound C1=C2C(Cl)=C(Cl)SC2=CC(C(=O)N2[C@H](C(N(CC=3C=C4N=CN=C(N)C4=CC=3)CC2)=O)CC)=C1 NXYOYUWOHAQXTE-SFHVURJKSA-N 0.000 description 1
JWVOPCZEXQCGFH-IBGZPJMESA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-(2-chloro-1-benzothiophene-6-carbonyl)-3-(methoxymethyl)piperazin-2-one Chemical compound C1=C2C=C(Cl)SC2=CC(C(=O)N2[C@H](C(N(CC=3C=C4N=CN=C(N)C4=CC=3)CC2)=O)COC)=C1 JWVOPCZEXQCGFH-IBGZPJMESA-N 0.000 description 1
QETSFYGRAGVYOF-NRFANRHFSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-(5-chloro-1h-indole-2-carbonyl)-3-ethylpiperazin-2-one Chemical compound ClC1=CC=C2NC(C(=O)N3[C@H](C(N(CC=4C=C5N=CN=C(N)C5=CC=4)CC3)=O)CC)=CC2=C1 QETSFYGRAGVYOF-NRFANRHFSA-N 0.000 description 1
XCIRDSLLXYZKSZ-NRFANRHFSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)methyl]-3-ethylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4SC5=CC(Cl)=CC=C5C=4)[C@H](C3=O)CC)=CC=C21 XCIRDSLLXYZKSZ-NRFANRHFSA-N 0.000 description 1
OEHFCDWITNEJFG-IBGZPJMESA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chlorothieno[2,3-b]pyridin-2-yl)methyl]-3-ethylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4SC5=NC(Cl)=CC=C5C=4)[C@H](C3=O)CC)=CC=C21 OEHFCDWITNEJFG-IBGZPJMESA-N 0.000 description 1
PJXSFICTERTWEL-ODOSRFNGSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(7-chloroisoquinolin-3-yl)methyl]-3-(methoxymethyl)-6-methylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3C(C)CN(CC=4N=CC5=CC(Cl)=CC=C5C=4)[C@H](C3=O)COC)=CC=C21 PJXSFICTERTWEL-ODOSRFNGSA-N 0.000 description 1
HIBQXOYYVVAPHE-QHCPKHFHSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(7-chloroisoquinolin-3-yl)methyl]-3-ethylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3CCN(CC=4N=CC5=CC(Cl)=CC=C5C=4)[C@H](C3=O)CC)=CC=C21 HIBQXOYYVVAPHE-QHCPKHFHSA-N 0.000 description 1
MPSYUYYWIDXSHV-IBGZPJMESA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(2,4-dichlorophenoxy)acetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC1=CC=C(Cl)C=C1Cl MPSYUYYWIDXSHV-IBGZPJMESA-N 0.000 description 1
SWJQILIZOWRKAT-INIZCTEOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(2,5-dichlorothiophen-3-yl)oxyacetyl]-3-propylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CCC)C(=O)COC=1C=C(Cl)SC=1Cl SWJQILIZOWRKAT-INIZCTEOSA-N 0.000 description 1
YXVIWQIOKJVXLH-INIZCTEOSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(3,5-dichlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC=1SC(Cl)=CC=1Cl YXVIWQIOKJVXLH-INIZCTEOSA-N 0.000 description 1
MKISMVBANVSZTE-FQEVSTJZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(3-chloroanilino)acetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)CNC1=CC=CC(Cl)=C1 MKISMVBANVSZTE-FQEVSTJZSA-N 0.000 description 1
MGHWXDIOSVNNMC-FXMQYSIJSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(3-chlorophenoxy)acetyl]-3-(methoxymethyl)-6-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)C(C)C1)=O)COC)C(=O)COC1=CC=CC(Cl)=C1 MGHWXDIOSVNNMC-FXMQYSIJSA-N 0.000 description 1
JXJHJNXYKPADKY-FQEVSTJZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(3-fluorophenoxy)acetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC1=CC=CC(F)=C1 JXJHJNXYKPADKY-FQEVSTJZSA-N 0.000 description 1
GAYCSJLTVUUHFI-FQEVSTJZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(4-chlorophenoxy)acetyl]-3-ethylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CC)C(=O)COC1=CC=C(Cl)C=C1 GAYCSJLTVUUHFI-FQEVSTJZSA-N 0.000 description 1
LBMGCIACVWBSQE-FQEVSTJZSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(4-chlorophenyl)sulfanylacetyl]-3-ethylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CC)C(=O)CSC1=CC=C(Cl)C=C1 LBMGCIACVWBSQE-FQEVSTJZSA-N 0.000 description 1
WPHPMSCRAMQWBI-UWBLVGDVSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(4-chlorothiophen-2-yl)oxyacetyl]-3-(methoxymethyl)-6-methylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)C(C)C1)=O)COC)C(=O)COC1=CC(Cl)=CS1 WPHPMSCRAMQWBI-UWBLVGDVSA-N 0.000 description 1
VFEIPQGTJKGRLE-SFHVURJKSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(6-chloropyridin-3-yl)oxyacetyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC1=CC=C(Cl)N=C1 VFEIPQGTJKGRLE-SFHVURJKSA-N 0.000 description 1
KQSVXMPQUMBFSM-NRFANRHFSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-chlorophenyl)prop-2-enoyl]-3-(methoxymethyl)piperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)C=CC1=CC=C(Cl)C=C1 KQSVXMPQUMBFSM-NRFANRHFSA-N 0.000 description 1
AFBXZJRPVFJXNX-NRFANRHFSA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-chlorophenyl)propanoyl]-3-ethylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CC)C(=O)CCC1=CC=C(Cl)C=C1 AFBXZJRPVFJXNX-NRFANRHFSA-N 0.000 description 1
PNSHQYXZORXFSB-IBGZPJMESA-N (3s)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(4-chlorothiophen-2-yl)prop-2-enoyl]-3-ethylpiperazin-2-one Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CC)C(=O)C=CC1=CC(Cl)=CS1 PNSHQYXZORXFSB-IBGZPJMESA-N 0.000 description 1
RQUHXBXBFREBPL-KRWDZBQOSA-N (3s)-1-[(4-aminoquinolin-7-yl)methyl]-4-[(6-chloronaphthalen-2-yl)methyl]-3-methylpiperazin-2-one Chemical compound NC1=CC=NC2=CC(CN3CCN(CC=4C=C5C=CC(Cl)=CC5=CC=4)[C@H](C3=O)C)=CC=C21 RQUHXBXBFREBPL-KRWDZBQOSA-N 0.000 description 1
BSPUWRUTIOUGMZ-BYPYZUCNSA-N (3s)-3-methylpiperazin-2-one Chemical compound C[C@@H]1NCCNC1=O BSPUWRUTIOUGMZ-BYPYZUCNSA-N 0.000 description 1
XJHXGOPGKXWQJF-IBGZPJMESA-N (3s)-4-(6-chloro-1-benzothiophene-2-carbonyl)-3-(methoxymethyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1=C(Cl)C=C2SC(C(=O)N3[C@H](C(N(CC=4NC5=CC=NC=C5C=4)CC3)=O)COC)=CC2=C1 XJHXGOPGKXWQJF-IBGZPJMESA-N 0.000 description 1
MKANOJYIQZQINX-HNNXBMFYSA-N (3s)-4-[(5-chloro-1h-indol-2-yl)methyl]-1-[(4-chloroquinolin-7-yl)methyl]-3-methylpiperazin-2-one Chemical compound ClC1=CC=NC2=CC(CN3CCN(CC=4NC5=CC=C(Cl)C=C5C=4)[C@H](C3=O)C)=CC=C21 MKANOJYIQZQINX-HNNXBMFYSA-N 0.000 description 1
WKAWCEJWIVMISL-SANMLTNESA-N (3s)-4-[(5-chloro-1h-indol-2-yl)methyl]-1-[[4-(ethylamino)quinolin-7-yl]methyl]-3-(methoxymethyl)piperazin-2-one Chemical compound ClC1=CC=C2NC(CN3CCN(C([C@@H]3COC)=O)CC=3C=C4N=CC=C(C4=CC=3)NCC)=CC2=C1 WKAWCEJWIVMISL-SANMLTNESA-N 0.000 description 1
PLKUCNHFYGDZQJ-CVEARBPZSA-N (3s,5r)-1-[(4-aminoquinolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)methyl]-3,5-dimethylpiperazin-2-one Chemical compound C1=C(Cl)C=C2SC(CN3[C@@H](C)C(=O)N(CC=4C=C5N=CC=C(N)C5=CC=4)C[C@H]3C)=CC2=C1 PLKUCNHFYGDZQJ-CVEARBPZSA-N 0.000 description 1
RQCDTIBVDRZIEJ-GJZGRUSLSA-N (3s,5s)-1-[(4-aminoquinolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]-3,5-dimethylpiperazin-2-one Chemical compound N1([C@@H](C)C(=O)N(CC=2C=C3N=CC=C(N)C3=CC=2)C[C@@H]1C)S(=O)(=O)C=CC1=CC=C(Cl)S1 RQCDTIBVDRZIEJ-GJZGRUSLSA-N 0.000 description 1
GPRVEWOEFMIGDL-NSYGIPOTSA-N (3s,6r)-1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-chloronaphthalen-2-yl)methyl]-3-(methoxymethyl)-6-methylpiperazin-2-one Chemical compound NC1=NC=NC2=CC(CN3[C@H](C)CN(CC=4C=C5C=CC(Cl)=CC5=CC=4)[C@H](C3=O)COC)=CC=C21 GPRVEWOEFMIGDL-NSYGIPOTSA-N 0.000 description 1
KKSUXMGCXOZILX-LURJTMIESA-N (6s)-1-ethyl-6-methylpiperazin-2-one Chemical compound CCN1[C@@H](C)CNCC1=O KKSUXMGCXOZILX-LURJTMIESA-N 0.000 description 1
125000006570 (C5-C6) heteroaryl group Chemical group 0.000 description 1
UQRSIWVKWPZGKA-OWOJBTEDSA-N (e)-3-(4-bromofuran-2-yl)prop-2-enal Chemical compound BrC1=COC(\C=C\C=O)=C1 UQRSIWVKWPZGKA-OWOJBTEDSA-N 0.000 description 1
NOJHKAVGUZWMPV-VOTSOKGWSA-N (e)-3-(4-chlorophenyl)-2-methylprop-2-enoic acid Chemical compound OC(=O)C(/C)=C/C1=CC=C(Cl)C=C1 NOJHKAVGUZWMPV-VOTSOKGWSA-N 0.000 description 1
WOGITNXCNOTRLK-VOTSOKGWSA-N (e)-3-phenylprop-2-enoyl chloride Chemical compound ClC(=O)\C=C\C1=CC=CC=C1 WOGITNXCNOTRLK-VOTSOKGWSA-N 0.000 description 1
SQDDGOVNJMIFFT-UHFFFAOYSA-N 1,1-bis(diethoxyphosphoryl)-n,n-dimethylmethanamine Chemical compound CCOP(=O)(OCC)C(N(C)C)P(=O)(OCC)OCC SQDDGOVNJMIFFT-UHFFFAOYSA-N 0.000 description 1
GZOKAVHTSXSLNB-UHFFFAOYSA-N 1,1-dimethoxypropan-2-amine Chemical compound COC(OC)C(C)N GZOKAVHTSXSLNB-UHFFFAOYSA-N 0.000 description 1
125000004605 1,2,3,4-tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 description 1
125000004607 1,2,3,4-tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 description 1
JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
JPRPJUMQRZTTED-UHFFFAOYSA-N 1,3-dioxolanyl Chemical group [CH]1OCCO1 JPRPJUMQRZTTED-UHFFFAOYSA-N 0.000 description 1
NFTWWHSKWXOTLL-UHFFFAOYSA-N 1,4-dimethylpiperazin-2-one Chemical compound CN1CCN(C)C(=O)C1 NFTWWHSKWXOTLL-UHFFFAOYSA-N 0.000 description 1
125000005940 1,4-dioxanyl group Chemical group 0.000 description 1
HKDFRDIIELOLTJ-UHFFFAOYSA-N 1,4-dithianyl Chemical group [CH]1CSCCS1 HKDFRDIIELOLTJ-UHFFFAOYSA-N 0.000 description 1
LHIHOZSYRJFMMV-UHFFFAOYSA-N 1-(6-chlorothieno[2,3-b]pyridin-2-yl)sulfonylpiperazin-2-one Chemical compound ClC1=CC=C2C(=N1)SC(=C2)S(=O)(=O)N1C(CNCC1)=O LHIHOZSYRJFMMV-UHFFFAOYSA-N 0.000 description 1
LXZXFDZHPYFHML-UHFFFAOYSA-N 1-(pyridin-2-ylmethyl)piperazin-2-one Chemical compound O=C1CNCCN1CC1=CC=CC=N1 LXZXFDZHPYFHML-UHFFFAOYSA-N 0.000 description 1
SRMLIFVFEGGONF-UHFFFAOYSA-N 1-[(4-aminocinnolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]piperazin-2-one Chemical compound C=1C=C2C(N)=CN=NC2=CC=1CN(C(C1)=O)CCN1S(=O)(=O)C=CC1=CC=C(Cl)S1 SRMLIFVFEGGONF-UHFFFAOYSA-N 0.000 description 1
ZLEZWHVRWAIBKL-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(4-chloro-5-fluoro-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound FC1=CC=C2SC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1Cl ZLEZWHVRWAIBKL-UHFFFAOYSA-N 0.000 description 1
LWBKHRGVKOCIHD-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5,6-dichloro-1-benzothiophen-2-yl)methyl]piperazin-2-one Chemical compound ClC1=C(Cl)C=C2SC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 LWBKHRGVKOCIHD-UHFFFAOYSA-N 0.000 description 1
URNXXYSVPPVRPK-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5,7-dichloro-1h-indol-2-yl)methyl]piperazin-2-one Chemical compound ClC1=CC(Cl)=C2NC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 URNXXYSVPPVRPK-UHFFFAOYSA-N 0.000 description 1
QFPJLWTUZOFRPA-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1-benzofuran-2-yl)methyl]piperazin-2-one Chemical compound ClC1=CC=C2OC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 QFPJLWTUZOFRPA-UHFFFAOYSA-N 0.000 description 1
HDFNWMFVGWFMHI-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1-methylindol-2-yl)methyl]piperazin-2-one Chemical compound ClC1=CC=C2N(C)C(CN3CC(=O)N(CC=4C=C5N=CN=C(N)C5=CC=4)CC3)=CC2=C1 HDFNWMFVGWFMHI-UHFFFAOYSA-N 0.000 description 1
KENYWWXQIRQHMJ-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(5-chloro-1h-indol-2-yl)methyl]piperazin-2-one Chemical compound ClC1=CC=C2NC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1 KENYWWXQIRQHMJ-UHFFFAOYSA-N 0.000 description 1
JYULZYNKIKLNAS-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(6-bromo-1h-benzimidazol-2-yl)methyl]piperazin-2-one Chemical compound C1=C(Br)C=C2NC(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=NC2=C1 JYULZYNKIKLNAS-UHFFFAOYSA-N 0.000 description 1
RKDSLORNBXSPHV-DUXPYHPUSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[(e)-3-(4-chlorothiophen-2-yl)prop-2-enoyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)\C=C\C1=CC(Cl)=CS1 RKDSLORNBXSPHV-DUXPYHPUSA-N 0.000 description 1
GYTXGVDCPIYVEW-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(3-chlorophenyl)sulfanylethyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CCSC1=CC=CC(Cl)=C1 GYTXGVDCPIYVEW-UHFFFAOYSA-N 0.000 description 1
WXYQDCFUOLKYFG-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(4-chlorophenoxy)ethyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CCOC1=CC=C(Cl)C=C1 WXYQDCFUOLKYFG-UHFFFAOYSA-N 0.000 description 1
PYBGKVGAMLVTJJ-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyethyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CCOC1=CC=C(Cl)S1 PYBGKVGAMLVTJJ-UHFFFAOYSA-N 0.000 description 1
MPJWBLWGXXDZLB-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(2-phenylphenyl)prop-2-ynyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC#CC1=CC=CC=C1C1=CC=CC=C1 MPJWBLWGXXDZLB-UHFFFAOYSA-N 0.000 description 1
UNARFIVYNMOISL-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)prop-2-ynyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CC#CC1=CC=C(Cl)S1 UNARFIVYNMOISL-UHFFFAOYSA-N 0.000 description 1
GDLWYPCQYQURAI-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[3-(5-chlorothiophen-2-yl)propyl]piperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1CCCC1=CC=C(Cl)S1 GDLWYPCQYQURAI-UHFFFAOYSA-N 0.000 description 1
XYLXZFHXDDBCSM-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-[[5-[2-methyl-5-(trifluoromethyl)pyrazol-3-yl]thiophen-2-yl]methyl]piperazin-2-one Chemical compound CN1N=C(C(F)(F)F)C=C1C(S1)=CC=C1CN1CC(=O)N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1 XYLXZFHXDDBCSM-UHFFFAOYSA-N 0.000 description 1
GJVUGAVNWDVJAQ-UHFFFAOYSA-N 1-[(4-aminoquinazolin-7-yl)methyl]-4-prop-2-ynylpiperazin-2-one Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN1CCN(CC#C)CC1=O GJVUGAVNWDVJAQ-UHFFFAOYSA-N 0.000 description 1
RMSPWQAFNIAUBI-UHFFFAOYSA-N 1-[(4-aminoquinolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-n-ethyl-6-oxopiperazine-2-carboxamide Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CC(N(C(=O)C3)CC=3C=C4N=CC=C(N)C4=CC=3)C(=O)NCC)=CC2=C1 RMSPWQAFNIAUBI-UHFFFAOYSA-N 0.000 description 1
WMGWAUCSWVFCFH-UHFFFAOYSA-N 1-[(4-aminoquinolin-7-yl)methyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-n-methyl-6-oxopiperazine-2-carboxamide Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CC(N(C(=O)C3)CC=3C=C4N=CC=C(N)C4=CC=3)C(=O)NC)=CC2=C1 WMGWAUCSWVFCFH-UHFFFAOYSA-N 0.000 description 1
WXKMOWPYULQBMB-UHFFFAOYSA-N 1-[(4-aminothieno[3,2-d]pyrimidin-6-yl)methyl]-4-[3-(4-bromothiophen-2-yl)prop-2-enoyl]piperazin-2-one Chemical compound S1C=2C(N)=NC=NC=2C=C1CN(C(C1)=O)CCN1C(=O)C=CC1=CC(Br)=CS1 WXKMOWPYULQBMB-UHFFFAOYSA-N 0.000 description 1
WGIRXZGTGLPSRO-UHFFFAOYSA-N 1-[2-[(2-amino-3,5,6-trichloropyridin-4-yl)amino]ethyl]-4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]piperazin-2-one Chemical compound NC1=NC(Cl)=C(Cl)C(NCCN2C(CN(CC2)S(=O)(=O)C=CC=2SC(Cl)=CC=2)=O)=C1Cl WGIRXZGTGLPSRO-UHFFFAOYSA-N 0.000 description 1
ZOPFYIDFIOOKSO-UHFFFAOYSA-N 1-[2-[(2-amino-5-chloropyridin-4-yl)amino]ethyl]-4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]piperazin-2-one Chemical compound C1=NC(N)=CC(NCCN2C(CN(CC2)S(=O)(=O)C=CC=2SC(Cl)=CC=2)=O)=C1Cl ZOPFYIDFIOOKSO-UHFFFAOYSA-N 0.000 description 1
GKCXTSCUEKLQQZ-UHFFFAOYSA-N 1-[3-(4-aminopyridin-3-yl)prop-1-enyl]-4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]piperazin-2-one Chemical compound NC1=CC=NC=C1CC=CN1C(=O)CN(S(=O)(=O)C=CC=2SC(Cl)=CC=2)CC1 GKCXTSCUEKLQQZ-UHFFFAOYSA-N 0.000 description 1
ASZGJHDSDBZNLM-UHFFFAOYSA-N 1-[3-(4-aminopyridin-3-yl)propyl]-4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]piperazin-2-one Chemical compound NC1=CC=NC=C1CCCN1C(=O)CN(S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)CC1 ASZGJHDSDBZNLM-UHFFFAOYSA-N 0.000 description 1
HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
HLVFKOKELQSXIQ-UHFFFAOYSA-N 1-bromo-2-methylpropane Chemical compound CC(C)CBr HLVFKOKELQSXIQ-UHFFFAOYSA-N 0.000 description 1
OAXSVEFCBLZGCA-UHFFFAOYSA-N 1-chloro-4-(isocyanatomethyl)benzene Chemical compound ClC1=CC=C(CN=C=O)C=C1 OAXSVEFCBLZGCA-UHFFFAOYSA-N 0.000 description 1
OORBDHOQLZRIQR-UHFFFAOYSA-N 1-fluoro-4-methyl-2-nitrobenzene Chemical compound CC1=CC=C(F)C([N+]([O-])=O)=C1 OORBDHOQLZRIQR-UHFFFAOYSA-N 0.000 description 1
125000001088 1-naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 1
YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
GHTDODSYDCPOCW-UHFFFAOYSA-N 1h-indole-6-carboxylic acid Chemical compound OC(=O)C1=CC=C2C=CNC2=C1 GHTDODSYDCPOCW-UHFFFAOYSA-N 0.000 description 1
UTQNKKSJPHTPBS-UHFFFAOYSA-N 2,2,2-trichloroethanone Chemical group ClC(Cl)(Cl)[C]=O UTQNKKSJPHTPBS-UHFFFAOYSA-N 0.000 description 1
DNDPLEAVNVOOQZ-UHFFFAOYSA-N 2,3,4,5,6-pentachloropyridine Chemical compound ClC1=NC(Cl)=C(Cl)C(Cl)=C1Cl DNDPLEAVNVOOQZ-UHFFFAOYSA-N 0.000 description 1
UACZEBCMUQWIIC-UHFFFAOYSA-N 2,3,5,6-tetrachloro-4-nitropyridine Chemical compound [O-][N+](=O)C1=C(Cl)C(Cl)=NC(Cl)=C1Cl UACZEBCMUQWIIC-UHFFFAOYSA-N 0.000 description 1
NJYBIFYEWYWYAN-UHFFFAOYSA-N 2,4-difluorobenzoic acid Chemical compound OC(=O)C1=CC=C(F)C=C1F NJYBIFYEWYWYAN-UHFFFAOYSA-N 0.000 description 1
WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical class OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 1
OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
NRHVNPYOTNGECT-UHFFFAOYSA-N 2-(3-chlorophenyl)ethanamine Chemical compound NCCC1=CC=CC(Cl)=C1 NRHVNPYOTNGECT-UHFFFAOYSA-N 0.000 description 1
UMQUIRYNOVNYPA-UHFFFAOYSA-N 2-(4-chlorophenyl)acetyl chloride Chemical compound ClC(=O)CC1=CC=C(Cl)C=C1 UMQUIRYNOVNYPA-UHFFFAOYSA-N 0.000 description 1
SRXFXCKTIGELTI-UHFFFAOYSA-N 2-(4-chlorophenyl)ethanamine Chemical compound NCCC1=CC=C(Cl)C=C1 SRXFXCKTIGELTI-UHFFFAOYSA-N 0.000 description 1
GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 1
SZQMTCSQWUYUML-UHFFFAOYSA-N 2-(phenylmethoxycarbonylamino)butanoic acid Chemical compound CCC(C(O)=O)NC(=O)OCC1=CC=CC=C1 SZQMTCSQWUYUML-UHFFFAOYSA-N 0.000 description 1
CQCAYWAIRTVXIY-UHFFFAOYSA-N 2-(triphenyl-$l^{5}-phosphanylidene)acetaldehyde Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC=O)C1=CC=CC=C1 CQCAYWAIRTVXIY-UHFFFAOYSA-N 0.000 description 1
WEMGYHDLQWOPPF-UHFFFAOYSA-N 2-[(2-chloropyridin-3-yl)amino]acetic acid Chemical compound OC(=O)CNC1=CC=CN=C1Cl WEMGYHDLQWOPPF-UHFFFAOYSA-N 0.000 description 1
YICDGDQVHIITHG-KRWDZBQOSA-N 2-[2-[2-[(2s)-4-[(4-aminoquinazolin-7-yl)methyl]-2-(methoxymethyl)-3-oxopiperazin-1-yl]-2-oxoethoxy]-5-chlorothiophen-3-yl]acetic acid Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)COC)C(=O)COC=1SC(Cl)=CC=1CC(O)=O YICDGDQVHIITHG-KRWDZBQOSA-N 0.000 description 1
DYRMFFAKRROPRA-KRWDZBQOSA-N 2-[2-[2-[(2s)-4-[(4-aminoquinazolin-7-yl)methyl]-2-ethyl-3-oxopiperazin-1-yl]-2-oxoethoxy]-5-chlorothiophen-3-yl]acetamide Chemical compound N1([C@H](C(N(CC=2C=C3N=CN=C(N)C3=CC=2)CC1)=O)CC)C(=O)COC=1SC(Cl)=CC=1CC(N)=O DYRMFFAKRROPRA-KRWDZBQOSA-N 0.000 description 1
RDMXMAHJTWRIGR-UHFFFAOYSA-N 2-[3-oxo-4-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-1-yl]sulfonyl-1-benzothiophene-5-carbonitrile Chemical compound N#CC1=CC=C2SC(S(=O)(=O)N3CC(N(CC3)CC=3NC4=CC=NC=C4C=3)=O)=CC2=C1 RDMXMAHJTWRIGR-UHFFFAOYSA-N 0.000 description 1
WKMYFMYQGXBZCX-UHFFFAOYSA-N 2-[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]-n-(2-pyridin-4-ylethyl)acetamide Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(=O)NCCC1=CC=NC=C1 WKMYFMYQGXBZCX-UHFFFAOYSA-N 0.000 description 1
XLJLQCXVEZVMCX-UHFFFAOYSA-N 2-[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]-n-[2-(1h-imidazol-5-yl)ethyl]acetamide Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(=O)NCCC1=CN=CN1 XLJLQCXVEZVMCX-UHFFFAOYSA-N 0.000 description 1
HDXMCPUBYMWVNU-UHFFFAOYSA-N 2-[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]-n-[2-(4-methyl-1,3-thiazol-5-yl)ethyl]acetamide Chemical compound N1=CSC(CCNC(=O)CN2C(CN(CC2)S(=O)(=O)C=2SC3=CC(Cl)=CC=C3C=2)=O)=C1C HDXMCPUBYMWVNU-UHFFFAOYSA-N 0.000 description 1
UJMXHXPGPLOJHN-UHFFFAOYSA-N 2-[4-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]phenyl]benzonitrile Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CC(C=C1)=CC=C1C1=CC=CC=C1C#N UJMXHXPGPLOJHN-UHFFFAOYSA-N 0.000 description 1
FMKGJQHNYMWDFJ-CVEARBPZSA-N 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile Chemical compound FC(COC1=NC=NC=C1CNC1=NC=C(C(=N1)N[C@H]1CC([C@H](CC1)O)(C)C)C#N)(C)F FMKGJQHNYMWDFJ-CVEARBPZSA-N 0.000 description 1
FAYUTNBVEKWALG-UHFFFAOYSA-N 2-acetamido-3-(5-chlorothiophen-2-yl)propanoic acid Chemical compound CC(=O)NC(C(O)=O)CC1=CC=C(Cl)S1 FAYUTNBVEKWALG-UHFFFAOYSA-N 0.000 description 1
RPGKFFKUTVJVPY-UHFFFAOYSA-N 2-amino-4-methylbenzoic acid Chemical compound CC1=CC=C(C(O)=O)C(N)=C1 RPGKFFKUTVJVPY-UHFFFAOYSA-N 0.000 description 1
LGNVAEIITHYWCG-UHFFFAOYSA-N 2-amino-4-methylbenzonitrile Chemical compound CC1=CC=C(C#N)C(N)=C1 LGNVAEIITHYWCG-UHFFFAOYSA-N 0.000 description 1
UUYDPHCMCYSNAY-UHFFFAOYSA-N 2-amino-n-methylacetamide Chemical compound CNC(=O)CN UUYDPHCMCYSNAY-UHFFFAOYSA-N 0.000 description 1
LYIIBVSRGJSHAV-UHFFFAOYSA-N 2-aminoacetaldehyde Chemical compound NCC=O LYIIBVSRGJSHAV-UHFFFAOYSA-N 0.000 description 1
125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
WJPSANINUBHCFE-UHFFFAOYSA-N 2-bromo-5-iodo-3-methylpyridine Chemical compound CC1=CC(I)=CN=C1Br WJPSANINUBHCFE-UHFFFAOYSA-N 0.000 description 1
AWEXRBQGAXYMCH-UHFFFAOYSA-N 2-chloro-5-thiophen-2-ylthiophene Chemical group S1C(Cl)=CC=C1C1=CC=CS1 AWEXRBQGAXYMCH-UHFFFAOYSA-N 0.000 description 1
MEQBJJUWDCYIAB-UHFFFAOYSA-N 2-chloropyridin-3-amine Chemical compound NC1=CC=CN=C1Cl MEQBJJUWDCYIAB-UHFFFAOYSA-N 0.000 description 1
125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
XHIRBFXXIZZLNG-UHFFFAOYSA-N 2-methyl-3-phenylprop-2-enoyl chloride Chemical compound ClC(=O)C(C)=CC1=CC=CC=C1 XHIRBFXXIZZLNG-UHFFFAOYSA-N 0.000 description 1
125000001216 2-naphthoyl group Chemical group C1=C(C=CC2=CC=CC=C12)C(=O)* 0.000 description 1
BENRCDFLRJLQHI-UHFFFAOYSA-N 2-pyrimidin-4-ylacetamide Chemical compound NC(=O)CC1=CC=NC=N1 BENRCDFLRJLQHI-UHFFFAOYSA-N 0.000 description 1
WYZSHSYANZLLRM-UHFFFAOYSA-N 2-thiophen-2-yloxyacetic acid Chemical compound OC(=O)COC1=CC=CS1 WYZSHSYANZLLRM-UHFFFAOYSA-N 0.000 description 1
125000001698 2H-pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
MONFTNMPQCIYGZ-UHFFFAOYSA-N 3,3-bis(bromomethyl)-7-chloro-2h-isoquinoline Chemical compound BrCC1(CBr)NC=C2C=C(Cl)C=CC2=C1 MONFTNMPQCIYGZ-UHFFFAOYSA-N 0.000 description 1
QIOUNGKEYTTYAH-UHFFFAOYSA-N 3-(bromomethyl)-1,7-dichloro-1,2-dihydroisoquinoline Chemical compound C1=C(Cl)C=C2C(Cl)NC(CBr)=CC2=C1 QIOUNGKEYTTYAH-UHFFFAOYSA-N 0.000 description 1
COHXZRBHAXPSJR-UHFFFAOYSA-N 3-(bromomethyl)-7-chloro-1h-quinolin-2-one Chemical compound C1=C(CBr)C(=O)NC2=CC(Cl)=CC=C21 COHXZRBHAXPSJR-UHFFFAOYSA-N 0.000 description 1
CWCDSJSKLIDUGX-UHFFFAOYSA-N 3-[[2-oxo-4-(4-phenyldiazenylphenyl)sulfonylpiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(CN2C(CN(CC2)S(=O)(=O)C=2C=CC(=CC=2)N=NC=2C=CC=CC=2)=O)=C1 CWCDSJSKLIDUGX-UHFFFAOYSA-N 0.000 description 1
ZIRAUZSPLGAYQM-UHFFFAOYSA-N 3-[[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazin-1-yl]methyl]-5,7-dichloro-1h-quinolin-2-one Chemical compound C1=C(Cl)C=C2NC(=O)C(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1Cl ZIRAUZSPLGAYQM-UHFFFAOYSA-N 0.000 description 1
VVNCGCDJSPPDCV-UHFFFAOYSA-N 3-[[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazin-1-yl]methyl]-5-chloro-1h-quinolin-2-one Chemical compound C1=CC=C2NC(=O)C(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=CC2=C1Cl VVNCGCDJSPPDCV-UHFFFAOYSA-N 0.000 description 1
FQDCPXBRTMWQOW-UHFFFAOYSA-N 3-[[4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazin-1-yl]methyl]-6-chloro-1h-quinoxalin-2-one Chemical compound ClC1=CC=C2NC(=O)C(CN3CCN(C(C3)=O)CC=3C=C4N=CN=C(C4=CC=3)N)=NC2=C1 FQDCPXBRTMWQOW-UHFFFAOYSA-N 0.000 description 1
ZHZSXQOPUKNNFL-UHFFFAOYSA-N 3-[[4-[5-(5-nitropyridin-2-yl)sulfonylthiophen-2-yl]sulfonyl-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(CN2C(CN(CC2)S(=O)(=O)C=2SC(=CC=2)S(=O)(=O)C=2N=CC(=CC=2)[N+]([O-])=O)=O)=C1 ZHZSXQOPUKNNFL-UHFFFAOYSA-N 0.000 description 1
CQJDYPZUDYXHLM-UHFFFAOYSA-N 3-chlorobenzenethiol Chemical compound SC1=CC=CC(Cl)=C1 CQJDYPZUDYXHLM-UHFFFAOYSA-N 0.000 description 1
SJTBRFHBXDZMPS-UHFFFAOYSA-N 3-fluorophenol Chemical compound OC1=CC=CC(F)=C1 SJTBRFHBXDZMPS-UHFFFAOYSA-N 0.000 description 1
125000004364 3-pyrrolinyl group Chemical group [H]C1=C([H])C([H])([H])N(*)C1([H])[H] 0.000 description 1
OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
MEAZHVVGVMPJHX-UHFFFAOYSA-N 4-(4-pyridin-3-ylbenzoyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound C1CN(CC=2NC3=CC=NC=C3C=2)C(=O)CN1C(=O)C(C=C1)=CC=C1C1=CC=CN=C1 MEAZHVVGVMPJHX-UHFFFAOYSA-N 0.000 description 1
YXBVWWLBELAFNZ-UHFFFAOYSA-N 4-(5-chloro-1h-indole-2-carbonyl)-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound N1=CC=C2NC(CN3CCN(CC3=O)C(=O)C=3NC4=CC=C(C=C4C=3)Cl)=CC2=C1 YXBVWWLBELAFNZ-UHFFFAOYSA-N 0.000 description 1
QLSDWNZNVJSIOW-UHFFFAOYSA-N 4-[(2-oxopiperazin-1-yl)methyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1CN1C(=O)CNCC1 QLSDWNZNVJSIOW-UHFFFAOYSA-N 0.000 description 1
LCJSHDGJISLCLP-UHFFFAOYSA-N 4-[(4-aminoquinazolin-7-yl)methyl]-n-(4-chlorophenyl)-3-oxopiperazine-1-carboxamide Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)NC1=CC=C(Cl)C=C1 LCJSHDGJISLCLP-UHFFFAOYSA-N 0.000 description 1
UBYLBYGTLLMYHH-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[(2-chloroquinolin-6-yl)methyl]piperazin-2-one Chemical compound N1=C(Cl)C=CC2=CC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)Cl)=CC=C21 UBYLBYGTLLMYHH-UHFFFAOYSA-N 0.000 description 1
HMDGYDZACVVICD-UHFFFAOYSA-N 4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-1-[2-(pyridazin-4-ylamino)ethyl]piperazin-2-one Chemical compound S1C2=CC(Cl)=CC=C2C=C1S(=O)(=O)N(CC1=O)CCN1CCNC1=CC=NN=C1 HMDGYDZACVVICD-UHFFFAOYSA-N 0.000 description 1
JDUZGIQKFOYSON-UHFFFAOYSA-N 4-[2-(5-chloro-4-methoxythiophen-2-yl)ethenylsulfonyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound S1C(Cl)=C(OC)C=C1C=CS(=O)(=O)N1CC(=O)N(CC=2NC3=CC=NC=C3C=2)CC1 JDUZGIQKFOYSON-UHFFFAOYSA-N 0.000 description 1
WLYMUWHXAGWHSQ-UHFFFAOYSA-N 4-[2-(5-chlorothiophen-2-yl)ethenylsulfonyl]-1-[2-[(2,3,5,6-tetrachloropyridin-4-yl)amino]ethyl]piperazin-2-one Chemical compound S1C(Cl)=CC=C1C=CS(=O)(=O)N1CC(=O)N(CCNC=2C(=C(Cl)N=C(Cl)C=2Cl)Cl)CC1 WLYMUWHXAGWHSQ-UHFFFAOYSA-N 0.000 description 1
RNRBWIJNNSNRSF-UHFFFAOYSA-N 4-[2-(5-chlorothiophen-2-yl)ethylsulfonyl]-1-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazin-2-one Chemical compound S1C(Cl)=CC=C1CCS(=O)(=O)N1CC(=O)N(CC=2NC3=CC=NC=C3C=2)CC1 RNRBWIJNNSNRSF-UHFFFAOYSA-N 0.000 description 1
VCFPPQBXBNDGLV-UHFFFAOYSA-N 4-[3-(5-chlorothiophen-2-yl)prop-2-enoyl]-1-[2-(pyridin-4-ylamino)ethyl]piperazin-2-one Chemical compound S1C(Cl)=CC=C1C=CC(=O)N1CC(=O)N(CCNC=2C=CN=CC=2)CC1 VCFPPQBXBNDGLV-UHFFFAOYSA-N 0.000 description 1
WYFCZWSWFGJODV-MIANJLSGSA-N 4-[[(1s)-2-[(e)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]prop-2-enoyl]-5-(4-methyl-2-oxopiperazin-1-yl)-3,4-dihydro-1h-isoquinoline-1-carbonyl]amino]benzoic acid Chemical compound O=C1CN(C)CCN1C1=CC=CC2=C1CCN(C(=O)\C=C\C=1C(=CC=C(Cl)C=1F)N1N=NN=C1)[C@@H]2C(=O)NC1=CC=C(C(O)=O)C=C1 WYFCZWSWFGJODV-MIANJLSGSA-N 0.000 description 1
MPMKMQHJHDHPBE-RUZDIDTESA-N 4-[[(2r)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid Chemical compound O=C([C@@]1(N(CC1)C(=O)C=1C2=CC=CC=C2SC=1)C)N(CCCC(O)=O)CC1=CC=CC(Cl)=C1 MPMKMQHJHDHPBE-RUZDIDTESA-N 0.000 description 1
QIHAVYPUEXRAOP-CABCVRRESA-N 4-[[(3s,5r)-4-[(6-chloro-1-benzothiophen-2-yl)methyl]-3,5-dimethyl-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C([C@H](N([C@@H](C)C1=O)CC=2SC3=CC(Cl)=CC=C3C=2)C)N1CC1=CC=C(C(N)=N)C=C1 QIHAVYPUEXRAOP-CABCVRRESA-N 0.000 description 1
HDLAJQPMYMPMCD-UHFFFAOYSA-N 4-[[4-(4-methylphenyl)sulfonyl-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CC(=O)N(CC=2C=CC(=CC=2)C(N)=N)CC1 HDLAJQPMYMPMCD-UHFFFAOYSA-N 0.000 description 1
VFYPUDNGFNHFJW-UHFFFAOYSA-N 4-[[4-[(6-chloro-1h-benzimidazol-2-yl)methyl]-2-oxopiperazin-1-yl]methyl]benzenecarboximidamide Chemical compound C1=CC(C(=N)N)=CC=C1CN1C(=O)CN(CC=2NC3=CC(Cl)=CC=C3N=2)CC1 VFYPUDNGFNHFJW-UHFFFAOYSA-N 0.000 description 1
INMZDDDQLHKGPF-UHFFFAOYSA-N 4-bromo-2-chloroaniline Chemical compound NC1=CC=C(Br)C=C1Cl INMZDDDQLHKGPF-UHFFFAOYSA-N 0.000 description 1
KNDOFJFSHZCKGT-UHFFFAOYSA-N 4-chloroquinoline Chemical compound C1=CC=C2C(Cl)=CC=NC2=C1 KNDOFJFSHZCKGT-UHFFFAOYSA-N 0.000 description 1
125000004863 4-trifluoromethoxyphenyl group Chemical group [H]C1=C([H])C(OC(F)(F)F)=C([H])C([H])=C1* 0.000 description 1
WGOLHUGPTDEKCF-UHFFFAOYSA-N 5-bromopyridin-2-amine Chemical compound NC1=CC=C(Br)C=N1 WGOLHUGPTDEKCF-UHFFFAOYSA-N 0.000 description 1
LVZXKIHSMKEBRO-UHFFFAOYSA-N 5-bromothiophen-2-amine Chemical compound NC1=CC=C(Br)S1 LVZXKIHSMKEBRO-UHFFFAOYSA-N 0.000 description 1
WUVWAXJXPRYUME-UHFFFAOYSA-N 5-chloro-2-methyl-1h-indole Chemical compound ClC1=CC=C2NC(C)=CC2=C1 WUVWAXJXPRYUME-UHFFFAOYSA-N 0.000 description 1
NSQYZXRKKMXGNS-UHFFFAOYSA-N 5-chloro-4-methoxythiophen-2-amine Chemical compound COC=1C=C(N)SC=1Cl NSQYZXRKKMXGNS-UHFFFAOYSA-N 0.000 description 1
APBUXOCTCHJEFL-UHFFFAOYSA-N 5-chlorothiophene-2-carbonyl azide Chemical compound ClC1=CC=C(C(=O)N=[N+]=[N-])S1 APBUXOCTCHJEFL-UHFFFAOYSA-N 0.000 description 1
QZLSBOVWPHXCLT-UHFFFAOYSA-N 5-chlorothiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=C(Cl)S1 QZLSBOVWPHXCLT-UHFFFAOYSA-N 0.000 description 1
CTAIEPPAOULMFY-UHFFFAOYSA-N 6-methoxypyridine-3-carbaldehyde Chemical compound COC1=CC=C(C=O)C=N1 CTAIEPPAOULMFY-UHFFFAOYSA-N 0.000 description 1
LOUXUHOSYWFSHV-UHFFFAOYSA-N 6-methyl-1h-quinolin-2-one Chemical compound N1=C(O)C=CC2=CC(C)=CC=C21 LOUXUHOSYWFSHV-UHFFFAOYSA-N 0.000 description 1
YFTIUIRRLXUUIK-UHFFFAOYSA-N 6-oxopiperazine-2-carboxylic acid Chemical compound OC(=O)C1CNCC(=O)N1 YFTIUIRRLXUUIK-UHFFFAOYSA-N 0.000 description 1
HJOKDCMXGALILQ-UHFFFAOYSA-N 7-[[4-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-2-oxopiperazin-1-yl]methyl]-1h-quinolin-2-one Chemical compound C1=CC(=O)NC2=CC(CN3CCN(CC3=O)S(=O)(=O)C3=CC4=CC=C(C=C4S3)Cl)=CC=C21 HJOKDCMXGALILQ-UHFFFAOYSA-N 0.000 description 1
OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
206010067484 Adverse reaction Diseases 0.000 description 1
208000024827 Alzheimer disease Diseases 0.000 description 1
VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
201000001320 Atherosclerosis Diseases 0.000 description 1
102000015081 Blood Coagulation Factors Human genes 0.000 description 1
108010039209 Blood Coagulation Factors Proteins 0.000 description 1
BVDRWUCJZICKPJ-BTJKTKAUSA-N C(\C=C/C(=O)O)(=O)O.C1(CCCCC1)NS(O)(=O)=O Chemical compound C(\C=C/C(=O)O)(=O)O.C1(CCCCC1)NS(O)(=O)=O BVDRWUCJZICKPJ-BTJKTKAUSA-N 0.000 description 1
KMICRHGLONVVIA-MFYZJFEASA-O CC[C@@H](C(N(CC1=CC=C2C(O)=CC=NC2=C1)CC1)=O)N1C(C=CC1=CC=C[S+]1Cl)=O Chemical compound CC[C@@H](C(N(CC1=CC=C2C(O)=CC=NC2=C1)CC1)=O)N1C(C=CC1=CC=C[S+]1Cl)=O KMICRHGLONVVIA-MFYZJFEASA-O 0.000 description 1
USWQXRQCOXQHNP-UHFFFAOYSA-N COC(=O)N1C(C(NCC1)=O)COCC Chemical compound COC(=O)N1C(C(NCC1)=O)COCC USWQXRQCOXQHNP-UHFFFAOYSA-N 0.000 description 1
NSZOCZROGWCUFV-ZOWNYOTGSA-N COC[C@@H](C(N(CC1=CC=C2C(N)=NC=NC2=C1)CC1)=O)N1C(O)=O.NC(S1)=CC=C1Cl Chemical compound COC[C@@H](C(N(CC1=CC=C2C(N)=NC=NC2=C1)CC1)=O)N1C(O)=O.NC(S1)=CC=C1Cl NSZOCZROGWCUFV-ZOWNYOTGSA-N 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
208000017667 Chronic Disease Diseases 0.000 description 1
101150065749 Churc1 gene Proteins 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
SGQJDKZIODLSSB-INIZCTEOSA-N ClC1=CC(=CS1)NC(=O)N1[C@H](C(N(CC1)CC1=CC=C2C(=NC=NC2=C1)N)=O)COC Chemical compound ClC1=CC(=CS1)NC(=O)N1[C@H](C(N(CC1)CC1=CC=C2C(=NC=NC2=C1)N)=O)COC SGQJDKZIODLSSB-INIZCTEOSA-N 0.000 description 1
229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
238000006969 Curtius rearrangement reaction Methods 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
108010016626 Dipeptides Proteins 0.000 description 1
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
239000005977 Ethylene Substances 0.000 description 1
PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
108010074105 Factor Va Proteins 0.000 description 1
108010049003 Fibrinogen Proteins 0.000 description 1
102000008946 Fibrinogen Human genes 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
USPFMEKVPDBMCG-LBPRGKRZSA-N N-benzyloxycarbonyl-L-leucine Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 USPFMEKVPDBMCG-LBPRGKRZSA-N 0.000 description 1
AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methyl-N-phenylamine Natural products CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 1
MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
LTYHQKYRUOVPHG-CEISFSOZSA-N NC1=CC=NC2=CC(=CC=C12)CN1C([C@@H](N(CC1C)C(C=CC=1SC=C(C1)Br)=O)COC)=O Chemical compound NC1=CC=NC2=CC(=CC=C12)CN1C([C@@H](N(CC1C)C(C=CC=1SC=C(C1)Br)=O)COC)=O LTYHQKYRUOVPHG-CEISFSOZSA-N 0.000 description 1
229910002651 NO3 Inorganic materials 0.000 description 1
NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
101150003085 Pdcl gene Proteins 0.000 description 1
YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 1
206010034962 Photopsia Diseases 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
102100038239 Protein Churchill Human genes 0.000 description 1
108010094028 Prothrombin Proteins 0.000 description 1
102100027378 Prothrombin Human genes 0.000 description 1
208000010378 Pulmonary Embolism Diseases 0.000 description 1
AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
238000006859 Swern oxidation reaction Methods 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
SWEDAZLCYJDAGW-UHFFFAOYSA-N Thiophene-2-thiol Chemical compound SC1=CC=CS1 SWEDAZLCYJDAGW-UHFFFAOYSA-N 0.000 description 1
206010047139 Vasoconstriction Diseases 0.000 description 1
206010047249 Venous thrombosis Diseases 0.000 description 1
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
BHMMIRRUPHNTEJ-UHFFFAOYSA-N [1-(3-chlorophenyl)pyrrolidin-3-yl] 4-[(4-aminoquinazolin-7-yl)methyl]-3-oxopiperazine-1-carboxylate Chemical compound C=1C=C2C(N)=NC=NC2=CC=1CN(C(C1)=O)CCN1C(=O)OC(C1)CCN1C1=CC=CC(Cl)=C1 BHMMIRRUPHNTEJ-UHFFFAOYSA-N 0.000 description 1
SORGEQQSQGNZFI-UHFFFAOYSA-N [azido(phenoxy)phosphoryl]oxybenzene Chemical compound C=1C=CC=CC=1OP(=O)(N=[N+]=[N-])OC1=CC=CC=C1 SORGEQQSQGNZFI-UHFFFAOYSA-N 0.000 description 1
125000004036 acetal group Chemical group 0.000 description 1
DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
150000001241 acetals Chemical class 0.000 description 1
XCJLXFIGEMUOEE-UHFFFAOYSA-N acetamide;2,2,2-trifluoroacetic acid Chemical compound CC(N)=O.OC(=O)C(F)(F)F XCJLXFIGEMUOEE-UHFFFAOYSA-N 0.000 description 1
125000002339 acetoacetyl group Chemical group O=C([*])C([H])([H])C(=O)C([H])([H])[H] 0.000 description 1
150000008065 acid anhydrides Chemical class 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
230000006838 adverse reaction Effects 0.000 description 1
229910052783 alkali metal Inorganic materials 0.000 description 1
150000001340 alkali metals Chemical class 0.000 description 1
229910052784 alkaline earth metal Inorganic materials 0.000 description 1
150000001345 alkine derivatives Chemical class 0.000 description 1
125000005907 alkyl ester group Chemical group 0.000 description 1
150000001350 alkyl halides Chemical class 0.000 description 1
125000005278 alkyl sulfonyloxy group Chemical group 0.000 description 1
230000002152 alkylating effect Effects 0.000 description 1
208000030961 allergic reaction Diseases 0.000 description 1
230000004075 alteration Effects 0.000 description 1
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
ZKPHYUDUHAIMCK-UHFFFAOYSA-N ambtos828244 Chemical compound C12=CC=CC(=O)N2CC2CN(CC(=O)OC)CC1C2 ZKPHYUDUHAIMCK-UHFFFAOYSA-N 0.000 description 1
150000001409 amidines Chemical class 0.000 description 1
125000004103 aminoalkyl group Chemical group 0.000 description 1
VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
235000011114 ammonium hydroxide Nutrition 0.000 description 1
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
229910052921 ammonium sulfate Inorganic materials 0.000 description 1
235000011130 ammonium sulphate Nutrition 0.000 description 1
230000033115 angiogenesis Effects 0.000 description 1
239000005557 antagonist Substances 0.000 description 1
239000000010 aprotic solvent Substances 0.000 description 1
239000008346 aqueous phase Substances 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
229960003121 arginine Drugs 0.000 description 1
210000001367 artery Anatomy 0.000 description 1
206010003246 arthritis Diseases 0.000 description 1
125000001769 aryl amino group Chemical group 0.000 description 1
125000005135 aryl sulfinyl group Chemical group 0.000 description 1
125000005279 aryl sulfonyloxy group Chemical group 0.000 description 1
150000008305 azaarenes Chemical class 0.000 description 1
150000007514 bases Chemical class 0.000 description 1
UPABQMWFWCMOFV-UHFFFAOYSA-N benethamine Chemical compound C=1C=CC=CC=1CNCCC1=CC=CC=C1 UPABQMWFWCMOFV-UHFFFAOYSA-N 0.000 description 1
150000003935 benzaldehydes Chemical class 0.000 description 1
JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
229940092714 benzenesulfonic acid Drugs 0.000 description 1
125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 description 1
125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
NVVOSONODVYVRG-MNOVXSKESA-N benzyl (2s,6r)-2,6-dimethyl-3-oxopiperazine-1-carboxylate Chemical compound C[C@@H]1CNC(=O)[C@H](C)N1C(=O)OCC1=CC=CC=C1 NVVOSONODVYVRG-MNOVXSKESA-N 0.000 description 1
ULBGEVLICUWAHV-MRXNPFEDSA-N benzyl (3R)-3-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-oxopiperazine-1-carboxylate Chemical compound C1C(=O)N[C@@H](CO[Si](C)(C)C(C)(C)C)CN1C(=O)OCC1=CC=CC=C1 ULBGEVLICUWAHV-MRXNPFEDSA-N 0.000 description 1
GZLWTZOTPJASQW-UHFFFAOYSA-N benzyl 2-(2-methoxyethyl)-3-oxopiperazine-1-carboxylate Chemical compound C1CNC(=O)C(CCOC)N1C(=O)OCC1=CC=CC=C1 GZLWTZOTPJASQW-UHFFFAOYSA-N 0.000 description 1
PQJGEHDSRUJMIF-UHFFFAOYSA-N benzyl 2-(ethoxymethyl)-3-oxopiperazine-1-carboxylate Chemical compound C1CNC(=O)C(COCC)N1C(=O)OCC1=CC=CC=C1 PQJGEHDSRUJMIF-UHFFFAOYSA-N 0.000 description 1
FHPKICGAGPSVKO-UHFFFAOYSA-N benzyl 2-butyl-3-oxopiperazine-1-carboxylate Chemical compound C1CNC(=O)C(CCCC)N1C(=O)OCC1=CC=CC=C1 FHPKICGAGPSVKO-UHFFFAOYSA-N 0.000 description 1
ULBGEVLICUWAHV-UHFFFAOYSA-N benzyl 3-[[tert-butyl(dimethyl)silyl]oxymethyl]-5-oxopiperazine-1-carboxylate Chemical compound C1C(=O)NC(CO[Si](C)(C)C(C)(C)C)CN1C(=O)OCC1=CC=CC=C1 ULBGEVLICUWAHV-UHFFFAOYSA-N 0.000 description 1
BAHFPJFBMJTOPU-UHFFFAOYSA-N benzyl 3-oxopiperazine-1-carboxylate Chemical compound C1CNC(=O)CN1C(=O)OCC1=CC=CC=C1 BAHFPJFBMJTOPU-UHFFFAOYSA-N 0.000 description 1
PUJDIJCNWFYVJX-UHFFFAOYSA-N benzyl carbamate Chemical compound NC(=O)OCC1=CC=CC=C1 PUJDIJCNWFYVJX-UHFFFAOYSA-N 0.000 description 1
125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000003114 blood coagulation factor Substances 0.000 description 1
239000012267 brine Substances 0.000 description 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
229910052794 bromium Inorganic materials 0.000 description 1
IYYIVELXUANFED-UHFFFAOYSA-N bromo(trimethyl)silane Chemical compound C[Si](C)(C)Br IYYIVELXUANFED-UHFFFAOYSA-N 0.000 description 1
244000309464 bull Species 0.000 description 1
125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
239000000920 calcium hydroxide Substances 0.000 description 1
229910001861 calcium hydroxide Inorganic materials 0.000 description 1
CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical group C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
235000011089 carbon dioxide Nutrition 0.000 description 1
VQXINLNPICQTLR-UHFFFAOYSA-N carbonyl diazide Chemical class [N-]=[N+]=NC(=O)N=[N+]=[N-] VQXINLNPICQTLR-UHFFFAOYSA-N 0.000 description 1
150000001735 carboxylic acids Chemical class 0.000 description 1
125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
238000013130 cardiovascular surgery Methods 0.000 description 1
239000000969 carrier Substances 0.000 description 1
238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
230000003915 cell function Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
230000002490 cerebral effect Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 1
AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical class OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 1
VDANGULDQQJODZ-UHFFFAOYSA-N chloroprocaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1Cl VDANGULDQQJODZ-UHFFFAOYSA-N 0.000 description 1
229960002023 chloroprocaine Drugs 0.000 description 1
OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
229960001231 choline Drugs 0.000 description 1
WCZVZNOTHYJIEI-UHFFFAOYSA-N cinnoline Chemical compound N1=NC=CC2=CC=CC=C21 WCZVZNOTHYJIEI-UHFFFAOYSA-N 0.000 description 1
235000015165 citric acid Nutrition 0.000 description 1
238000004140 cleaning Methods 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
229940125782 compound 2 Drugs 0.000 description 1
229940127113 compound 57 Drugs 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
GBRBMTNGQBKBQE-UHFFFAOYSA-L copper;diiodide Chemical compound I[Cu]I GBRBMTNGQBKBQE-UHFFFAOYSA-L 0.000 description 1
208000029078 coronary artery disease Diseases 0.000 description 1
239000002537 cosmetic Substances 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
239000013058 crude material Substances 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
125000001162 cycloheptenyl group Chemical group C1(=CCCCCC1)* 0.000 description 1
125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 1
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
125000004855 decalinyl group Chemical group C1(CCCC2CCCCC12)* 0.000 description 1
125000003493 decenyl group Chemical group [H]C([*])=C([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
230000005595 deprotonation Effects 0.000 description 1
238000010537 deprotonation reaction Methods 0.000 description 1
ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
229940043237 diethanolamine Drugs 0.000 description 1
HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
229910001873 dinitrogen Inorganic materials 0.000 description 1
SXZIXHOMFPUIRK-UHFFFAOYSA-N diphenylmethanimine Chemical compound C=1C=CC=CC=1C(=N)C1=CC=CC=C1 SXZIXHOMFPUIRK-UHFFFAOYSA-N 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
238000009510 drug design Methods 0.000 description 1
238000001035 drying Methods 0.000 description 1
239000012039 electrophile Substances 0.000 description 1
238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
239000003480 eluent Substances 0.000 description 1
238000001952 enzyme assay Methods 0.000 description 1
238000010931 ester hydrolysis Methods 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
HHFAWKCIHAUFRX-UHFFFAOYSA-N ethoxide Chemical compound CC[O-] HHFAWKCIHAUFRX-UHFFFAOYSA-N 0.000 description 1
125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
UOUDEEISQIAYSK-UHFFFAOYSA-N ethyl 2-(3-fluorophenoxy)acetate Chemical compound CCOC(=O)COC1=CC=CC(F)=C1 UOUDEEISQIAYSK-UHFFFAOYSA-N 0.000 description 1
AXDLHROQOWTKTN-IBGZPJMESA-N ethyl 2-[2-[2-[(2s)-4-[(4-aminoquinazolin-7-yl)methyl]-2-(methoxymethyl)-3-oxopiperazin-1-yl]-2-oxoethoxy]-5-chlorothiophen-3-yl]acetate Chemical compound C1=C(Cl)SC(OCC(=O)N2[C@H](C(=O)N(CC=3C=C4N=CN=C(N)C4=CC=3)CC2)COC)=C1CC(=O)OCC AXDLHROQOWTKTN-IBGZPJMESA-N 0.000 description 1
GECZTEFMPHWWSC-UHFFFAOYSA-N ethyl 2-sulfanyl-2-thiophen-2-ylacetate Chemical compound CCOC(=O)C(S)C1=CC=CS1 GECZTEFMPHWWSC-UHFFFAOYSA-N 0.000 description 1
XRHQGYIZIZMPOT-UHFFFAOYSA-N ethyl 2-thiophen-2-yloxyacetate Chemical compound CCOC(=O)COC1=CC=CS1 XRHQGYIZIZMPOT-UHFFFAOYSA-N 0.000 description 1
YNUNTAWVARFSQZ-UHFFFAOYSA-N ethyl 2-thiophen-2-ylsulfanylacetate Chemical compound CCOC(=O)CSC1=CC=CS1 YNUNTAWVARFSQZ-UHFFFAOYSA-N 0.000 description 1
WBJINCZRORDGAQ-UHFFFAOYSA-N ethyl formate Chemical compound CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
229940012952 fibrinogen Drugs 0.000 description 1
239000012065 filter cake Substances 0.000 description 1
239000006260 foam Substances 0.000 description 1
235000019256 formaldehyde Nutrition 0.000 description 1
229960004279 formaldehyde Drugs 0.000 description 1
235000019253 formic acid Nutrition 0.000 description 1
CNUDBTRUORMMPA-UHFFFAOYSA-N formylthiophene Chemical compound O=CC1=CC=CS1 CNUDBTRUORMMPA-UHFFFAOYSA-N 0.000 description 1
239000003574 free electron Substances 0.000 description 1
VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical compound [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
125000003838 furazanyl group Chemical group 0.000 description 1
239000007789 gas Substances 0.000 description 1
230000008570 general process Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
229940093915 gynecological organic acid Drugs 0.000 description 1
125000001475 halogen functional group Chemical group 0.000 description 1
230000002140 halogenating effect Effects 0.000 description 1
150000005748 halopyridines Chemical group 0.000 description 1
125000005842 heteroatom Chemical group 0.000 description 1
239000008241 heterogeneous mixture Substances 0.000 description 1
125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
150000004677 hydrates Chemical class 0.000 description 1
COQRGFWWJBEXRC-UHFFFAOYSA-N hydron;methyl 2-aminoacetate;chloride Chemical compound Cl.COC(=O)CN COQRGFWWJBEXRC-UHFFFAOYSA-N 0.000 description 1
USZLCYNVCCDPLQ-UHFFFAOYSA-N hydron;n-methoxymethanamine;chloride Chemical compound Cl.CNOC USZLCYNVCCDPLQ-UHFFFAOYSA-N 0.000 description 1
125000005946 imidazo[1,2-a]pyridyl group Chemical group 0.000 description 1
125000002636 imidazolinyl group Chemical group 0.000 description 1
125000001841 imino group Chemical group [H]N=* 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
125000000814 indol-3-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C([*])C2=C1[H] 0.000 description 1
125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 description 1
125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
230000007794 irritation Effects 0.000 description 1
125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
125000001786 isothiazolyl group Chemical group 0.000 description 1
125000000842 isoxazolyl group Chemical group 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
OVEHNNQXLPJPPL-UHFFFAOYSA-N lithium;n-propan-2-ylpropan-2-amine Chemical compound [Li].CC(C)NC(C)C OVEHNNQXLPJPPL-UHFFFAOYSA-N 0.000 description 1
229960003646 lysine Drugs 0.000 description 1
VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
239000000347 magnesium hydroxide Substances 0.000 description 1
229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
229940098779 methanesulfonic acid Drugs 0.000 description 1
NBTOZLQBSIZIKS-UHFFFAOYSA-N methoxide Chemical compound [O-]C NBTOZLQBSIZIKS-UHFFFAOYSA-N 0.000 description 1
YPHRCQHMSQLRIC-BYPYZUCNSA-N methyl (2s)-6-oxopiperazine-2-carboxylate Chemical compound COC(=O)[C@@H]1CNCC(=O)N1 YPHRCQHMSQLRIC-BYPYZUCNSA-N 0.000 description 1
HRRHKFFXEHQMFI-UHFFFAOYSA-N methyl 1-[(4-aminoquinazolin-7-yl)methyl]-4-[2-(5-chlorothiophen-2-yl)oxyacetyl]-6-oxopiperazine-2-carboxylate Chemical compound C1C(=O)N(CC=2C=C3N=CN=C(N)C3=CC=2)C(C(=O)OC)CN1C(=O)COC1=CC=C(Cl)S1 HRRHKFFXEHQMFI-UHFFFAOYSA-N 0.000 description 1
VQRXMIGFCMMVRN-UHFFFAOYSA-N methyl 1-[(6-chloro-1-benzothiophen-2-yl)sulfonyl]-5-oxo-4-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazine-2-carboxylate Chemical compound C1=C(Cl)C=C2SC(S(=O)(=O)N3CC(=O)N(CC=4NC5=CC=NC=C5C=4)CC3C(=O)OC)=CC2=C1 VQRXMIGFCMMVRN-UHFFFAOYSA-N 0.000 description 1
JEBXDTGUTKTTBN-UHFFFAOYSA-N methyl 1-[2-(5-chlorothiophen-2-yl)oxyacetyl]-5-oxo-4-(1h-pyrrolo[3,2-c]pyridin-2-ylmethyl)piperazine-2-carboxylate Chemical compound COC(=O)C1CN(CC=2NC3=CC=NC=C3C=2)C(=O)CN1C(=O)COC1=CC=C(Cl)S1 JEBXDTGUTKTTBN-UHFFFAOYSA-N 0.000 description 1
AYYOZKHMSABVRP-UHFFFAOYSA-N methyl 1h-indole-6-carboxylate Chemical compound COC(=O)C1=CC=C2C=CNC2=C1 AYYOZKHMSABVRP-UHFFFAOYSA-N 0.000 description 1
NTNUDYROPUKXNA-UHFFFAOYSA-N methyl 2-(triphenyl-$l^{5}-phosphanylidene)acetate Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC(=O)OC)C1=CC=CC=C1 NTNUDYROPUKXNA-UHFFFAOYSA-N 0.000 description 1
QLCDZHWIWTWMFY-UHFFFAOYSA-N methyl 2-[[3-[tert-butyl(dimethyl)silyl]oxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]propyl]amino]acetate Chemical compound COC(=O)CNCC(CO[Si](C)(C)C(C)(C)C)NC(=O)OC(C)(C)C QLCDZHWIWTWMFY-UHFFFAOYSA-N 0.000 description 1
LXVAWARDQKGFTJ-UHFFFAOYSA-N methyl 3-chloro-1-(4-methylphenyl)sulfonylindole-6-carboxylate Chemical compound C12=CC(C(=O)OC)=CC=C2C(Cl)=CN1S(=O)(=O)C1=CC=C(C)C=C1 LXVAWARDQKGFTJ-UHFFFAOYSA-N 0.000 description 1
125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
239000011707 mineral Substances 0.000 description 1
230000002297 mitogenic effect Effects 0.000 description 1
XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 1
125000002757 morpholinyl group Chemical group 0.000 description 1
LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
HZJSCAJYXJLSHJ-UHFFFAOYSA-N n-[2-(1,3-thiazol-4-yl)ethyl]acetamide Chemical compound CC(=O)NCCC1=CSC=N1 HZJSCAJYXJLSHJ-UHFFFAOYSA-N 0.000 description 1
YMRQGDVRCHGJPW-UHFFFAOYSA-N n-benzyl-2,3,5,6-tetrachloropyridin-4-amine Chemical compound ClC1=NC(Cl)=C(Cl)C(NCC=2C=CC=CC=2)=C1Cl YMRQGDVRCHGJPW-UHFFFAOYSA-N 0.000 description 1
TYRGLVWXHJRKMT-QMMMGPOBSA-N n-benzyloxycarbonyl-l-serine-betalactone Chemical compound OC(=O)[C@H](C)NC(=O)OCC1=CC=CC=C1 TYRGLVWXHJRKMT-QMMMGPOBSA-N 0.000 description 1
125000004370 n-butenyl group Chemical group [H]\C([H])=C(/[H])C([H])([H])C([H])([H])* 0.000 description 1
BZKSAWDBBGWYNF-UHFFFAOYSA-N n-methylquinolin-4-amine Chemical compound C1=CC=C2C(NC)=CC=NC2=C1 BZKSAWDBBGWYNF-UHFFFAOYSA-N 0.000 description 1
125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000001624 naphthyl group Chemical group 0.000 description 1
125000005029 naphthylthio group Chemical group C1(=CC=CC2=CC=CC=C12)S* 0.000 description 1
208000015122 neurodegenerative disease Diseases 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
MCSAJNNLRCFZED-UHFFFAOYSA-N nitroethane Chemical compound CC[N+]([O-])=O MCSAJNNLRCFZED-UHFFFAOYSA-N 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 description 1
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
125000004365 octenyl group Chemical group C(=CCCCCCC)* 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
150000007524 organic acids Chemical class 0.000 description 1
235000005985 organic acids Nutrition 0.000 description 1
229960003104 ornithine Drugs 0.000 description 1
125000001715 oxadiazolyl group Chemical group 0.000 description 1
125000002971 oxazolyl group Chemical group 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
230000020477 pH reduction Effects 0.000 description 1
229910052763 palladium Inorganic materials 0.000 description 1
125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
239000012026 peptide coupling reagents‎ Substances 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
239000012071 phase Substances 0.000 description 1
125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
125000006678 phenoxycarbonyl group Chemical group 0.000 description 1
125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
229910000065 phosphene Inorganic materials 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
QHGWRVOSXCSSPO-UHFFFAOYSA-N piperazin-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.O=C1CNCCN1 QHGWRVOSXCSSPO-UHFFFAOYSA-N 0.000 description 1
125000004193 piperazinyl group Chemical group 0.000 description 1
125000005936 piperidyl group Chemical group 0.000 description 1
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
229920000137 polyphosphoric acid Polymers 0.000 description 1
229910000343 potassium bisulfate Inorganic materials 0.000 description 1
USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
239000001120 potassium sulphate Substances 0.000 description 1
239000000843 powder Substances 0.000 description 1
150000003141 primary amines Chemical class 0.000 description 1
MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
229960004919 procaine Drugs 0.000 description 1
230000008569 process Effects 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
TVDSBUOJIPERQY-UHFFFAOYSA-N prop-2-yn-1-ol Chemical compound OCC#C TVDSBUOJIPERQY-UHFFFAOYSA-N 0.000 description 1
IVRIRQXJSNCSPQ-UHFFFAOYSA-N propan-2-yl carbonochloridate Chemical compound CC(C)OC(Cl)=O IVRIRQXJSNCSPQ-UHFFFAOYSA-N 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
229940039716 prothrombin Drugs 0.000 description 1
108010014806 prothrombinase complex Proteins 0.000 description 1
125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
125000003373 pyrazinyl group Chemical group 0.000 description 1
125000003072 pyrazolidinyl group Chemical group 0.000 description 1
125000003226 pyrazolyl group Chemical group 0.000 description 1
125000002098 pyridazinyl group Chemical group 0.000 description 1
125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 1
125000000714 pyrimidinyl group Chemical group 0.000 description 1
125000000719 pyrrolidinyl group Chemical group 0.000 description 1
125000006085 pyrrolopyridyl group Chemical group 0.000 description 1
125000000168 pyrrolyl group Chemical group 0.000 description 1
JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
ZHNFLHYOFXQIOW-LPYZJUEESA-N quinine sulfate dihydrate Chemical compound [H+].[H+].O.O.[O-]S([O-])(=O)=O.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21.C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 ZHNFLHYOFXQIOW-LPYZJUEESA-N 0.000 description 1
125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
125000004621 quinuclidinyl group Chemical group N12C(CC(CC1)CC2)* 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
238000004366 reverse phase liquid chromatography Methods 0.000 description 1
238000006798 ring closing metathesis reaction Methods 0.000 description 1
YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
229960001860 salicylate Drugs 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
230000007017 scission Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
235000009518 sodium iodide Nutrition 0.000 description 1
235000010288 sodium nitrite Nutrition 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
229960002317 succinimide Drugs 0.000 description 1
IIACRCGMVDHOTQ-UHFFFAOYSA-M sulfamate Chemical compound NS([O-])(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-M 0.000 description 1
BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
229940095064 tartrate Drugs 0.000 description 1
MBTRMYMICPKJNH-UHFFFAOYSA-N tert-butyl n-[3-[tert-butyl(dimethyl)silyl]oxy-1-[methoxy(methyl)amino]-1-oxopropan-2-yl]carbamate Chemical compound CC(C)(C)[Si](C)(C)OCC(C(=O)N(C)OC)NC(=O)OC(C)(C)C MBTRMYMICPKJNH-UHFFFAOYSA-N 0.000 description 1
BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
238000012360 testing method Methods 0.000 description 1
DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 1
125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
125000005958 tetrahydrothienyl group Chemical group 0.000 description 1
125000003507 tetrahydrothiofenyl group Chemical group 0.000 description 1
125000001984 thiazolidinyl group Chemical group 0.000 description 1
125000000335 thiazolyl group Chemical group 0.000 description 1
ZASCXWTVGGZQIZ-UHFFFAOYSA-N thieno[3,2-d]pyrimidin-2-amine Chemical compound NC1=NC=C2SC=CC2=N1 ZASCXWTVGGZQIZ-UHFFFAOYSA-N 0.000 description 1
RBNBDIMXFJYDLQ-UHFFFAOYSA-N thieno[3,2-d]pyrimidine Chemical compound C1=NC=C2SC=CC2=N1 RBNBDIMXFJYDLQ-UHFFFAOYSA-N 0.000 description 1
125000005301 thienylmethyl group Chemical group [H]C1=C([H])C([H])=C(S1)C([H])([H])* 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
125000004568 thiomorpholinyl group Chemical group 0.000 description 1
229930192474 thiophene Natural products 0.000 description 1
XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
238000009901 transfer hydrogenation reaction Methods 0.000 description 1
125000004306 triazinyl group Chemical group 0.000 description 1
125000001425 triazolyl group Chemical group 0.000 description 1
AJSTXXYNEIHPMD-UHFFFAOYSA-N triethyl borate Chemical compound CCOB(OCC)OCC AJSTXXYNEIHPMD-UHFFFAOYSA-N 0.000 description 1
ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
LZTRCELOJRDYMQ-UHFFFAOYSA-N triphenylmethanol Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(O)C1=CC=CC=C1 LZTRCELOJRDYMQ-UHFFFAOYSA-N 0.000 description 1
FIQMHBFVRAXMOP-UHFFFAOYSA-N triphenylphosphane oxide Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=O)C1=CC=CC=C1 FIQMHBFVRAXMOP-UHFFFAOYSA-N 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
210000005167 vascular cell Anatomy 0.000 description 1
230000009723 vascular congestion Effects 0.000 description 1
230000025033 vasoconstriction Effects 0.000 description 1
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
239000003039 volatile agent Substances 0.000 description 1
239000008096 xylene Substances 0.000 description 1
229910052725 zinc Inorganic materials 0.000 description 1
239000011701 zinc Substances 0.000 description 1
UGZADUVQMDAIAO-UHFFFAOYSA-L zinc hydroxide Chemical compound [OH-].[OH-].[Zn+2] UGZADUVQMDAIAO-UHFFFAOYSA-L 0.000 description 1
229940007718 zinc hydroxide Drugs 0.000 description 1
229910021511 zinc hydroxide Inorganic materials 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Psychiatry (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Steroid Compounds (AREA)

SK1108-2000A 1998-01-27 1999-01-27 Substituované oxoazaheterocyklické inhibítory faktora xa, farmaceutický prostriedok s ich obsahom a ich použitie SK11082000A3 (sk)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US7270798P	1998-01-27	1998-01-27
PCT/US1999/001682 WO1999037304A1 (fr)	1998-01-27	1999-01-27	COMPOSES OXOAZAHETEROCYCLYLE SUBSTITUES INHIBITEURS DU FACTEUR Xa

Publications (1)

Publication Number	Publication Date
SK11082000A3 true SK11082000A3 (sk)	2001-01-18

Family

ID=22109280

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SK1108-2000A SK11082000A3 (sk)	1998-01-27	1999-01-27	Substituované oxoazaheterocyklické inhibítory faktora xa, farmaceutický prostriedok s ich obsahom a ich použitie

Country Status (25)

Country	Link
US (1)	US7612075B2 (fr)
EP (1)	EP1051176B1 (fr)
JP (1)	JP4676613B2 (fr)
KR (1)	KR20010034442A (fr)
CN (1)	CN1291892A (fr)
AP (1)	AP2000001889A0 (fr)
AT (1)	ATE346050T1 (fr)
AU (1)	AU745425B2 (fr)
BG (1)	BG104633A (fr)
BR (1)	BR9907300A (fr)
CA (1)	CA2319198C (fr)
DE (1)	DE69934093T2 (fr)
EA (1)	EA200000768A1 (fr)
EE (1)	EE200000435A (fr)
HU (1)	HUP0101810A3 (fr)
IL (2)	IL137517A0 (fr)
IS (1)	IS5574A (fr)
NO (1)	NO20003808L (fr)
PL (1)	PL342243A1 (fr)
SK (1)	SK11082000A3 (fr)
TR (1)	TR200002182T2 (fr)
UA (1)	UA59433C2 (fr)
WO (1)	WO1999037304A1 (fr)
YU (1)	YU47600A (fr)
ZA (1)	ZA99607B (fr)

Families Citing this family (144)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ID23991A (id)	1997-09-30	2000-06-14	Daiichi Seiyaku Co	Turunan-turunan sulfonil
CA2317017A1 (fr) *	1998-02-05	1999-08-12	Takeda Chemical Industries, Ltd.	Derives de sulfamide, leur procede de production et leur utilisation
US7517884B2 (en)	1998-03-30	2009-04-14	Kalypsys Inc.	Sulfonyl-substituted bicyclic compounds as modulators of PPAR
EP1104754A1 (fr) *	1998-08-11	2001-06-06	Daiichi Pharmaceutical Co., Ltd.	Nouveaux derives sulfonyle
JP2003529531A (ja) *	1998-11-25	2003-10-07	アヴェンティスファーマシューティカルズインコーポレイテッド	置換オキソアザへテロシクリルＸａ因子阻害剤
AU3127900A (en) *	1998-12-23	2000-07-31	Du Pont Pharmaceuticals Company	Thrombin or factor xa inhibitors
DE60027718T2 (de)	1999-06-22	2007-05-16	Takeda Pharmaceutical Co. Ltd.	Acylhydrazinderivate, verfahren zu ihrer herstellung und ihre verwendung
SK1182002A3 (en) *	1999-07-28	2002-11-06	Aventis Pharm Prod Inc	Substituted oxoazaheterocyclyl compounds
SE9902987D0 (sv)	1999-08-24	1999-08-24	Astra Pharma Prod	Novel compounds
DE19962924A1 (de)	1999-12-24	2001-07-05	Bayer Ag	Substituierte Oxazolidinone und ihre Verwendung
JP2001294572A (ja) *	2000-02-09	2001-10-23	Dai Ichi Seiyaku Co Ltd	新規スルホニル誘導体
DE10012732A1 (de)	2000-03-18	2001-09-20	Aventis Behring Gmbh	Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
AR030357A1 (es) *	2000-08-18	2003-08-20	Lundbeck & Co As H	Derivados 4 -, 5 -, 6 - y 7-indol
US20040072860A1 (en) *	2000-09-29	2004-04-15	Bing-Yan Zhu	Piperazin-2-one amides as inhibitors of factor xa
DE60116655T2 (de)	2000-11-08	2006-11-16	Takeda Pharmaceutical Co. Ltd.	Carbamatderivate, verfahren zu deren herstellung und deren verwendung
DE10105989A1 (de)	2001-02-09	2002-08-14	Bayer Ag	Substituierte Oxazolidinone und ihre Verwendung
GB0104050D0 (en)	2001-02-19	2001-04-04	Astrazeneca Ab	Chemical compounds
GB0107228D0 (en)	2001-03-22	2001-05-16	Astrazeneca Ab	Chemical compounds
DK1598339T3 (da)	2001-04-18	2009-09-28	Euro Celtique Sa	1-(4-amino-cyclohexyl)-1,3-dihydro-2H-benzimidazol-2-on derivater og beslægtede forbindelser som nociceptin analoger og ORL1-ligander til behandling af smerte
GB0112836D0 (en)	2001-05-25	2001-07-18	Smithkline Beecham Plc	Medicaments
GB0114005D0 (en)	2001-06-08	2001-08-01	Glaxo Group Ltd	Chemical compounds
GB0114004D0 (en)	2001-06-08	2001-08-01	Glaxo Group Ltd	Chemical compounds
DE10129725A1 (de)	2001-06-20	2003-01-02	Bayer Ag	Kombinationstherapie substituierter Oxazolidinone
NZ530202A (en)	2001-07-02	2005-06-24	Astrazeneca Ab	Piperidine derivatives useful as modulators of chemokine receptor activity
DE10134482A1 (de)	2001-07-16	2003-01-30	Bayer Ag	Substituierte Isoindole und ihre Verwendung
DE10137163A1 (de)	2001-07-30	2003-02-13	Bayer Ag	Substituierte Isoindole und ihre Verwendung
GB0120461D0 (en)	2001-08-22	2001-10-17	Astrazeneca Ab	Novel compounds
ES2335092T3 (es)	2001-08-24	2010-03-22	Yale University	Compuestos de piperazinona como agentes antitumorales y anticancer.
GB0122503D0 (en)	2001-09-18	2001-11-07	Astrazeneca Ab	Chemical compounds
DE10155727A1 (de) *	2001-11-13	2003-05-28	Morphochem Ag	Serin Protease Inhibitoren
SE0103818D0 (sv)	2001-11-15	2001-11-15	Astrazeneca Ab	Chemical compounds
EP1314733A1 (fr)	2001-11-22	2003-05-28	Aventis Pharma Deutschland GmbH	Indole-2-carboxamides comme inhibiteurs du facteur Xa
GB0130677D0 (en)	2001-12-21	2002-02-06	Glaxo Group Ltd	Medicaments and novel compounds
AU2003212882A1 (en)	2002-02-01	2003-09-02	Euro-Celtique S.A.	2 - piperazine - pyridines useful for treating pain
GB0203020D0 (en)	2002-02-08	2002-03-27	Glaxo Group Ltd	Chemical compounds
EP1472222A1 (fr)	2002-02-08	2004-11-03	Glaxo Group Limited	Derives piperidylcarboxamide, et leur utilisation dans le traitement des maladies dont la mediation est assuree par les tachykinines
SE0200843D0 (sv)	2002-03-19	2002-03-19	Astrazeneca Ab	Chemical compounds
SE0200844D0 (sv)	2002-03-19	2002-03-19	Astrazeneca Ab	Chemical compounds
AU2003231359B2 (en)	2002-04-16	2009-04-30	Teijin Limited	Piperidine derivatives having CCR3 antagonism
KR20040104596A (ko)	2002-04-25	2004-12-10	데이진 가부시키가이샤	Ｃｃｒ３ 길항 작용을 갖는 ４,４-２치환 피페리딘 유도체
KR20030084444A (ko) *	2002-04-26	2003-11-01	주식회사 파나진	Ｐｎａ 올리고머를 합성하기 위한 신규한 단량체 및 그의제조방법
US6864261B2 (en)	2002-05-02	2005-03-08	Euro-Celtique S.A.	Therapeutic agents useful for treating pain
TW200409637A (en)	2002-06-26	2004-06-16	Glaxo Group Ltd	Compounds
HUE025683T2 (hu)	2002-12-03	2016-04-28	Pharmacyclics Llc	VIIA faktor inhibitor 2-(2-hidroxi-bifenil-3-il)-1H-benzoimidazol-5-karboxamidin-származékok
US7429581B2 (en)	2002-12-23	2008-09-30	Sanofi-Aventis Deutschland Gmbh	Pyrazole-derivatives as factor Xa inhibitors
US7582635B2 (en)	2002-12-24	2009-09-01	Purdue Pharma, L.P.	Therapeutic agents useful for treating pain
DE10300111A1 (de)	2003-01-07	2004-07-15	Bayer Healthcare Ag	Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
TW200508224A (en) *	2003-02-12	2005-03-01	Bristol Myers Squibb Co	Cyclic derivatives as modulators of chemokine receptor activity
SE0300957D0 (sv)	2003-04-01	2003-04-01	Astrazeneca Ab	Chemical compounds
SE0301369D0 (sv)	2003-05-09	2003-05-09	Astrazeneca Ab	Chemical compounds
GB0314738D0 (en)	2003-06-24	2003-07-30	Glaxo Group Ltd	Novel compounds
PL1641775T3 (pl)	2003-07-03	2009-07-31	Euro Celtique Sa	Pochodne 2-pirydynoalkin użyteczne do leczenia bólu
ATE430741T1 (de)	2003-07-24	2009-05-15	Euro Celtique Sa	Piperidinverbindungen und pharmazeutische zusammensetzungen, die diese enthalten
US7163937B2 (en)	2003-08-21	2007-01-16	Bristol-Myers Squibb Company	Cyclic derivatives as modulators of chemokine receptor activity
BRPI0416665A (pt)	2003-11-17	2007-01-16	Boehringer Ingelheim Int	indóis substituìdos com piperidina ou heteroderivados dos mesmos
DE10355461A1 (de)	2003-11-27	2005-06-23	Bayer Healthcare Ag	Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
WO2005084672A1 (fr) *	2004-03-03	2005-09-15	Boehringer Ingelheim International Gmbh	Antagonistes de cgrp selectionnes, procedes de fabrication et utilisation en tant que medicament
US7269708B2 (en) *	2004-04-20	2007-09-11	Rambus Inc.	Memory controller for non-homogenous memory system
GB0414093D0 (en)	2004-06-23	2004-07-28	Glaxo Group Ltd	Novel compounds
MX2007002214A (es) *	2004-09-03	2007-05-07	Yuhan Corp	Derivados de pirrolo[3,2-c]piridina y procesos para su preparacion.
GB0420831D0 (en)	2004-09-17	2004-10-20	Glaxo Group Ltd	Novel compounds
TW200630337A (en)	2004-10-14	2006-09-01	Euro Celtique Sa	Piperidinyl compounds and the use thereof
BRPI0516435B1 (pt)	2004-10-29	2021-09-21	Kalypsys , Inc	Composto, e composição farmacêutica
EP1685841A1 (fr)	2005-01-31	2006-08-02	Bayer Health Care Aktiengesellschaft	Prevention et traitement de troubles thromboemboliques
KR101063663B1 (ko)	2005-02-17	2011-09-07	아스텔라스세이야쿠 가부시키가이샤	피리딜 비방향족 질소 함유 헤테로환-1-카르복실산에스테르유도체
US8197472B2 (en)	2005-03-25	2012-06-12	Maquet Cardiovascular, Llc	Tissue welding and cutting apparatus and method
US7918848B2 (en)	2005-03-25	2011-04-05	Maquet Cardiovascular, Llc	Tissue welding and cutting apparatus and method
EP1994019B1 (fr)	2005-04-30	2011-11-02	Boehringer Ingelheim International GmbH	Nouveaux indoles substitues par une piperidine et leur utilisation comme modulateurs ccr3
US20060281768A1 (en) *	2005-06-10	2006-12-14	Gaul Michael D	Thienopyrimidine and thienopyridine kinase modulators
ES2397418T3 (es)	2005-07-21	2013-03-06	Astrazeneca Ab	Derivados de piperidina
US7544685B2 (en)	2005-08-17	2009-06-09	H. Lundbeck A/S	2,3-dihydroindole compounds
US8143285B2 (en) *	2005-09-06	2012-03-27	Shionogi & Co., Ltd.	Indolecarboxylic acid derivative having PGD2 receptor antagonistic activity
DE102005045518A1 (de)	2005-09-23	2007-03-29	Bayer Healthcare Ag	2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
ES2625378T3 (es)	2005-09-27	2017-07-19	Shionogi & Co., Ltd.	Derivado de sulfonamida que tiene actividad antagonista del receptor de PGD2
PT1934208E (pt)	2005-10-04	2011-06-01	Bayer Schering Pharma Ag	Nova forma polimorfa de 5-cloro-n-({(5s)-2-oxo-3-[4-(3- oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2- tiofenocarboxamida
DE102005047561A1 (de)	2005-10-04	2007-04-05	Bayer Healthcare Ag	Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DK1940815T3 (en)	2005-10-25	2018-11-05	Kalypsys Inc	SALTS OF MODULATORS OF PPAR AND PROCEDURES FOR TREATMENT OF SUBSTITUTE DISEASES
WO2007080430A1 (fr) *	2006-01-16	2007-07-19	Generics [Uk] Limited	Nouveau procédé
WO2007110449A1 (fr) *	2006-03-29	2007-10-04	Euro-Celtique S.A.	Composés de benzènesulfonamide et utilisation de ceux-ci
US8791264B2 (en) *	2006-04-13	2014-07-29	Purdue Pharma L.P.	Benzenesulfonamide compounds and their use as blockers of calcium channels
WO2007118854A1 (fr) *	2006-04-13	2007-10-25	Euro-Celtique S.A.	Composés à base de benzènesulfonamide et leur utilisation
US8017612B2 (en)	2006-04-18	2011-09-13	Japan Tobacco Inc.	Piperazine compound and use thereof as a HCV polymerase inhibitor
US7629351B2 (en)	2006-07-28	2009-12-08	Bristol-Myers Squibb Company	N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-2-oxo-3-(6-(trifluoromethyl)quinazolin-4-ylamino) pyrrolidin-1-yl)cyclohexyl)acetamide and other modulators of chemokine receptor activity, crystalline forms and process
US7671062B2 (en)	2006-07-28	2010-03-02	Bristol-Myers Squibb Company	Modulators of chemokine receptor activity, crystalline forms and process
US7687508B2 (en)	2006-07-28	2010-03-30	Bristol-Myers Squibb Company	Cyclic derivatives as modulators of chemokine receptor activity
AU2007303846B2 (en) *	2006-10-04	2011-03-10	Pfizer Products Inc.	Pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as calcium receptor antagonists
JP5581055B2 (ja)	2006-10-27	2014-08-27	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ピペリジル−プロパン−チオールｃｃｒ３モジュレーター
US20080176861A1 (en)	2007-01-23	2008-07-24	Kalypsys, Inc.	Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
CN101679347B (zh) *	2007-03-20	2014-10-22	柯瑞斯公司	作为hsp90抑制剂的稠和的氨基吡啶
WO2008116107A2 (fr) *	2007-03-21	2008-09-25	Takeda San Diego, Inc.	Activateurs de glucokinase
US8399486B2 (en)	2007-04-09	2013-03-19	Purdue Pharma L.P.	Benzenesulfonyl compounds and the use thereof
EP2479173A1 (fr)	2007-04-27	2012-07-25	Purdue Pharma LP	Agents thérapeutiques utiles pour traiter la douleur
TWI362930B (en)	2007-04-27	2012-05-01	Purdue Pharma Lp	Trpv1 antagonists and uses thereof
CA2695998A1 (fr) *	2007-07-19	2009-01-22	F. Hoffmann-La Roche Ag	Nouveaux composes heterocyclyles
WO2009024823A2 (fr)	2007-08-22	2009-02-26	Astrazeneca Ab	Dérivés de cyclopropyl amide 978
WO2009040659A2 (fr) *	2007-09-28	2009-04-02	Purdue Pharma L.P.	Composés benzènesulfonamides et leurs utilisations
AU2008311727A1 (en) *	2007-10-10	2009-04-16	Takeda Pharmaceutical Company Limited	Amide compound
JP2011500767A (ja)	2007-10-26	2011-01-06	グラクソグループリミテッド	Ｐ２ｘ７モジュレータとしての４−ベンゾイル−１−置換ピペラジン−２−オン誘導体
KR100967171B1 (ko)	2007-12-26	2010-07-05	재단법인서울대학교산학협력재단	Δ5-2-옥소피페라진 유도체 및 그의 고체상 합성 방법
WO2009113600A1 (fr)	2008-03-12	2009-09-17	宇部興産株式会社	Composé d'acide pyridylaminoacétique
TW200944526A (en)	2008-04-22	2009-11-01	Vitae Pharmaceuticals Inc	Carbamate and urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
US9968396B2 (en)	2008-05-27	2018-05-15	Maquet Cardiovascular Llc	Surgical instrument and method
EP3175806B1 (fr)	2008-05-27	2018-10-17	Maquet Cardiovascular LLC	Instrument chirurgical
US9402680B2 (en)	2008-05-27	2016-08-02	Maquet Cardiovasular, Llc	Surgical instrument and method
GB0813142D0 (en)	2008-07-17	2008-08-27	Glaxo Group Ltd	Novel compounds
GB0813144D0 (en)	2008-07-17	2008-08-27	Glaxo Group Ltd	Novel compounds
US8759362B2 (en) *	2008-10-24	2014-06-24	Purdue Pharma L.P.	Bicycloheteroaryl compounds and their use as TRPV1 ligands
US8703962B2 (en) *	2008-10-24	2014-04-22	Purdue Pharma L.P.	Monocyclic compounds and their use as TRPV1 ligands
SI2373172T1 (sl)	2008-12-03	2013-12-31	Presidio Pharmaceuticals, Inc.	Inhibitorji HCV NS5A
CA2745864A1 (fr)	2008-12-23	2010-07-01	F.Hoffmann-La Roche Ag	Dihydropyridone amides en tant que modulateurs de p2x7
US8153808B2 (en)	2008-12-23	2012-04-10	Roche Palo Alto Llc	Dihydropyridone amides as P2X7 modulators
WO2010072605A1 (fr)	2008-12-23	2010-07-01	F. Hoffmann-La Roche Ag	Amides de dihydropyridone utiles comme modulateurs de p2x7
CN102264722B (zh)	2008-12-23	2014-04-02	霍夫曼-拉罗奇有限公司	作为p2x7调节剂的二氢吡啶酮酰胺
CN102264701A (zh)	2008-12-23	2011-11-30	霍夫曼-拉罗奇有限公司	作为p2x7调节剂的二氢吡啶酮脲
TW201039825A (en)	2009-02-20	2010-11-16	Astrazeneca Ab	Cyclopropyl amide derivatives 983
HUE026742T2 (en)	2009-03-30	2016-07-28	Ube Industries	A pharmaceutical composition for the treatment or prevention of glaucoma
TW201044234A (en) *	2009-06-08	2010-12-16	Chunghwa Picture Tubes Ltd	Method of scanning touch panel
US9955858B2 (en) *	2009-08-21	2018-05-01	Maquet Cardiovascular Llc	Surgical instrument and method for use
US8383812B2 (en)	2009-10-13	2013-02-26	Bristol-Myers Squibb Company	N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes
WO2011050284A1 (fr) *	2009-10-23	2011-04-28	Glaxosmithkline Llc	Agents antiviraux de pyrazolylpyridine
US8716286B2 (en)	2009-10-30	2014-05-06	Glaxo Group Limited	Crystalline forms of (3R, 6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione
MX2012009473A (es)	2010-02-18	2012-09-12	Astrazeneca Ab	Procesos para preparar derivados de ciclopropilamidas e intermedios asociados con estas.
JP5876423B2 (ja)	2010-06-22	2016-03-02	塩野義製薬株式会社	Ｔｒｐｖ１阻害活性を有する化合物とその使用
WO2012027495A1 (fr)	2010-08-27	2012-03-01	University Of The Pacific	Analogues de pipérazinylpyrimidine en tant qu'inhibiteurs de protéine kinase
CN103261205B (zh) *	2010-11-12	2015-08-19	姚雪彪	动点马达蛋白cenp-e小分子抑制剂syntelin及其应用
JP5951625B2 (ja)	2010-11-24	2016-07-13	ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨークＴｈｅＴｒｕｓｔｅｅｓＯｆＣｏｌｕｍｂｉａＵｎｉｖｅｒｓｉｔｙＩｎＴｈｅＣｉｔｙＯｆＮｅｗＹｏｒｋ	加齢性黄斑変性症およびシュタルガルト病の処置のための非レチノイドｒｂｐ４アンタゴニスト
KR101589837B1 (ko)	2011-06-22	2016-01-29	퍼듀 퍼머 엘피	디히드록시 치환기를 포함하는 trpv1 길항제 및 그의 용도
US9394293B2 (en)	2011-08-10	2016-07-19	Purdue Pharma L.P.	TRPV1 antagonists including dihydroxy substituent and uses thereof
US9333202B2 (en)	2012-05-01	2016-05-10	The Trustees Of Columbia University In The City Of New York	Non-retinoid antagonists for treatment of age-related macular degeneration and stargardt disease
EP2968303B1 (fr)	2013-03-14	2018-07-04	The Trustees of Columbia University in the City of New York	Octahydrocyclopentapyrroles, leur préparation et leur utilisation
WO2014151936A1 (fr)	2013-03-14	2014-09-25	The Trustees Of Columbia University In The City Of New York	Octahydropyrrolopyrroles, leur préparation et leur utilisation
US9938291B2 (en)	2013-03-14	2018-04-10	The Trustess Of Columbia University In The City Of New York	N-alkyl-2-phenoxyethanamines, their preparation and use
ES2705247T3 (es)	2013-03-14	2019-03-22	Univ Columbia	4-fenilpiperidinas, su preparación y uso
EP2824806B1 (fr) *	2013-07-09	2020-03-04	ABB Schweiz AG	Unité de propulsion de navire
AU2015253232B2 (en)	2014-04-30	2020-10-01	The Trustees Of Columbia University In The City Of New York	Substituted 4-phenylpiperidines, their preparation and use
CA2988572A1 (fr)	2015-06-26	2016-12-29	Takeda Pharmaceutical Company Limited	Derives de 2,3-dihydro-4 h-1,3-benzoxazin-4-one comme modulateurs du recepteur m1 muscarinique cholinergique
WO2017012502A1 (fr)	2015-07-17	2017-01-26	Sunshine Lake Pharma Co., Ltd.	Composés de quinazoline substitués, ainsi que préparation et utilisations de ceux-ci
EP3366679B1 (fr)	2015-10-20	2021-03-24	Takeda Pharmaceutical Company Limited	Composé hétérocyclique
KR20180075630A (ko)	2015-11-02	2018-07-04	얀센 파마슈티카 엔.브이.	[1,2,4]트리아졸로[1,5-a]피리미딘-7-일 화합물
CN109890824B (zh)	2016-11-02	2022-05-24	詹森药业有限公司	作为pde2抑制剂的[1,2,4]三唑并[1,5-a]嘧啶化合物
US10947242B2 (en)	2016-11-02	2021-03-16	Janssen Pharmaceutica, Nv	[1,2,4]triazolo[1,5and#8208;A]pyrimidine compounds as PDE2 inhibitors
ES2855032T3 (es)	2016-11-02	2021-09-23	Janssen Pharmaceutica Nv	Compuestos de [1,2,4]triazolo[1,5-a]pirimidina como inhibidores de PDE2
JP7145875B2 (ja)	2017-04-18	2022-10-03	武田薬品工業株式会社	アセチルコリン受容体のモジュレーターとして有用な複素環化合物
CN116606271B (zh) *	2023-07-21	2023-09-29	北京百力格生物科技有限公司	一种3,6-二氯偏苯三酸酐的合成方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2877227A (en) *		1959-03-10		Chichi
GB808046A (en) *	1955-12-13	1959-01-28	Roche Products Ltd	Novel substituted pyridone-acetic acid derivatives and process for the manufacture thereof
US3935214A (en) *	1968-07-26	1976-01-27	Donau-Pharmazie Gesellschaft M.B.H.	2-or 3 keto-3-or-2-phenyl-1,4-disubstituted piperazines
JPS49110680A (fr) *	1973-03-12	1974-10-22
JPS5793962A (en) *	1980-12-01	1982-06-11	Otsuka Pharmaceut Co Ltd	Carbostyryl derivative
IL92011A0 (en) *	1988-10-19	1990-07-12	Abbott Lab	Heterocyclic peptide renin inhibitors
US5120718A (en) *	1991-06-13	1992-06-09	Abbott Laboratories	Candida acid protease inhibiting compounds
TW394760B (en) *	1993-09-07	2000-06-21	Hoffmann La Roche	Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
IL115420A0 (en) *	1994-09-26	1995-12-31	Zeneca Ltd	Aminoheterocyclic derivatives
WO1996016947A1 (fr)	1994-12-01	1996-06-06	Toyama Chemical Co., Ltd.	Nouveau derive de 2,3-dicetopiperazine ou sel de celui-ci
GB9508622D0 (en)	1995-04-28	1995-06-14	Pfizer Ltd	Therapeutic agants
US5612353A (en) *	1995-06-07	1997-03-18	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
GB9516709D0 (en)	1995-08-15	1995-10-18	Zeneca Ltd	Medicament
GB9602166D0 (en)	1996-02-02	1996-04-03	Zeneca Ltd	Aminoheterocyclic derivatives
GB9602294D0 (en)	1996-02-05	1996-04-03	Zeneca Ltd	Heterocyclic compounds
JP2000508631A (ja) *	1996-04-03	2000-07-11	メルクエンドカンパニーインコーポレーテッド	ファルネシルタンパク質トランスフェラーゼの阻害剤
AU2733997A (en) *	1996-04-17	1997-11-07	Du Pont Pharmaceuticals Company	N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors
JP2000516602A (ja)	1996-08-14	2000-12-12	ゼネカ・リミテッド	置換ピリミジン誘導体および薬剤としてのそれらの使用
AU4172397A (en) *	1996-09-06	1998-03-26	Biochem Pharma Inc.	Lactam inhibitors of thrombin
UA56197C2 (uk)	1996-11-08	2003-05-15	Зенека Лімітед	Гетероциклічні похідні
CA2285335A1 (fr) *	1997-04-14	1998-10-22	Cor Therapeutics, Inc.	Inhibiteurs selectifs du facteur xa
WO1998046627A1 (fr) *	1997-04-14	1998-10-22	Cor Therapeutics, Inc.	INHIBITEURS SELECTIFS DU FACTEUR Xa
NZ500353A (en) *	1997-04-14	2002-02-01	Cor Therapeutics Inc	Cyclic diaza compounds that are selective inhibitors of factor Xa
EP0975659A1 (fr)	1997-04-14	2000-02-02	Cor Therapeutics, Inc.	INHIBITEURS SELECTIFS DU FACTEUR Xa
ATE334975T1 (de)	1997-05-30	2006-08-15	Takeda Pharmaceutical	Sulfonamidderivate, ihre herstellung und verwendung
GB9715895D0 (en)	1997-07-29	1997-10-01	Zeneca Ltd	Heterocyclic compounds
GB9715894D0 (en)	1997-07-29	1997-10-01	Zeneca Ltd	Heterocyclic derivatives
GB9715892D0 (en) *	1997-07-29	1997-10-01	Zeneca Ltd	Heterocyclic compounds
ID23991A (id)	1997-09-30	2000-06-14	Daiichi Seiyaku Co	Turunan-turunan sulfonil
WO1999033805A1 (fr) *	1997-12-26	1999-07-08	Mochida Pharmaceutical Co., Ltd.	Composes aromatiques presentant des groupements amino cycliques ou leur sels
JP2000204081A (ja) *	1998-02-05	2000-07-25	Takeda Chem Ind Ltd	スルホンアミド誘導体、その製造法及び用途
CA2317017A1 (fr) *	1998-02-05	1999-08-12	Takeda Chemical Industries, Ltd.	Derives de sulfamide, leur procede de production et leur utilisation
WO1999046267A1 (fr) *	1998-03-12	1999-09-16	Novo Nordisk A/S	Modulateurs de proteine tyrosine phosphatases (ptpases)
DE19835950A1 (de) *	1998-08-08	2000-02-10	Merck Patent Gmbh	Piperazinonderivate

1999
- 1999-01-27 BR BR9907300-5A patent/BR9907300A/pt not_active IP Right Cessation
- 1999-01-27 DE DE69934093T patent/DE69934093T2/de not_active Expired - Lifetime
- 1999-01-27 HU HU0101810A patent/HUP0101810A3/hu unknown
- 1999-01-27 EA EA200000768A patent/EA200000768A1/ru unknown
- 1999-01-27 JP JP2000528286A patent/JP4676613B2/ja not_active Expired - Fee Related
- 1999-01-27 CN CN99803501A patent/CN1291892A/zh active Pending
- 1999-01-27 UA UA2000085034A patent/UA59433C2/uk unknown
- 1999-01-27 WO PCT/US1999/001682 patent/WO1999037304A1/fr not_active Ceased
- 1999-01-27 TR TR2000/02182T patent/TR200002182T2/xx unknown
- 1999-01-27 EE EEP200000435A patent/EE200000435A/xx unknown
- 1999-01-27 ZA ZA9900607A patent/ZA99607B/xx unknown
- 1999-01-27 SK SK1108-2000A patent/SK11082000A3/sk unknown
- 1999-01-27 KR KR1020007008221A patent/KR20010034442A/ko not_active Withdrawn
- 1999-01-27 AT AT99906684T patent/ATE346050T1/de not_active IP Right Cessation
- 1999-01-27 IL IL13751799A patent/IL137517A0/xx active IP Right Grant
- 1999-01-27 YU YU47600A patent/YU47600A/sh unknown
- 1999-01-27 CA CA2319198A patent/CA2319198C/fr not_active Expired - Fee Related
- 1999-01-27 PL PL99342243A patent/PL342243A1/xx not_active Application Discontinuation
- 1999-01-27 AU AU26533/99A patent/AU745425B2/en not_active Ceased
- 1999-01-27 AP APAP/P/2000/001889A patent/AP2000001889A0/en unknown
- 1999-01-27 EP EP99906684A patent/EP1051176B1/fr not_active Expired - Lifetime
2000
- 2000-07-25 NO NO20003808A patent/NO20003808L/no not_active Application Discontinuation
- 2000-07-25 IS IS5574A patent/IS5574A/is unknown
- 2000-07-25 BG BG104633A patent/BG104633A/bg unknown
- 2000-07-25 IL IL137517A patent/IL137517A/en not_active IP Right Cessation
2003
- 2003-07-25 US US10/628,093 patent/US7612075B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69934093D1 (de)	2007-01-04
EA200000768A1 (ru)	2001-06-25
EP1051176A4 (fr)	2002-06-12
IL137517A0 (en)	2001-07-24
AU745425B2 (en)	2002-03-21
IL137517A (en)	2006-12-10
CN1291892A (zh)	2001-04-18
CA2319198C (fr)	2011-02-22
ZA99607B (en)	1999-07-27
UA59433C2 (uk)	2003-09-15
US20040102450A1 (en)	2004-05-27
NO20003808D0 (no)	2000-07-25
IS5574A (is)	2000-07-25
BG104633A (bg)	2001-03-30
HUP0101810A2 (hu)	2002-04-29
EP1051176B1 (fr)	2006-11-22
EP1051176A1 (fr)	2000-11-15
JP2002501024A (ja)	2002-01-15
US7612075B2 (en)	2009-11-03
AP2000001889A0 (en)	2000-09-30
YU47600A (sh)	2002-09-19
TR200002182T2 (tr)	2000-12-21
KR20010034442A (ko)	2001-04-25
PL342243A1 (en)	2001-06-04
AU2653399A (en)	1999-08-09
BR9907300A (pt)	2000-10-24
CA2319198A1 (fr)	1999-07-29
DE69934093T2 (de)	2007-06-21
HUP0101810A3 (en)	2002-05-28
NO20003808L (no)	2000-09-26
WO1999037304A1 (fr)	1999-07-29
ATE346050T1 (de)	2006-12-15
JP4676613B2 (ja)	2011-04-27
EE200000435A (et)	2002-02-15

Publication	Publication Date	Title
SK11082000A3 (sk)	2001-01-18	Substituované oxoazaheterocyklické inhibítory faktora xa, farmaceutický prostriedok s ich obsahom a ich použitie
AU773227B2 (en)	2004-05-20	Substituted oxoazaheterocyclyl compounds
US6281227B1 (en)	2001-08-28	Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
JP2003529531A (ja)	2003-10-07	置換オキソアザへテロシクリルＸａ因子阻害剤
EP0944386B1 (fr)	2002-09-18	Composes a base d'acide sulfonique ou de sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide
US6602864B1 (en)	2003-08-05	Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
SI9720019A (sl)	1999-02-28	Spojine substituirani N-/(aminoiminometil) fenilalkil/-azaheterociklamidi sulfonskih kislin
CZ20002728A3 (cs)	2000-11-15	Substituované oxoazaheterocyklylové inhibitory faktoru Xa, způsob jejich přípravy a farmaceutický prostředek, který je obsahuje
MXPA00007250A (en)	2002-03-05	SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
CZ20004497A3 (en)	2001-06-13	Sulfonyl- or sulfonylamino-N-(heteroaralkyl)azaheterocyclylamide derivatives and pharmaceutical preparation containing thereof